data_2djc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2djc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.471 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.971 0.415 . . . . 1.05 112.02 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -63.96 -15.75 59.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.654 -0.703 . . . . 2.2799999999999998 112.267 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.98 1.91 30.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.644 -0.788 . . . . 0.54000000000000004 111.411 173.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.471 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 4.4 m-85 -117.69 -178.72 3.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.094 0.473 . . . . 0.97999999999999998 110.111 -175.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -160.78 158.55 28.73 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.613 -0.884 . . . . 2.54 108.613 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.541 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 15.8 ptt180 -88.32 126.5 35.22 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 108.688 -0.856 . . . . 3.8300000000000001 108.688 174.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.4 p -79.48 -166.63 1.0 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.19 -0.914 . . . . 1.3500000000000001 110.348 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.95 -22.95 67.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.067 0.461 . . . . 1.1899999999999999 110.727 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -108.22 10.01 27.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.008 -0.542 . . . . 2.4500000000000002 111.398 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 77.69 19.35 75.94 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.499 -0.858 . . . . 0.46999999999999997 112.482 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.436 ' HE ' ' HB2' ' A' ' 18' ' ' ARG . 13.9 ttm180 -82.56 139.35 33.88 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.837 -0.431 . . . . 4.2300000000000004 109.837 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.1 m -83.89 99.63 10.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.23 0.538 . . . . 0.37 110.505 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -113.73 136.74 22.05 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.816 -0.629 . . . . 3.1400000000000001 109.836 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.21 138.13 83.08 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.043 1.829 . . . . 0.56999999999999995 110.374 171.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--N 1.323 -0.556 0 N-CA-C 113.445 0.906 . . . . 1.3899999999999999 113.445 -168.756 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.634 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.759 0.314 . . . . 1.05 111.375 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.2 m -59.53 -33.56 71.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.908 -0.587 . . . . 2.2799999999999998 110.993 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.49 29.61 5.4 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.863 -0.684 . . . . 0.54000000000000004 111.886 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.634 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 51.2 m-85 -133.44 172.17 13.07 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.98 -0.378 . . . . 0.97999999999999998 109.98 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 4.7 pt20 -151.44 160.04 43.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.124 -0.489 . . . . 2.54 110.778 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.604 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 52.6 mtm180 -91.27 115.98 28.46 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.736 -0.468 . . . . 3.8300000000000001 109.736 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 15' ' ' ALA . 36.7 p -84.91 -154.13 0.18 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.737 -0.665 . . . . 1.3500000000000001 110.671 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.404 ' H ' ' HB ' ' A' ' 14' ' ' THR . . . -50.51 -54.41 22.51 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.234 0.334 . . . . 1.1899999999999999 111.805 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -93.93 20.87 7.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.936 0.398 . . . . 2.4500000000000002 110.829 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.604 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 66.59 26.03 72.85 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.433 -0.889 . . . . 0.46999999999999997 111.63 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -78.78 134.31 37.02 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.105 -0.702 . . . . 4.2300000000000004 109.105 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 77.2 m -78.76 101.46 7.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.331 0.586 . . . . 0.37 111.519 -173.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -102.88 138.1 19.48 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.053 -0.976 . . . . 3.1400000000000001 110.104 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.76 141.92 92.1 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.264 1.976 . . . . 0.56999999999999995 111.131 175.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 C--N 1.32 -0.684 0 CA-C-O 120.936 0.398 . . . . 1.3899999999999999 111.862 -173.696 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.637 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 120.601 0.239 . . . . 1.05 111.246 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.0 m -61.49 -29.65 70.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 2.2799999999999998 110.879 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.81 17.72 8.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.125 -0.56 . . . . 0.54000000000000004 112.25 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.637 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 17.7 m-85 -127.03 156.96 40.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.042 -0.355 . . . . 0.97999999999999998 110.042 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -146.23 172.52 13.33 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 110.209 -0.293 . . . . 2.54 110.209 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -88.97 133.28 34.37 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.248 -0.649 . . . . 3.8300000000000001 109.248 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 18' ' ' ARG . 82.1 p -79.59 -173.32 3.71 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.063 -0.971 . . . . 1.3500000000000001 110.066 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.33 -11.52 57.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.463 0.649 . . . . 1.1899999999999999 110.167 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.668 ' OD2' ' HD3' ' A' ' 18' ' ' ARG . 10.3 p-10 -117.98 18.32 13.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.664 -0.698 . . . . 2.4500000000000002 111.706 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.66 23.83 76.53 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.891 -0.671 . . . . 0.46999999999999997 113.776 170.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.668 ' HD3' ' OD2' ' A' ' 16' ' ' ASP . 31.3 mtp180 -104.72 147.1 28.05 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 117.079 0.439 . . . . 4.2300000000000004 110.016 176.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.6 m -81.81 111.24 17.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.363 0.601 . . . . 0.37 111.35 -173.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 56.0 tttp -113.05 137.2 21.83 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.391 -0.822 . . . . 3.1400000000000001 109.091 176.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.446 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 8.5 Cg_exo -70.02 141.73 44.94 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.433 2.088 . . . . 0.56999999999999995 111.145 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 p . . . . . 0 C--N 1.323 -0.582 0 CA-C-O 120.901 0.381 . . . . 1.3899999999999999 111.753 -175.821 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.684 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.457 -0.113 0 N-CA-C 110.443 -0.206 . . . . 1.05 110.443 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.3 m -56.09 -41.25 74.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.177 0.513 . . . . 2.2799999999999998 110.858 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -113.63 31.17 6.75 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.805 -0.712 . . . . 0.54000000000000004 112.167 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.684 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 60.8 m-85 -138.13 158.14 44.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.25 0.547 . . . . 0.97999999999999998 110.57 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.447 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 27.3 tt0 -146.17 155.77 42.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.631 -0.713 . . . . 2.54 109.886 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.613 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 83.2 mtm180 -87.05 120.2 28.06 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.438 -0.578 . . . . 3.8300000000000001 109.438 176.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.1 p -79.59 -162.32 0.41 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.988 -1.005 . . . . 1.3500000000000001 110.59 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.89 -18.43 62.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.78 0.324 . . . . 1.1899999999999999 111.282 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.5 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 4.0 m-20 -105.11 2.89 29.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.312 -0.404 . . . . 2.4500000000000002 110.854 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.613 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 74.89 12.25 83.24 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 119.98 -1.105 . . . . 0.46999999999999997 111.333 -173.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.5 ' HG3' ' HB2' ' A' ' 16' ' ' ASP . 54.0 mtm180 -79.57 137.22 37.08 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.367 -0.605 . . . . 4.2300000000000004 109.367 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 72.4 m -79.61 103.1 9.29 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.921 -0.581 . . . . 0.37 111.244 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -104.5 139.53 20.19 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.587 -0.733 . . . . 3.1400000000000001 109.728 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 36.9 Cg_exo -57.08 136.31 75.85 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.626 2.218 . . . . 0.56999999999999995 112.065 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 1.3899999999999999 111.084 179.477 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.704 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 110.378 -0.23 . . . . 1.05 110.378 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 m -63.91 -23.19 67.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.224 0.535 . . . . 2.2799999999999998 110.582 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.08 24.44 5.38 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.836 -0.62 . . . . 0.54000000000000004 111.637 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.704 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 40.4 m-85 -135.11 155.86 50.0 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.159 0.504 . . . . 0.97999999999999998 110.181 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -138.76 156.75 47.11 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.89 -0.595 . . . . 2.54 110.077 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.546 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 65.1 mtp180 -88.76 122.77 32.52 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.277 -0.638 . . . . 3.8300000000000001 109.277 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.2 p -79.87 -168.74 1.71 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.674 -0.693 . . . . 1.3500000000000001 110.046 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.3 -19.73 48.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.105 0.479 . . . . 1.1899999999999999 111.272 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -111.99 10.94 20.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.43 0.633 . . . . 2.4500000000000002 110.621 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 71.01 15.51 74.27 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.62 -0.718 . . . . 0.46999999999999997 112.868 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -79.68 139.59 37.33 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.009 -0.737 . . . . 4.2300000000000004 109.009 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.9 98.47 7.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.524 0.678 . . . . 0.37 111.351 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -101.99 133.55 20.62 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.154 -0.93 . . . . 3.1400000000000001 109.615 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.97 138.04 65.78 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.325 2.017 . . . . 0.56999999999999995 112.314 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 116.402 -0.363 . . . . 1.3899999999999999 110.877 178.593 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.65 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 121.03 0.443 . . . . 1.05 111.633 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 p -69.93 -14.96 62.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.617 -0.719 . . . . 2.2799999999999998 111.071 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.37 21.29 5.16 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.934 -0.866 . . . . 0.54000000000000004 110.934 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.65 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 51.0 m-85 -136.66 153.1 51.0 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.336 0.589 . . . . 0.97999999999999998 110.49 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -136.15 160.13 39.6 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.444 -0.798 . . . . 2.54 109.852 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.416 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 25.7 ptt180 -87.11 129.7 34.82 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.739 -0.837 . . . . 3.8300000000000001 108.739 175.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.2 p -81.07 -170.3 2.65 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.872 -0.604 . . . . 1.3500000000000001 109.541 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.29 -17.75 62.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.307 0.575 . . . . 1.1899999999999999 110.723 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -113.69 14.72 18.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.444 -0.798 . . . . 2.4500000000000002 111.531 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 69.34 24.87 75.9 Favored Glycine 0 C--O 1.235 0.187 0 C-N-CA 121.277 -0.487 . . . . 0.46999999999999997 113.161 174.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -91.03 143.33 26.82 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.163 -0.68 . . . . 4.2300000000000004 109.163 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.69 100.12 7.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.265 0.555 . . . . 0.37 110.913 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -97.72 134.31 22.53 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.269 -0.878 . . . . 3.1400000000000001 110.305 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -66.3 141.6 63.07 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.03 1.82 . . . . 0.56999999999999995 110.205 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.3 p . . . . . 0 C--N 1.319 -0.723 0 CA-C-O 121.065 0.459 . . . . 1.3899999999999999 112.118 -172.498 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 121.055 0.455 . . . . 1.05 112.147 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -69.08 -38.85 79.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.138 0.494 . . . . 2.2799999999999998 110.297 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.56 -3.18 86.39 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.563 -0.615 . . . . 0.54000000000000004 111.563 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.431 ' HB2' ' HB2' ' A' ' 8' ' ' ALA . 10.0 m-85 -117.43 178.77 4.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.898 -0.408 . . . . 0.97999999999999998 109.898 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.519 HE21 HG21 ' A' ' 22' ' ' THR . 4.0 pt20 -159.24 179.09 9.31 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.594 -0.521 . . . . 2.54 109.594 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.525 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 39.1 ptt180 -88.37 133.68 34.03 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.378 0.609 . . . . 3.8300000000000001 110.61 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.6 p -81.72 -167.02 1.35 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.366 -0.834 . . . . 1.3500000000000001 109.57 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.61 69.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.955 0.354 . . . . 1.1899999999999999 111.955 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -105.17 6.09 32.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.374 -0.376 . . . . 2.4500000000000002 111.494 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.525 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 83.48 41.34 8.44 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.354 -0.927 . . . . 0.46999999999999997 112.779 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -99.17 178.36 4.94 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.832 -1.173 . . . . 4.2300000000000004 107.832 172.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.1 m -103.92 123.88 47.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.986 0.422 . . . . 0.37 111.671 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -139.8 143.72 35.92 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.771 -0.65 . . . . 3.1400000000000001 109.401 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.44 147.3 22.75 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.877 2.384 . . . . 0.56999999999999995 112.329 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.519 HG21 HE21 ' A' ' 12' ' ' GLN . 43.6 p . . . . . 0 C--N 1.32 -0.701 0 N-CA-C 112.568 0.581 . . . . 1.3899999999999999 112.568 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.649 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 120.601 0.238 . . . . 1.05 111.109 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -66.14 -25.24 66.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.855 0.36 . . . . 2.2799999999999998 110.505 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -121.53 21.76 7.98 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.151 -0.547 . . . . 0.54000000000000004 112.136 175.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.649 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 54.6 m-85 -134.71 149.88 50.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.995 0.426 . . . . 0.97999999999999998 110.385 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -131.85 154.23 49.38 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.92 -0.582 . . . . 2.54 109.437 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.609 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 11.2 ptm180 -87.89 147.04 25.27 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.487 0.661 . . . . 3.8300000000000001 109.733 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 p -99.76 -164.53 1.13 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.705 -1.134 . . . . 1.3500000000000001 109.473 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.98 -34.7 63.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.007 0.432 . . . . 1.1899999999999999 111.187 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.37 -3.76 57.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.971 -0.559 . . . . 2.4500000000000002 111.609 -175.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.609 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 82.21 6.42 88.8 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.105 -1.045 . . . . 0.46999999999999997 110.635 -174.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -79.21 133.03 36.7 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.617 -0.512 . . . . 4.2300000000000004 109.617 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.27 127.35 32.26 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.097 -0.502 . . . . 0.37 112.24 -171.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 63.3 mttp -123.3 142.09 37.71 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.658 -0.701 . . . . 3.1400000000000001 109.165 170.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 13.0 Cg_exo -68.3 144.19 61.3 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.081 2.521 . . . . 0.56999999999999995 112.011 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.2 p . . . . . 0 C--N 1.318 -0.779 0 CA-C-N 115.984 -0.553 . . . . 1.3899999999999999 111.163 179.726 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.7 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 109.56 -0.533 . . . . 1.05 109.56 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 m -61.01 -37.24 81.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.038 0.447 . . . . 2.2799999999999998 110.965 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.78 29.03 7.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.719 -0.753 . . . . 0.54000000000000004 112.078 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.7 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 27.5 m-85 -133.64 163.65 28.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.034 0.445 . . . . 0.97999999999999998 110.698 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -153.32 175.88 12.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.969 -0.56 . . . . 2.54 109.881 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -88.66 139.17 30.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.256 0.551 . . . . 3.8300000000000001 110.645 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.2 p -83.0 -173.37 4.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.203 -0.908 . . . . 1.3500000000000001 108.792 172.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.76 -4.83 21.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.008 0.432 . . . . 1.1899999999999999 110.724 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.428 ' OD2' ' HD3' ' A' ' 18' ' ' ARG . 22.2 t70 -108.4 6.81 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.872 -0.604 . . . . 2.4500000000000002 110.476 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.47 4.37 84.39 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.832 -0.622 . . . . 0.46999999999999997 113.051 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.428 ' HD3' ' OD2' ' A' ' 16' ' ' ASP . 36.0 mtp180 -96.49 159.54 14.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.682 0.277 . . . . 4.2300000000000004 110.668 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.2 m -88.54 122.32 31.87 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.579 0.704 . . . . 0.37 112.7 -168.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -121.68 139.72 30.5 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 114.991 -1.004 . . . . 3.1400000000000001 110.257 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -58.27 148.22 80.18 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.397 2.065 . . . . 0.56999999999999995 111.19 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 C--N 1.32 -0.71 0 CA-C-O 121.208 0.528 . . . . 1.3899999999999999 111.849 -174.66 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.639 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.392 0.139 . . . . 1.05 110.686 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -22.95 62.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.28 0.562 . . . . 2.2799999999999998 110.801 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.73 16.74 25.87 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.235 -0.746 . . . . 0.54000000000000004 111.235 175.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.639 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 64.7 m-85 -136.16 173.29 11.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.43 0.633 . . . . 0.97999999999999998 110.982 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 9.8 pt20 -148.46 171.96 15.24 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.874 -0.787 . . . . 2.54 108.874 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.542 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 11.0 ptp180 -104.46 139.04 39.96 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.608 0.718 . . . . 3.8300000000000001 110.408 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.0 p -79.39 -172.45 3.22 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.702 -1.135 . . . . 1.3500000000000001 109.167 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.03 -31.59 67.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.131 0.491 . . . . 1.1899999999999999 110.789 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.36 -14.28 20.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.126 -0.488 . . . . 2.4500000000000002 111.937 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 105.52 18.3 12.08 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 119.729 -1.224 . . . . 0.46999999999999997 113.364 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -80.02 141.34 36.01 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.159 -0.682 . . . . 4.2300000000000004 109.159 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 64.1 m -82.02 109.68 16.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.244 0.545 . . . . 0.37 111.727 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 17.5 tptp -110.28 136.76 20.51 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.54 -0.755 . . . . 3.1400000000000001 109.339 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.68 141.93 74.12 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.72 2.28 . . . . 0.56999999999999995 112.34 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.985 0.421 . . . . 1.3899999999999999 110.87 178.693 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.677 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 120.696 0.284 . . . . 1.05 110.747 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -62.69 -29.06 70.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.998 -0.546 . . . . 2.2799999999999998 110.714 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.41 30.27 4.77 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.671 -0.695 . . . . 0.54000000000000004 111.875 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.677 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 37.6 m-85 -136.34 161.14 36.63 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.307 0.575 . . . . 0.97999999999999998 111.0 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -143.54 163.98 31.66 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.765 -0.652 . . . . 2.54 109.945 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.2 mtm180 -89.73 127.82 36.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.139 0.495 . . . . 3.8300000000000001 109.999 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.3 p -80.51 -176.52 5.76 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.386 -0.825 . . . . 1.3500000000000001 109.12 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.77 47.77 0.26 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.229 0.538 . . . . 1.1899999999999999 111.25 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -161.04 -35.8 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.521 -0.763 . . . . 2.4500000000000002 110.828 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.36 -0.39 23.67 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.416 -0.897 . . . . 0.46999999999999997 110.945 -171.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -78.12 133.85 37.78 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.395 -0.594 . . . . 4.2300000000000004 109.395 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.1 m -86.2 126.46 34.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.265 -0.425 . . . . 0.37 111.223 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.505 ' HG3' ' HD2' ' A' ' 21' ' ' PRO . 36.0 ttmt -124.19 140.49 35.04 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.858 -0.61 . . . . 3.1400000000000001 109.474 176.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.505 ' HD2' ' HG3' ' A' ' 20' ' ' LYS . 44.6 Cg_exo -55.12 145.11 66.43 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.047 2.498 . . . . 0.56999999999999995 112.013 177.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.9 p . . . . . 0 C--N 1.318 -0.803 0 CA-C-N 116.075 -0.511 . . . . 1.3899999999999999 111.714 -177.181 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.53 ' HB1' ' HD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 C--O 1.228 -0.06 0 N-CA-C 112.367 0.506 . . . . 1.05 112.367 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -31.82 71.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.727 -0.669 . . . . 2.2799999999999998 110.802 175.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.45 10.76 73.98 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.965 -0.636 . . . . 0.54000000000000004 111.725 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.53 ' HD1' ' HB1' ' A' ' 8' ' ' ALA . 47.5 m-85 -130.83 -179.87 5.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.002 0.429 . . . . 0.97999999999999998 110.057 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -157.93 171.19 20.71 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.939 -0.763 . . . . 2.54 108.939 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.508 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.2 ptp180 -89.07 138.24 31.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.1 0.476 . . . . 3.8300000000000001 110.664 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.6 p -87.65 -167.77 2.0 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.615 -0.72 . . . . 1.3500000000000001 109.394 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.15 -31.58 70.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.89 0.376 . . . . 1.1899999999999999 110.874 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -107.4 19.98 19.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.889 0.852 . . . . 2.4500000000000002 110.384 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.508 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 69.44 25.89 75.06 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.321 -0.854 . . . . 0.46999999999999997 113.297 175.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 16.0 mmt180 -87.77 169.01 12.46 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.644 -0.873 . . . . 4.2300000000000004 108.644 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.1 m -98.16 113.46 25.37 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.162 0.506 . . . . 0.37 111.886 -174.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -111.15 136.53 20.86 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.345 -0.843 . . . . 3.1400000000000001 109.73 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.24 134.44 48.87 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.646 2.231 . . . . 0.56999999999999995 112.209 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.552 -0.295 . . . . 1.3899999999999999 110.871 179.733 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.631 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 109.874 -0.417 . . . . 1.05 109.874 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 m -61.5 -36.39 80.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.044 0.45 . . . . 2.2799999999999998 110.848 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.16 25.1 14.59 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.943 -0.646 . . . . 0.54000000000000004 111.798 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.631 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 43.9 m-85 -134.62 166.27 23.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.251 0.548 . . . . 0.97999999999999998 110.674 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -158.74 146.83 18.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.19 -0.671 . . . . 2.54 109.19 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 17.3 ptp180 -87.85 125.59 34.55 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.595 0.712 . . . . 3.8300000000000001 109.517 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.1 p -80.63 -164.51 0.72 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.447 -1.251 . . . . 1.3500000000000001 110.186 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.77 -11.88 41.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.032 0.444 . . . . 1.1899999999999999 111.032 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.415 ' HB3' ' HG2' ' A' ' 18' ' ' ARG . 8.0 t70 -102.47 1.35 35.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.318 0.58 . . . . 2.4500000000000002 111.078 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 74.54 13.41 81.89 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.934 -0.651 . . . . 0.46999999999999997 112.045 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 13.9 mmt180 -93.11 137.61 32.3 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.015 -0.365 . . . . 4.2300000000000004 110.015 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.3 m -79.45 98.07 6.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.922 -0.581 . . . . 0.37 110.494 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -98.19 139.04 20.97 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.447 -0.797 . . . . 3.1400000000000001 109.122 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.32 121.5 9.72 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.42 2.08 . . . . 0.56999999999999995 111.33 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 121.124 0.488 . . . . 1.3899999999999999 111.072 -179.39 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.666 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 110.342 -0.244 . . . . 1.05 110.342 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -71.93 -7.36 48.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.14 0.495 . . . . 2.2799999999999998 111.029 177.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.94 22.31 3.29 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.753 -0.939 . . . . 0.54000000000000004 110.753 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.666 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 18.2 m-85 -134.27 155.92 49.35 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.984 -0.376 . . . . 0.97999999999999998 109.984 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -144.77 155.46 43.54 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.55 -0.537 . . . . 2.54 109.55 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.621 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 99.5 mtt180 -88.67 120.34 29.97 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.466 0.651 . . . . 3.8300000000000001 109.655 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.461 HG23 ' HD2' ' A' ' 20' ' ' LYS . 58.9 p -80.43 -163.3 0.55 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.493 -1.231 . . . . 1.3500000000000001 110.606 -177.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.81 -27.48 59.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.896 0.332 . . . . 1.1899999999999999 111.896 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.17 1.59 45.07 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.601 -0.272 . . . . 2.4500000000000002 111.469 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 79.89 12.64 83.23 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.186 -1.007 . . . . 0.46999999999999997 111.526 -175.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -84.87 142.77 29.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.546 -0.327 . . . . 4.2300000000000004 110.5 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.1 m -82.89 104.01 12.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.186 -0.461 . . . . 0.37 111.573 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.461 ' HD2' HG23 ' A' ' 14' ' ' THR . 87.4 mttt -108.24 146.1 32.87 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.021 -0.536 . . . . 3.1400000000000001 109.837 172.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 4.9 Cg_exo -72.93 129.14 13.93 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.38 2.054 . . . . 0.56999999999999995 112.206 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 116.095 -0.502 . . . . 1.3899999999999999 110.502 176.885 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.656 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 110.147 -0.316 . . . . 1.05 110.147 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -65.31 -25.7 67.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.113 0.482 . . . . 2.2799999999999998 110.386 174.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.08 24.92 8.58 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.078 -0.582 . . . . 0.54000000000000004 111.756 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.656 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 39.7 m-85 -141.21 160.26 40.49 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.045 0.45 . . . . 0.97999999999999998 110.913 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -144.67 171.64 14.11 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.86 -0.609 . . . . 2.54 109.815 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -89.08 142.17 27.87 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.252 0.549 . . . . 3.8300000000000001 110.687 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 p -90.08 -175.78 4.67 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.616 -0.883 . . . . 1.3500000000000001 108.616 171.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.35 -14.99 31.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.004 0.43 . . . . 1.1899999999999999 110.911 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -107.97 10.54 28.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.028 -0.533 . . . . 2.4500000000000002 111.246 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.49 5.76 74.07 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.038 -0.601 . . . . 0.46999999999999997 113.206 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -80.05 150.92 30.17 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.524 -0.547 . . . . 4.2300000000000004 109.524 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.2 m -86.17 110.22 19.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.478 0.656 . . . . 0.37 111.09 -174.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 46.9 tttp -101.5 136.89 19.52 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.075 -0.966 . . . . 3.1400000000000001 109.37 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 24.4 Cg_exo -62.76 140.08 78.43 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.292 1.995 . . . . 0.56999999999999995 111.995 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.6 p . . . . . 0 C--N 1.326 -0.443 0 CA-C-O 120.7 0.286 . . . . 1.3899999999999999 110.875 179.142 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.142 0 N-CA-C 112.192 0.442 . . . . 1.05 112.192 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.7 m -66.27 -36.96 84.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.954 -0.566 . . . . 2.2799999999999998 110.861 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.03 6.04 84.06 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.128 -0.558 . . . . 0.54000000000000004 111.872 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -123.83 -179.44 4.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.008 -0.738 . . . . 0.97999999999999998 109.008 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -161.26 170.35 20.4 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.916 -0.402 . . . . 2.54 109.916 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 76.1 mtm180 -88.43 123.7 33.23 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.224 0.535 . . . . 3.8300000000000001 109.702 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.464 ' C ' ' H ' ' A' ' 16' ' ' ASP . 70.7 p -80.88 -167.7 1.5 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.116 -0.947 . . . . 1.3500000000000001 110.614 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.69 41.37 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.009 0.433 . . . . 1.1899999999999999 111.651 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 14' ' ' THR . 19.4 t70 -160.55 -31.75 0.06 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.708 -0.678 . . . . 2.4500000000000002 109.662 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.33 -0.64 20.66 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.576 -0.821 . . . . 0.46999999999999997 112.004 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.461 ' HG3' ' OD2' ' A' ' 16' ' ' ASP . 74.4 mtp180 -79.16 164.36 24.29 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.058 -0.349 . . . . 4.2300000000000004 110.058 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.3 m -104.7 110.83 23.32 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.861 -0.609 . . . . 0.37 111.465 -172.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 30.4 mtpp -121.66 146.69 46.2 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.861 -0.609 . . . . 3.1400000000000001 109.958 174.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 23.5 Cg_exo -63.49 148.26 92.66 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.909 2.406 . . . . 0.56999999999999995 111.97 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.3 p . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.956 -0.565 . . . . 1.3899999999999999 110.756 179.228 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.68 ' HB1' ' CD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 112.886 0.698 . . . . 1.05 112.886 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -65.1 -33.97 77.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.545 -0.752 . . . . 2.2799999999999998 111.05 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.34 6.65 80.86 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.936 -0.649 . . . . 0.54000000000000004 111.552 176.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.68 ' CD1' ' HB1' ' A' ' 8' ' ' ALA . 30.9 m-85 -123.09 178.18 5.2 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.653 -0.499 . . . . 0.97999999999999998 109.653 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -161.1 170.92 19.5 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.094 -0.706 . . . . 2.54 109.094 171.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.557 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.3 ptp180 -88.5 137.63 32.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.303 0.573 . . . . 3.8300000000000001 110.922 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.3 p -86.54 -165.32 1.24 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.031 -0.986 . . . . 1.3500000000000001 109.845 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.01 -18.62 65.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.644 0.259 . . . . 1.1899999999999999 111.406 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -109.54 -6.6 15.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.614 0.721 . . . . 2.4500000000000002 110.594 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.557 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 91.24 20.1 39.82 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.168 -1.015 . . . . 0.46999999999999997 111.92 -177.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -79.23 155.69 28.47 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.88 -0.785 . . . . 4.2300000000000004 108.88 175.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -91.04 99.95 12.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.494 0.664 . . . . 0.37 111.708 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -96.92 127.95 37.25 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.01 -0.995 . . . . 3.1400000000000001 109.71 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.92 147.19 96.25 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.653 2.235 . . . . 0.56999999999999995 111.75 176.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.205 -0.452 . . . . 1.3899999999999999 110.865 179.328 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.564 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 120.77 0.319 . . . . 1.05 111.511 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 m -75.67 76.1 2.66 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.342 -0.984 . . . . 2.2799999999999998 108.342 168.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.87 -16.95 1.78 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.798 -1.092 . . . . 0.54000000000000004 110.885 -171.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.564 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 82.2 m-85 -120.12 170.45 9.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.409 0.623 . . . . 0.97999999999999998 110.019 174.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 29.6 pt20 -144.38 174.89 10.52 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.523 -0.762 . . . . 2.54 109.297 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 13' ' ' ARG . 11.4 ptp180 -89.54 143.12 27.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.99 0.424 . . . . 3.8300000000000001 110.997 -175.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.444 HG21 ' O ' ' A' ' 18' ' ' ARG . 58.2 p -90.8 -171.65 3.1 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.731 -0.84 . . . . 1.3500000000000001 108.731 171.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.48 -16.36 60.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.921 0.391 . . . . 1.1899999999999999 111.147 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -109.83 -23.29 11.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.019 -0.537 . . . . 2.4500000000000002 111.282 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.2 15.79 8.17 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.138 -1.029 . . . . 0.46999999999999997 112.892 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.444 ' O ' HG21 ' A' ' 14' ' ' THR . 33.6 ttm180 -78.57 155.87 29.45 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.982 -0.747 . . . . 4.2300000000000004 108.982 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.4 m -86.52 107.96 18.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.472 0.653 . . . . 0.37 111.184 -175.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 38.3 ttpt -107.1 130.65 22.55 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.565 -0.743 . . . . 3.1400000000000001 109.559 174.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.25 148.8 68.24 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.112 1.875 . . . . 0.56999999999999995 111.5 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.1 p . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 116.001 -0.545 . . . . 1.3899999999999999 112.224 -174.541 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.595 ' HB3' ' HD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 C--O 1.22 -0.455 0 N-CA-C 111.634 0.235 . . . . 1.05 111.634 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -73.87 -27.23 60.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.268 0.556 . . . . 2.2799999999999998 110.957 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.35 6.8 59.42 Favored Glycine 0 CA--C 1.509 -0.286 0 N-CA-C 110.874 -0.891 . . . . 0.54000000000000004 110.874 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.595 ' HD1' ' HB3' ' A' ' 8' ' ' ALA . 95.4 m-85 -138.57 -173.49 3.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.947 -1.131 . . . . 0.97999999999999998 107.947 178.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -162.22 178.77 8.44 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.05 -0.722 . . . . 2.54 109.05 170.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.41 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 9.3 ptp85 -88.0 134.16 33.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.431 0.634 . . . . 3.8300000000000001 110.5 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.9 p -80.82 -166.15 1.05 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.446 -0.797 . . . . 1.3500000000000001 109.614 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.16 -35.95 80.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.794 0.331 . . . . 1.1899999999999999 111.08 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -101.85 0.06 34.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.2 0.524 . . . . 2.4500000000000002 111.147 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 93.88 26.86 13.61 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.575 -0.821 . . . . 0.46999999999999997 113.675 174.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -88.62 171.69 9.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.24 -0.652 . . . . 4.2300000000000004 109.24 174.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.1 m -97.1 107.03 19.47 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.014 0.376 . . . . 0.37 112.014 -174.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -105.2 130.33 23.27 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 109.491 -0.559 . . . . 3.1400000000000001 109.491 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -61.05 138.37 77.92 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.559 2.173 . . . . 0.56999999999999995 112.144 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 116.241 -0.436 . . . . 1.3899999999999999 110.947 -179.568 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.686 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 110.222 -0.288 . . . . 1.05 110.222 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.8 t -64.34 -19.1 65.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.513 0.197 . . . . 2.2799999999999998 111.355 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.74 11.43 7.89 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.721 -0.752 . . . . 0.54000000000000004 112.052 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.686 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 23.7 m-85 -126.27 160.45 30.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.027 -0.36 . . . . 0.97999999999999998 110.027 -176.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -147.24 159.64 43.41 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.545 -0.539 . . . . 2.54 109.545 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.535 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 11.8 mtp180 -87.62 116.17 25.56 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.478 -0.934 . . . . 3.8300000000000001 108.478 174.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.0 p -79.87 -162.52 0.44 Allowed 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.756 -1.111 . . . . 1.3500000000000001 110.424 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.03 -10.88 33.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.851 0.357 . . . . 1.1899999999999999 110.712 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -107.88 2.25 23.31 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.454 -0.339 . . . . 2.4500000000000002 111.891 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 68.38 11.93 62.73 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.033 -1.079 . . . . 0.46999999999999997 111.031 -172.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -82.3 134.23 35.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.383 -0.599 . . . . 4.2300000000000004 109.383 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.7 m -79.28 93.08 5.22 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.272 0.558 . . . . 0.37 110.652 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -99.52 140.24 21.47 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.491 -0.777 . . . . 3.1400000000000001 109.844 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -66.26 126.12 15.16 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.011 1.807 . . . . 0.56999999999999995 110.757 171.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 C--N 1.318 -0.772 0 CA-C-O 121.021 0.438 . . . . 1.3899999999999999 111.177 -179.069 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 120.489 0.185 . . . . 12.67 110.973 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -97.36 -69.41 0.76 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.063 0.459 . . . . 10.84 110.081 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -98.85 111.69 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.567 0.698 . . . . 8.0600000000000005 110.175 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.09 84.45 7.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.817 -0.629 . . . . 6.8300000000000001 110.007 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -146.63 -121.8 0.07 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.538 -0.756 . . . . 4.4000000000000004 110.373 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.618 ' HA2' ' HG2' ' A' ' 13' ' ' ARG . . . -169.53 -155.86 10.34 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.511 -0.852 . . . . 3.3100000000000001 112.513 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 84.1 m -115.88 -146.37 0.4 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.28 -0.267 . . . . 1.3300000000000001 110.28 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.471 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . -54.82 162.95 1.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.971 0.415 . . . . 1.05 112.02 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -63.96 -15.75 59.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.654 -0.703 . . . . 2.2799999999999998 112.267 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.98 1.91 30.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.644 -0.788 . . . . 0.54000000000000004 111.411 173.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.471 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 4.4 m-85 -117.69 -178.72 3.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.094 0.473 . . . . 0.97999999999999998 110.111 -175.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -160.78 158.55 28.73 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.613 -0.884 . . . . 2.54 108.613 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.618 ' HG2' ' HA2' ' A' ' 6' ' ' GLY . 15.8 ptt180 -88.32 126.5 35.22 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 108.688 -0.856 . . . . 3.8300000000000001 108.688 174.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.4 p -79.48 -166.63 1.0 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.19 -0.914 . . . . 1.3500000000000001 110.348 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.95 -22.95 67.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.067 0.461 . . . . 1.1899999999999999 110.727 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -108.22 10.01 27.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.008 -0.542 . . . . 2.4500000000000002 111.398 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 77.69 19.35 75.94 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.499 -0.858 . . . . 0.46999999999999997 112.482 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.436 ' HE ' ' HB2' ' A' ' 18' ' ' ARG . 13.9 ttm180 -82.56 139.35 33.88 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.837 -0.431 . . . . 4.2300000000000004 109.837 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.1 m -83.89 99.63 10.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.23 0.538 . . . . 0.37 110.505 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -113.73 136.74 22.05 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.816 -0.629 . . . . 3.1400000000000001 109.836 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.626 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 34.5 Cg_exo -59.21 138.13 83.08 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.043 1.829 . . . . 0.56999999999999995 110.374 171.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -81.18 -53.84 6.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.445 0.906 . . . . 1.3899999999999999 113.445 -168.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.626 ' CE2' ' HB2' ' A' ' 21' ' ' PRO . 91.8 m-85 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.105 -0.95 . . . . 2.9199999999999999 110.59 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 109.132 -0.692 . . . . 12.67 109.132 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -61.34 -40.87 95.84 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.003 -0.74 . . . . 10.84 109.003 171.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -144.78 137.64 26.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.208 -1.034 . . . . 8.0600000000000005 108.208 170.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.77 121.41 44.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.787 0.327 . . . . 6.8300000000000001 111.023 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.57 -84.34 0.61 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.806 -0.633 . . . . 4.4000000000000004 110.878 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.61 -75.16 2.27 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.187 -1.006 . . . . 3.3100000000000001 111.741 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.2 m -106.35 -107.13 0.31 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.777 0.322 . . . . 1.3300000000000001 110.825 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.634 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.4 -176.46 4.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.347 -0.388 . . . . 1.05 111.375 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.2 m -59.53 -33.56 71.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.908 -0.587 . . . . 2.2799999999999998 110.993 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.49 29.61 5.4 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.863 -0.684 . . . . 0.54000000000000004 111.886 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.634 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 51.2 m-85 -133.44 172.17 13.07 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.98 -0.378 . . . . 0.97999999999999998 109.98 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 4.7 pt20 -151.44 160.04 43.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.124 -0.489 . . . . 2.54 110.778 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.604 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 52.6 mtm180 -91.27 115.98 28.46 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.736 -0.468 . . . . 3.8300000000000001 109.736 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 15' ' ' ALA . 36.7 p -84.91 -154.13 0.18 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.737 -0.665 . . . . 1.3500000000000001 110.671 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' H ' ' HB ' ' A' ' 14' ' ' THR . . . -50.51 -54.41 22.51 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.234 0.334 . . . . 1.1899999999999999 111.805 -177.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -93.93 20.87 7.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.936 0.398 . . . . 2.4500000000000002 110.829 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.604 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 66.59 26.03 72.85 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.433 -0.889 . . . . 0.46999999999999997 111.63 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -78.78 134.31 37.02 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.105 -0.702 . . . . 4.2300000000000004 109.105 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 77.2 m -78.76 101.46 7.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.331 0.586 . . . . 0.37 111.519 -173.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -102.88 138.1 19.48 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.053 -0.976 . . . . 3.1400000000000001 110.104 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.631 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 26.5 Cg_exo -61.76 141.92 92.1 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.264 1.976 . . . . 0.56999999999999995 111.131 175.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.8 p -81.09 122.89 27.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.936 0.398 . . . . 1.3899999999999999 111.862 -173.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.631 ' CE2' ' HB2' ' A' ' 21' ' ' PRO . 66.3 m-85 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 118.332 -0.842 . . . . 2.9199999999999999 109.554 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.275 -0.269 . . . . 12.67 110.275 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -149.68 -76.45 0.15 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.59 0.233 . . . . 10.84 110.576 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -116.23 -73.35 0.65 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.008 0.432 . . . . 8.0600000000000005 110.228 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.41 -74.45 0.07 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.033 -0.53 . . . . 6.8300000000000001 109.914 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.48 157.09 39.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.709 -0.678 . . . . 4.4000000000000004 109.794 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 12' ' ' GLN . . . -77.13 -79.26 0.7 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.777 -0.725 . . . . 3.3100000000000001 112.928 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.438 ' N ' ' HA ' ' A' ' 12' ' ' GLN . 22.6 m -128.73 -95.45 0.41 Allowed 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.501 -0.411 . . . . 1.3300000000000001 110.906 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.637 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.72 -175.61 4.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.457 -0.338 . . . . 1.05 111.246 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.0 m -61.49 -29.65 70.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 2.2799999999999998 110.879 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.81 17.72 8.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.125 -0.56 . . . . 0.54000000000000004 112.25 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.637 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 17.7 m-85 -127.03 156.96 40.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.042 -0.355 . . . . 0.97999999999999998 110.042 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.486 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 4.1 pt20 -146.23 172.52 13.33 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 110.209 -0.293 . . . . 2.54 110.209 175.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -88.97 133.28 34.37 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.248 -0.649 . . . . 3.8300000000000001 109.248 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 18' ' ' ARG . 82.1 p -79.59 -173.32 3.71 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.063 -0.971 . . . . 1.3500000000000001 110.066 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.33 -11.52 57.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.463 0.649 . . . . 1.1899999999999999 110.167 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.668 ' OD2' ' HD3' ' A' ' 18' ' ' ARG . 10.3 p-10 -117.98 18.32 13.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.664 -0.698 . . . . 2.4500000000000002 111.706 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.66 23.83 76.53 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.891 -0.671 . . . . 0.46999999999999997 113.776 170.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.668 ' HD3' ' OD2' ' A' ' 16' ' ' ASP . 31.3 mtp180 -104.72 147.1 28.05 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 117.079 0.439 . . . . 4.2300000000000004 110.016 176.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.6 m -81.81 111.24 17.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.363 0.601 . . . . 0.37 111.35 -173.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 56.0 tttp -113.05 137.2 21.83 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.391 -0.822 . . . . 3.1400000000000001 109.091 176.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 8.5 Cg_exo -70.02 141.73 44.94 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.433 2.088 . . . . 0.56999999999999995 111.145 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 p -87.57 105.29 17.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.901 0.381 . . . . 1.3899999999999999 111.753 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.483 ' CE2' ' HB2' ' A' ' 21' ' ' PRO . 76.8 m-85 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.339 -0.839 . . . . 2.9199999999999999 109.617 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.474 0.178 . . . . 12.67 111.096 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -60.52 -43.18 97.39 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.096 0.474 . . . . 10.84 110.324 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -120.46 136.71 54.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.892 -0.595 . . . . 8.0600000000000005 110.433 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.06 -40.48 0.92 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.317 -0.856 . . . . 6.8300000000000001 109.43 174.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.46 128.79 33.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.553 -0.749 . . . . 4.4000000000000004 110.058 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 12' ' ' GLN . . . -69.59 -39.99 78.09 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.8 -0.714 . . . . 3.3100000000000001 112.251 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.495 ' SG ' ' HG3' ' A' ' 13' ' ' ARG . 2.9 m -132.97 -90.15 0.4 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.858 -0.423 . . . . 1.3300000000000001 109.858 177.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.684 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -92.94 -175.09 3.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.158 -0.473 . . . . 1.05 110.443 175.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.3 m -56.09 -41.25 74.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.177 0.513 . . . . 2.2799999999999998 110.858 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -113.63 31.17 6.75 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.805 -0.712 . . . . 0.54000000000000004 112.167 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.684 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 60.8 m-85 -138.13 158.14 44.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.25 0.547 . . . . 0.97999999999999998 110.57 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.571 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 27.3 tt0 -146.17 155.77 42.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.631 -0.713 . . . . 2.54 109.886 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.613 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 83.2 mtm180 -87.05 120.2 28.06 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.438 -0.578 . . . . 3.8300000000000001 109.438 176.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.1 p -79.59 -162.32 0.41 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.988 -1.005 . . . . 1.3500000000000001 110.59 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.89 -18.43 62.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.78 0.324 . . . . 1.1899999999999999 111.282 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.5 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 4.0 m-20 -105.11 2.89 29.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.312 -0.404 . . . . 2.4500000000000002 110.854 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.613 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 74.89 12.25 83.24 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 119.98 -1.105 . . . . 0.46999999999999997 111.333 -173.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.5 ' HG3' ' HB2' ' A' ' 16' ' ' ASP . 54.0 mtm180 -79.57 137.22 37.08 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.367 -0.605 . . . . 4.2300000000000004 109.367 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 72.4 m -79.61 103.1 9.29 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.921 -0.581 . . . . 0.37 111.244 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -104.5 139.53 20.19 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.587 -0.733 . . . . 3.1400000000000001 109.728 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 36.9 Cg_exo -57.08 136.31 75.85 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.626 2.218 . . . . 0.56999999999999995 112.065 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 p -89.37 -14.46 35.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 1.3899999999999999 111.084 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 . . . . . 0 C--O 1.247 0.957 0 CA-C-O 117.747 -1.121 . . . . 2.9199999999999999 111.1 179.617 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.723 0.297 . . . . 12.67 110.526 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -96.16 157.4 15.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.299 -0.41 . . . . 10.84 110.273 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -129.68 134.05 47.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.366 -0.379 . . . . 8.0600000000000005 111.092 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.75 -45.59 7.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.067 0.461 . . . . 6.8300000000000001 110.08 174.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.82 12.61 23.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.703 -0.68 . . . . 4.4000000000000004 110.573 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.503 ' HA2' ' H ' ' A' ' 13' ' ' ARG . . . -140.11 -170.54 12.04 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.927 -0.869 . . . . 3.3100000000000001 110.927 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.6 m -119.09 -92.2 0.54 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.842 0.321 . . . . 1.3300000000000001 110.402 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.704 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -92.02 -175.3 4.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.47 -0.332 . . . . 1.05 110.378 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 m -63.91 -23.19 67.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.224 0.535 . . . . 2.2799999999999998 110.582 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.08 24.44 5.38 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.836 -0.62 . . . . 0.54000000000000004 111.637 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.704 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 40.4 m-85 -135.11 155.86 50.0 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.159 0.504 . . . . 0.97999999999999998 110.181 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -138.76 156.75 47.11 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.89 -0.595 . . . . 2.54 110.077 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.546 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 65.1 mtp180 -88.76 122.77 32.52 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.277 -0.638 . . . . 3.8300000000000001 109.277 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.2 p -79.87 -168.74 1.71 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.674 -0.693 . . . . 1.3500000000000001 110.046 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.3 -19.73 48.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.105 0.479 . . . . 1.1899999999999999 111.272 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -111.99 10.94 20.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.43 0.633 . . . . 2.4500000000000002 110.621 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 71.01 15.51 74.27 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.62 -0.718 . . . . 0.46999999999999997 112.868 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -79.68 139.59 37.33 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.009 -0.737 . . . . 4.2300000000000004 109.009 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.9 98.47 7.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.524 0.678 . . . . 0.37 111.351 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -101.99 133.55 20.62 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.154 -0.93 . . . . 3.1400000000000001 109.615 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.97 138.04 65.78 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.325 2.017 . . . . 0.56999999999999995 112.314 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 p -91.58 -12.84 33.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.402 -0.363 . . . . 1.3899999999999999 110.877 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 . . . . . 0 C--O 1.245 0.866 0 CA-C-N 115.497 -0.774 . . . . 2.9199999999999999 111.434 177.696 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.73 0.3 . . . . 12.67 110.487 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -150.0 -30.76 0.21 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.071 0.462 . . . . 10.84 110.186 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -118.76 116.56 26.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.892 -0.595 . . . . 8.0600000000000005 110.582 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.18 132.44 49.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.363 -0.38 . . . . 6.8300000000000001 110.185 177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.03 -65.77 0.98 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.064 0.459 . . . . 4.4000000000000004 111.169 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.54 -91.89 0.14 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.508 -0.853 . . . . 3.3100000000000001 112.355 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.8 m -118.61 -109.98 0.35 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.818 -0.353 . . . . 1.3300000000000001 111.73 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.65 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.75 -175.27 4.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.03 0.443 . . . . 1.05 111.633 -175.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 p -69.93 -14.96 62.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.617 -0.719 . . . . 2.2799999999999998 111.071 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.37 21.29 5.16 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.934 -0.866 . . . . 0.54000000000000004 110.934 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.65 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 51.0 m-85 -136.66 153.1 51.0 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.336 0.589 . . . . 0.97999999999999998 110.49 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -136.15 160.13 39.6 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.444 -0.798 . . . . 2.54 109.852 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.416 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 25.7 ptt180 -87.11 129.7 34.82 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.739 -0.837 . . . . 3.8300000000000001 108.739 175.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.2 p -81.07 -170.3 2.65 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.872 -0.604 . . . . 1.3500000000000001 109.541 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.29 -17.75 62.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.307 0.575 . . . . 1.1899999999999999 110.723 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -113.69 14.72 18.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.444 -0.798 . . . . 2.4500000000000002 111.531 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 69.34 24.87 75.9 Favored Glycine 0 C--O 1.235 0.187 0 C-N-CA 121.277 -0.487 . . . . 0.46999999999999997 113.161 174.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -91.03 143.33 26.82 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.163 -0.68 . . . . 4.2300000000000004 109.163 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.69 100.12 7.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.265 0.555 . . . . 0.37 110.913 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -97.72 134.31 22.53 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.269 -0.878 . . . . 3.1400000000000001 110.305 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.532 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 14.2 Cg_exo -66.3 141.6 63.07 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.03 1.82 . . . . 0.56999999999999995 110.205 172.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.3 p -80.08 113.49 18.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.065 0.459 . . . . 1.3899999999999999 112.118 -172.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 21' ' ' PRO . 56.5 m-85 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 108.782 -0.821 . . . . 2.9199999999999999 108.782 176.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.21 0.052 . . . . 12.67 111.097 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -67.92 -55.5 12.55 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.709 0.29 . . . . 10.84 111.27 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -139.13 -78.34 0.34 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.122 -0.49 . . . . 8.0600000000000005 109.704 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.87 -71.07 0.25 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.795 -0.817 . . . . 6.8300000000000001 108.795 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.94 -4.79 53.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.677 -0.692 . . . . 4.4000000000000004 109.613 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.9 93.4 1.28 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.445 -0.798 . . . . 3.3100000000000001 111.405 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.2 m -107.72 -179.11 3.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.674 0.273 . . . . 1.3300000000000001 110.853 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 11' ' ' TYR . . . -60.69 169.15 1.93 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.606 -0.725 . . . . 1.05 112.147 -177.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -69.08 -38.85 79.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.138 0.494 . . . . 2.2799999999999998 110.297 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.56 -3.18 86.39 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.563 -0.615 . . . . 0.54000000000000004 111.563 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.431 ' HB2' ' HB2' ' A' ' 8' ' ' ALA . 10.0 m-85 -117.43 178.77 4.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.898 -0.408 . . . . 0.97999999999999998 109.898 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.519 HE21 HG21 ' A' ' 22' ' ' THR . 4.0 pt20 -159.24 179.09 9.31 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.594 -0.521 . . . . 2.54 109.594 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.525 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 39.1 ptt180 -88.37 133.68 34.03 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.378 0.609 . . . . 3.8300000000000001 110.61 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.6 p -81.72 -167.02 1.35 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.366 -0.834 . . . . 1.3500000000000001 109.57 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.61 69.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.955 0.354 . . . . 1.1899999999999999 111.955 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -105.17 6.09 32.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.374 -0.376 . . . . 2.4500000000000002 111.494 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.525 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 83.48 41.34 8.44 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.354 -0.927 . . . . 0.46999999999999997 112.779 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -99.17 178.36 4.94 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.832 -1.173 . . . . 4.2300000000000004 107.832 172.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.1 m -103.92 123.88 47.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.986 0.422 . . . . 0.37 111.671 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -139.8 143.72 35.92 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.771 -0.65 . . . . 3.1400000000000001 109.401 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.44 147.3 22.75 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.877 2.384 . . . . 0.56999999999999995 112.329 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.519 HG21 HE21 ' A' ' 12' ' ' GLN . 43.6 p -86.77 -21.13 26.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.568 0.581 . . . . 1.3899999999999999 112.568 -174.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 . . . . . 0 C--O 1.245 0.852 0 O-C-N 123.851 0.719 . . . . 2.9199999999999999 110.414 -176.627 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 121.021 0.439 . . . . 12.67 110.105 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -87.8 121.67 30.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.834 -0.621 . . . . 10.84 111.544 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -139.81 104.7 4.95 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.868 -0.606 . . . . 8.0600000000000005 109.529 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.73 116.08 30.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.117 0.484 . . . . 6.8300000000000001 110.695 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.94 -51.72 3.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.876 -0.602 . . . . 4.4000000000000004 110.436 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' HA2' ' H ' ' A' ' 13' ' ' ARG . . . 124.77 -119.0 3.5 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.676 -0.773 . . . . 3.3100000000000001 112.334 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 m -125.69 -95.72 0.45 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.739 0.304 . . . . 1.3300000000000001 111.033 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.649 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -92.15 -174.71 3.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.234 -0.439 . . . . 1.05 111.109 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -66.14 -25.24 66.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.855 0.36 . . . . 2.2799999999999998 110.505 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -121.53 21.76 7.98 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.151 -0.547 . . . . 0.54000000000000004 112.136 175.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.649 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 54.6 m-85 -134.71 149.88 50.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.995 0.426 . . . . 0.97999999999999998 110.385 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -131.85 154.23 49.38 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.92 -0.582 . . . . 2.54 109.437 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.609 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 11.2 ptm180 -87.89 147.04 25.27 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.487 0.661 . . . . 3.8300000000000001 109.733 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 p -99.76 -164.53 1.13 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.705 -1.134 . . . . 1.3500000000000001 109.473 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.98 -34.7 63.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.007 0.432 . . . . 1.1899999999999999 111.187 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.37 -3.76 57.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.971 -0.559 . . . . 2.4500000000000002 111.609 -175.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.609 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 82.21 6.42 88.8 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.105 -1.045 . . . . 0.46999999999999997 110.635 -174.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -79.21 133.03 36.7 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.617 -0.512 . . . . 4.2300000000000004 109.617 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.27 127.35 32.26 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.097 -0.502 . . . . 0.37 112.24 -171.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 63.3 mttp -123.3 142.09 37.71 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.658 -0.701 . . . . 3.1400000000000001 109.165 170.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 13.0 Cg_exo -68.3 144.19 61.3 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.081 2.521 . . . . 0.56999999999999995 112.011 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.2 p -95.66 110.84 22.89 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.984 -0.553 . . . . 1.3899999999999999 111.163 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 . . . . . 0 C--O 1.243 0.714 0 CA-C-O 118.234 -0.889 . . . . 2.9199999999999999 110.123 -179.006 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.595 ' HG3' ' H ' ' A' ' 2' ' ' ASN . 5.2 pt-20 . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 111.714 0.264 . . . . 12.67 111.714 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.595 ' H ' ' HG3' ' A' ' 1' ' ' GLU . 17.6 m120 71.56 121.73 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.2 0.6 . . . . 10.84 110.995 -175.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.483 ' CE2' ' HB2' ' A' ' 5' ' ' ALA . 59.7 t80 -88.4 130.13 35.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.838 -0.619 . . . . 8.0600000000000005 110.74 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.55 95.31 3.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.998 0.428 . . . . 6.8300000000000001 110.743 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.483 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . . . -93.15 116.61 29.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.069 -0.514 . . . . 4.4000000000000004 111.411 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.47 -144.45 18.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.107 -0.568 . . . . 3.3100000000000001 112.338 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.414 ' N ' ' HA ' ' A' ' 12' ' ' GLN . 1.2 m -125.1 -89.37 0.58 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.218 -0.66 . . . . 1.3300000000000001 109.218 173.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.7 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -90.67 -175.34 4.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.886 -0.597 . . . . 1.05 109.56 172.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 m -61.01 -37.24 81.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.038 0.447 . . . . 2.2799999999999998 110.965 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.78 29.03 7.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.719 -0.753 . . . . 0.54000000000000004 112.078 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.7 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 27.5 m-85 -133.64 163.65 28.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.034 0.445 . . . . 0.97999999999999998 110.698 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.414 ' HA ' ' N ' ' A' ' 7' ' ' CYS . 28.4 pt20 -153.32 175.88 12.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.969 -0.56 . . . . 2.54 109.881 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -88.66 139.17 30.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.256 0.551 . . . . 3.8300000000000001 110.645 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.2 p -83.0 -173.37 4.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.203 -0.908 . . . . 1.3500000000000001 108.792 172.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.76 -4.83 21.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.008 0.432 . . . . 1.1899999999999999 110.724 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.428 ' OD2' ' HD3' ' A' ' 18' ' ' ARG . 22.2 t70 -108.4 6.81 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.872 -0.604 . . . . 2.4500000000000002 110.476 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.47 4.37 84.39 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.832 -0.622 . . . . 0.46999999999999997 113.051 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.428 ' HD3' ' OD2' ' A' ' 16' ' ' ASP . 36.0 mtp180 -96.49 159.54 14.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.682 0.277 . . . . 4.2300000000000004 110.668 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.2 m -88.54 122.32 31.87 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.579 0.704 . . . . 0.37 112.7 -168.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -121.68 139.72 30.5 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 114.991 -1.004 . . . . 3.1400000000000001 110.257 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.484 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 34.4 Cg_exo -58.27 148.22 80.18 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.397 2.065 . . . . 0.56999999999999995 111.19 174.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.3 p -86.19 120.22 27.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.208 0.528 . . . . 1.3899999999999999 111.849 -174.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 21' ' ' PRO . 73.6 m-85 . . . . . 0 C--O 1.245 0.865 0 CA-C-N 115.302 -0.863 . . . . 2.9199999999999999 109.064 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.573 0.225 . . . . 12.67 110.734 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -59.39 -47.65 84.65 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.048 0.451 . . . . 10.84 110.961 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -139.95 141.22 36.46 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.151 -0.477 . . . . 8.0600000000000005 110.045 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.07 150.27 38.93 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.166 -0.47 . . . . 6.8300000000000001 109.895 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.3 113.09 15.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.83 0.348 . . . . 4.4000000000000004 110.887 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.826 ' HA2' ' HG2' ' A' ' 13' ' ' ARG . . . -86.01 -100.74 0.74 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.001 -0.619 . . . . 3.3100000000000001 112.021 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.96 -95.44 0.44 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.7 0.286 . . . . 1.3300000000000001 110.378 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.639 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.71 -178.07 4.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.624 -0.262 . . . . 1.05 110.686 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -22.95 62.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.28 0.562 . . . . 2.2799999999999998 110.801 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.73 16.74 25.87 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.235 -0.746 . . . . 0.54000000000000004 111.235 175.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.639 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 64.7 m-85 -136.16 173.29 11.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.43 0.633 . . . . 0.97999999999999998 110.982 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 9.8 pt20 -148.46 171.96 15.24 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.874 -0.787 . . . . 2.54 108.874 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.826 ' HG2' ' HA2' ' A' ' 6' ' ' GLY . 11.0 ptp180 -104.46 139.04 39.96 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.608 0.718 . . . . 3.8300000000000001 110.408 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.0 p -79.39 -172.45 3.22 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.702 -1.135 . . . . 1.3500000000000001 109.167 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.03 -31.59 67.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.131 0.491 . . . . 1.1899999999999999 110.789 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.36 -14.28 20.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.126 -0.488 . . . . 2.4500000000000002 111.937 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 105.52 18.3 12.08 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 119.729 -1.224 . . . . 0.46999999999999997 113.364 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -80.02 141.34 36.01 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.159 -0.682 . . . . 4.2300000000000004 109.159 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 64.1 m -82.02 109.68 16.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.244 0.545 . . . . 0.37 111.727 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 17.5 tptp -110.28 136.76 20.51 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.54 -0.755 . . . . 3.1400000000000001 109.339 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.68 141.93 74.12 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.72 2.28 . . . . 0.56999999999999995 112.34 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 p -90.98 128.4 36.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.985 0.421 . . . . 1.3899999999999999 110.87 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.562 -0.733 . . . . 2.9199999999999999 109.959 -178.286 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 110.193 -0.299 . . . . 12.67 110.193 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.6 t30 65.41 110.33 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.526 0.73 . . . . 10.84 111.576 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -118.61 157.74 26.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.034 -0.53 . . . . 8.0600000000000005 110.609 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.73 -57.62 1.44 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.04 -0.527 . . . . 6.8300000000000001 110.942 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.71 -23.97 14.15 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.11 0.411 . . . . 4.4000000000000004 112.11 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.29 -158.28 22.99 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.57 -0.824 . . . . 3.3100000000000001 112.036 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.4 m -113.79 -96.5 0.45 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.799 0.333 . . . . 1.3300000000000001 110.255 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.677 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.73 -175.91 4.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.433 -0.348 . . . . 1.05 110.747 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -62.69 -29.06 70.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.998 -0.546 . . . . 2.2799999999999998 110.714 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.41 30.27 4.77 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.671 -0.695 . . . . 0.54000000000000004 111.875 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.677 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 37.6 m-85 -136.34 161.14 36.63 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.307 0.575 . . . . 0.97999999999999998 111.0 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -143.54 163.98 31.66 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.765 -0.652 . . . . 2.54 109.945 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.2 mtm180 -89.73 127.82 36.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.139 0.495 . . . . 3.8300000000000001 109.999 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.3 p -80.51 -176.52 5.76 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.386 -0.825 . . . . 1.3500000000000001 109.12 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.77 47.77 0.26 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.229 0.538 . . . . 1.1899999999999999 111.25 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -161.04 -35.8 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.521 -0.763 . . . . 2.4500000000000002 110.828 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.36 -0.39 23.67 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.416 -0.897 . . . . 0.46999999999999997 110.945 -171.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -78.12 133.85 37.78 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.395 -0.594 . . . . 4.2300000000000004 109.395 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.1 m -86.2 126.46 34.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.265 -0.425 . . . . 0.37 111.223 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.505 ' HG3' ' HD2' ' A' ' 21' ' ' PRO . 36.0 ttmt -124.19 140.49 35.04 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.858 -0.61 . . . . 3.1400000000000001 109.474 176.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.505 ' HD2' ' HG3' ' A' ' 20' ' ' LYS . 44.6 Cg_exo -55.12 145.11 66.43 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.047 2.498 . . . . 0.56999999999999995 112.013 177.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.9 p -88.35 120.36 29.64 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.075 -0.511 . . . . 1.3899999999999999 111.714 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.121 -0.942 . . . . 2.9199999999999999 109.367 177.849 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.781 0.324 . . . . 12.67 110.256 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -97.93 172.96 7.31 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.267 -0.642 . . . . 10.84 109.267 171.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -144.21 150.32 37.78 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.615 -0.434 . . . . 8.0600000000000005 110.909 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.97 -76.33 0.59 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.033 -0.53 . . . . 6.8300000000000001 110.415 177.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.2 96.81 7.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.258 -0.428 . . . . 4.4000000000000004 110.777 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.09 86.08 0.65 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.646 -0.788 . . . . 3.3100000000000001 111.809 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.9 m -79.66 176.71 9.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 1.3300000000000001 111.091 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.53 ' HB1' ' HD1' ' A' ' 11' ' ' TYR . . . -60.29 169.37 1.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.893 -0.594 . . . . 1.05 112.367 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -31.82 71.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.727 -0.669 . . . . 2.2799999999999998 110.802 175.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.45 10.76 73.98 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.965 -0.636 . . . . 0.54000000000000004 111.725 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.53 ' HD1' ' HB1' ' A' ' 8' ' ' ALA . 47.5 m-85 -130.83 -179.87 5.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.002 0.429 . . . . 0.97999999999999998 110.057 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -157.93 171.19 20.71 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.939 -0.763 . . . . 2.54 108.939 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.508 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.2 ptp180 -89.07 138.24 31.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.1 0.476 . . . . 3.8300000000000001 110.664 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.6 p -87.65 -167.77 2.0 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.615 -0.72 . . . . 1.3500000000000001 109.394 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.15 -31.58 70.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.89 0.376 . . . . 1.1899999999999999 110.874 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -107.4 19.98 19.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.889 0.852 . . . . 2.4500000000000002 110.384 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.508 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 69.44 25.89 75.06 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.321 -0.854 . . . . 0.46999999999999997 113.297 175.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 16.0 mmt180 -87.77 169.01 12.46 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.644 -0.873 . . . . 4.2300000000000004 108.644 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.1 m -98.16 113.46 25.37 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.162 0.506 . . . . 0.37 111.886 -174.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -111.15 136.53 20.86 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.345 -0.843 . . . . 3.1400000000000001 109.73 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.24 134.44 48.87 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.646 2.231 . . . . 0.56999999999999995 112.209 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.4 p -82.15 131.54 35.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.552 -0.295 . . . . 1.3899999999999999 110.871 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.585 -0.721 . . . . 2.9199999999999999 110.068 -179.442 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.761 0.315 . . . . 12.67 110.806 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -58.85 -57.23 13.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.742 -0.663 . . . . 10.84 111.982 -174.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -129.49 84.76 2.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.972 0.415 . . . . 8.0600000000000005 111.16 -176.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.86 102.43 15.03 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.011 -0.541 . . . . 6.8300000000000001 109.945 174.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.7 142.23 34.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.213 -0.448 . . . . 4.4000000000000004 111.224 -175.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.629 ' HA2' ' HG3' ' A' ' 12' ' ' GLN . . . 112.61 -124.19 6.58 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.57 -0.824 . . . . 3.3100000000000001 112.37 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.0 m -138.61 -90.54 0.21 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.197 -0.297 . . . . 1.3300000000000001 110.197 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.631 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.28 -177.73 4.94 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.874 -0.417 . . . . 1.05 109.874 172.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 m -61.5 -36.39 80.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.044 0.45 . . . . 2.2799999999999998 110.848 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.16 25.1 14.59 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.943 -0.646 . . . . 0.54000000000000004 111.798 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.631 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 43.9 m-85 -134.62 166.27 23.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.251 0.548 . . . . 0.97999999999999998 110.674 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.629 ' HG3' ' HA2' ' A' ' 6' ' ' GLY . 7.5 tt0 -158.74 146.83 18.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.19 -0.671 . . . . 2.54 109.19 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 17.3 ptp180 -87.85 125.59 34.55 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.595 0.712 . . . . 3.8300000000000001 109.517 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.1 p -80.63 -164.51 0.72 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.447 -1.251 . . . . 1.3500000000000001 110.186 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.77 -11.88 41.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.032 0.444 . . . . 1.1899999999999999 111.032 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.415 ' HB3' ' HG2' ' A' ' 18' ' ' ARG . 8.0 t70 -102.47 1.35 35.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.318 0.58 . . . . 2.4500000000000002 111.078 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 74.54 13.41 81.89 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.934 -0.651 . . . . 0.46999999999999997 112.045 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 13.9 mmt180 -93.11 137.61 32.3 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.015 -0.365 . . . . 4.2300000000000004 110.015 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.3 m -79.45 98.07 6.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.922 -0.581 . . . . 0.37 110.494 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -98.19 139.04 20.97 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.447 -0.797 . . . . 3.1400000000000001 109.122 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.32 121.5 9.72 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.42 2.08 . . . . 0.56999999999999995 111.33 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p -95.29 125.0 39.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.124 0.488 . . . . 1.3899999999999999 111.072 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 C--O 1.249 1.058 0 CA-C-N 115.589 -0.732 . . . . 2.9199999999999999 110.118 -177.057 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 109.695 -0.483 . . . . 12.67 109.695 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -82.06 144.06 31.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.321 -0.4 . . . . 10.84 110.01 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -104.49 -180.0 4.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.343 -0.389 . . . . 8.0600000000000005 110.904 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.19 157.31 36.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.153 -0.476 . . . . 6.8300000000000001 110.57 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.48 160.09 14.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 4.4000000000000004 111.198 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -114.67 -22.72 4.96 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.64 -0.791 . . . . 3.3100000000000001 112.806 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 32.0 m -122.94 -95.73 0.47 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.621 -0.34 . . . . 1.3300000000000001 110.897 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.666 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.89 -176.68 4.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.5 -0.318 . . . . 1.05 110.342 177.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -71.93 -7.36 48.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.14 0.495 . . . . 2.2799999999999998 111.029 177.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.94 22.31 3.29 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.753 -0.939 . . . . 0.54000000000000004 110.753 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.666 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 18.2 m-85 -134.27 155.92 49.35 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.984 -0.376 . . . . 0.97999999999999998 109.984 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -144.77 155.46 43.54 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.55 -0.537 . . . . 2.54 109.55 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.621 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 99.5 mtt180 -88.67 120.34 29.97 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.466 0.651 . . . . 3.8300000000000001 109.655 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.461 HG23 ' HD2' ' A' ' 20' ' ' LYS . 58.9 p -80.43 -163.3 0.55 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.493 -1.231 . . . . 1.3500000000000001 110.606 -177.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.81 -27.48 59.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.896 0.332 . . . . 1.1899999999999999 111.896 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.17 1.59 45.07 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.601 -0.272 . . . . 2.4500000000000002 111.469 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.621 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 79.89 12.64 83.23 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.186 -1.007 . . . . 0.46999999999999997 111.526 -175.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -84.87 142.77 29.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.546 -0.327 . . . . 4.2300000000000004 110.5 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.1 m -82.89 104.01 12.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.186 -0.461 . . . . 0.37 111.573 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.461 ' HD2' HG23 ' A' ' 14' ' ' THR . 87.4 mttt -108.24 146.1 32.87 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.021 -0.536 . . . . 3.1400000000000001 109.837 172.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 4.9 Cg_exo -72.93 129.14 13.93 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.38 2.054 . . . . 0.56999999999999995 112.206 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 p -91.34 -20.81 21.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.095 -0.502 . . . . 1.3899999999999999 110.502 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 . . . . . 0 C--O 1.251 1.134 0 CA-C-N 114.953 -1.021 . . . . 2.9199999999999999 110.282 179.226 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.67 0.272 . . . . 12.67 111.313 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -77.33 151.14 35.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.777 -0.192 . . . . 10.84 110.488 -177.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -104.58 136.63 43.76 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.296 -0.261 . . . . 8.0600000000000005 110.296 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -101.94 -35.3 9.04 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.696 -0.483 . . . . 6.8300000000000001 109.696 175.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -160.26 173.5 15.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.447 -0.797 . . . . 4.4000000000000004 109.647 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 12' ' ' GLN . . . -88.23 -92.85 1.04 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.821 -0.704 . . . . 3.3100000000000001 111.784 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -128.21 -88.09 0.55 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.724 -0.473 . . . . 1.3300000000000001 109.724 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.656 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -92.02 -177.07 4.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.122 -0.49 . . . . 1.05 110.147 173.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -65.31 -25.7 67.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.113 0.482 . . . . 2.2799999999999998 110.386 174.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.08 24.92 8.58 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.078 -0.582 . . . . 0.54000000000000004 111.756 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.656 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 39.7 m-85 -141.21 160.26 40.49 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.045 0.45 . . . . 0.97999999999999998 110.913 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.541 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 3.9 pt20 -144.67 171.64 14.11 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.86 -0.609 . . . . 2.54 109.815 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -89.08 142.17 27.87 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.252 0.549 . . . . 3.8300000000000001 110.687 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 p -90.08 -175.78 4.67 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.616 -0.883 . . . . 1.3500000000000001 108.616 171.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.35 -14.99 31.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.004 0.43 . . . . 1.1899999999999999 110.911 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -107.97 10.54 28.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.028 -0.533 . . . . 2.4500000000000002 111.246 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.49 5.76 74.07 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.038 -0.601 . . . . 0.46999999999999997 113.206 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -80.05 150.92 30.17 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.524 -0.547 . . . . 4.2300000000000004 109.524 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.2 m -86.17 110.22 19.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.478 0.656 . . . . 0.37 111.09 -174.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 46.9 tttp -101.5 136.89 19.52 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.075 -0.966 . . . . 3.1400000000000001 109.37 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 24.4 Cg_exo -62.76 140.08 78.43 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.292 1.995 . . . . 0.56999999999999995 111.995 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.6 p -88.48 -5.53 58.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.7 0.286 . . . . 1.3899999999999999 110.875 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.061 -0.971 . . . . 2.9199999999999999 111.418 176.251 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 2' ' ' ASN . 1.5 mm-40 . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 109.591 -0.522 . . . . 12.67 109.591 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 1' ' ' GLU . 48.5 m-80 72.41 -55.98 0.66 Allowed 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.727 0.642 . . . . 10.84 109.869 -173.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 5' ' ' ALA . 24.8 t80 -80.54 119.09 22.74 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.239 -0.652 . . . . 8.0600000000000005 109.239 173.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.73 93.98 8.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.096 0.474 . . . . 6.8300000000000001 111.203 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.455 ' HB3' ' CE2' ' A' ' 3' ' ' PHE . . . -116.62 12.36 14.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.874 -0.603 . . . . 4.4000000000000004 110.878 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.41 -92.27 1.01 Allowed Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.658 -0.782 . . . . 3.3100000000000001 112.643 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.4 m -119.58 176.42 5.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.698 0.285 . . . . 1.3300000000000001 111.289 -175.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.5 166.86 3.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.936 -0.574 . . . . 1.05 112.192 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.7 m -66.27 -36.96 84.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.954 -0.566 . . . . 2.2799999999999998 110.861 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.03 6.04 84.06 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.128 -0.558 . . . . 0.54000000000000004 111.872 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -123.83 -179.44 4.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.008 -0.738 . . . . 0.97999999999999998 109.008 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -161.26 170.35 20.4 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.916 -0.402 . . . . 2.54 109.916 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 76.1 mtm180 -88.43 123.7 33.23 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.224 0.535 . . . . 3.8300000000000001 109.702 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.464 ' C ' ' H ' ' A' ' 16' ' ' ASP . 70.7 p -80.88 -167.7 1.5 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.116 -0.947 . . . . 1.3500000000000001 110.614 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.69 41.37 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.009 0.433 . . . . 1.1899999999999999 111.651 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 14' ' ' THR . 19.4 t70 -160.55 -31.75 0.06 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.708 -0.678 . . . . 2.4500000000000002 109.662 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.33 -0.64 20.66 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.576 -0.821 . . . . 0.46999999999999997 112.004 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.461 ' HG3' ' OD2' ' A' ' 16' ' ' ASP . 74.4 mtp180 -79.16 164.36 24.29 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.058 -0.349 . . . . 4.2300000000000004 110.058 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.3 m -104.7 110.83 23.32 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.861 -0.609 . . . . 0.37 111.465 -172.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 30.4 mtpp -121.66 146.69 46.2 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.861 -0.609 . . . . 3.1400000000000001 109.958 174.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 23.5 Cg_exo -63.49 148.26 92.66 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.909 2.406 . . . . 0.56999999999999995 111.97 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.3 p -90.92 -6.27 54.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.956 -0.565 . . . . 1.3899999999999999 110.756 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 . . . . . 0 C--O 1.251 1.152 0 CA-C-N 114.993 -1.003 . . . . 2.9199999999999999 111.132 178.241 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.705 0.288 . . . . 12.67 111.198 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -72.11 150.23 44.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.277 0.56 . . . . 10.84 112.014 -173.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -97.37 115.07 27.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.692 -0.685 . . . . 8.0600000000000005 109.721 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.79 120.33 37.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.824 0.345 . . . . 6.8300000000000001 111.399 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.32 156.34 19.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.713 -0.676 . . . . 4.4000000000000004 109.765 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.43 -71.61 0.32 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.506 -0.854 . . . . 3.3100000000000001 111.886 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 86.6 m -125.78 165.26 18.97 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.765 -0.457 . . . . 1.3300000000000001 109.765 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.68 ' HB1' ' CD1' ' A' ' 11' ' ' TYR . . . -63.74 172.42 2.2 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.886 0.698 . . . . 1.05 112.886 -173.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -65.1 -33.97 77.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.545 -0.752 . . . . 2.2799999999999998 111.05 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.34 6.65 80.86 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.936 -0.649 . . . . 0.54000000000000004 111.552 176.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.68 ' CD1' ' HB1' ' A' ' 8' ' ' ALA . 30.9 m-85 -123.09 178.18 5.2 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.653 -0.499 . . . . 0.97999999999999998 109.653 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -161.1 170.92 19.5 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.094 -0.706 . . . . 2.54 109.094 171.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.557 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.3 ptp180 -88.5 137.63 32.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.303 0.573 . . . . 3.8300000000000001 110.922 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.3 p -86.54 -165.32 1.24 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.031 -0.986 . . . . 1.3500000000000001 109.845 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.01 -18.62 65.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.644 0.259 . . . . 1.1899999999999999 111.406 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -109.54 -6.6 15.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.614 0.721 . . . . 2.4500000000000002 110.594 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.557 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 91.24 20.1 39.82 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.168 -1.015 . . . . 0.46999999999999997 111.92 -177.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -79.23 155.69 28.47 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.88 -0.785 . . . . 4.2300000000000004 108.88 175.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -91.04 99.95 12.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.494 0.664 . . . . 0.37 111.708 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -96.92 127.95 37.25 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.01 -0.995 . . . . 3.1400000000000001 109.71 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.92 147.19 96.25 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.653 2.235 . . . . 0.56999999999999995 111.75 176.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.2 p -96.76 -5.12 39.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.205 -0.452 . . . . 1.3899999999999999 110.865 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 . . . . . 0 C--O 1.249 1.059 0 CA-C-N 115.352 -0.84 . . . . 2.9199999999999999 110.949 178.339 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 111.495 0.183 . . . . 12.67 111.495 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.33 -18.52 26.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.947 0.403 . . . . 10.84 111.336 -175.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -97.53 106.67 19.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.163 -0.471 . . . . 8.0600000000000005 109.864 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.6 110.12 19.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.133 -0.485 . . . . 6.8300000000000001 110.016 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.64 81.0 7.85 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.153 -0.476 . . . . 4.4000000000000004 110.518 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.92 -81.88 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.444 -0.884 . . . . 3.3100000000000001 113.033 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.4 t -114.35 -101.24 0.42 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.746 -0.381 . . . . 1.3300000000000001 111.149 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.564 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -92.41 173.69 7.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.164 -0.471 . . . . 1.05 111.511 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 m -75.67 76.1 2.66 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.342 -0.984 . . . . 2.2799999999999998 108.342 168.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.87 -16.95 1.78 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.798 -1.092 . . . . 0.54000000000000004 110.885 -171.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.564 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 82.2 m-85 -120.12 170.45 9.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.409 0.623 . . . . 0.97999999999999998 110.019 174.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 29.6 pt20 -144.38 174.89 10.52 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.523 -0.762 . . . . 2.54 109.297 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 13' ' ' ARG . 11.4 ptp180 -89.54 143.12 27.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.99 0.424 . . . . 3.8300000000000001 110.997 -175.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.444 HG21 ' O ' ' A' ' 18' ' ' ARG . 58.2 p -90.8 -171.65 3.1 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.731 -0.84 . . . . 1.3500000000000001 108.731 171.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.48 -16.36 60.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.921 0.391 . . . . 1.1899999999999999 111.147 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -109.83 -23.29 11.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.019 -0.537 . . . . 2.4500000000000002 111.282 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.2 15.79 8.17 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.138 -1.029 . . . . 0.46999999999999997 112.892 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.444 ' O ' HG21 ' A' ' 14' ' ' THR . 33.6 ttm180 -78.57 155.87 29.45 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.982 -0.747 . . . . 4.2300000000000004 108.982 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.4 m -86.52 107.96 18.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.472 0.653 . . . . 0.37 111.184 -175.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 38.3 ttpt -107.1 130.65 22.55 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.565 -0.743 . . . . 3.1400000000000001 109.559 174.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 32.5 Cg_exo -57.25 148.8 68.24 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.112 1.875 . . . . 0.56999999999999995 111.5 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.1 p -84.83 98.55 10.36 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.001 -0.545 . . . . 1.3899999999999999 112.224 -174.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.558 ' CZ ' ' HB2' ' A' ' 21' ' ' PRO . 51.6 m-85 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.268 -0.872 . . . . 2.9199999999999999 109.934 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.611 0.243 . . . . 12.67 111.217 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -65.4 -60.87 2.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.763 0.316 . . . . 10.84 110.975 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -107.39 95.88 6.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.907 0.384 . . . . 8.0600000000000005 110.264 -178.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.9 15.25 14.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.023 0.44 . . . . 6.8300000000000001 111.21 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -97.23 105.39 17.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.054 -0.521 . . . . 4.4000000000000004 110.966 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.14 -126.57 8.02 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.668 -0.777 . . . . 3.3100000000000001 112.301 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 84.4 m -128.1 172.22 11.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.692 0.246 . . . . 1.3300000000000001 110.385 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.595 ' HB3' ' HD1' ' A' ' 11' ' ' TYR . . . -61.91 168.41 3.16 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.992 -0.549 . . . . 1.05 111.634 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -73.87 -27.23 60.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.268 0.556 . . . . 2.2799999999999998 110.957 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.35 6.8 59.42 Favored Glycine 0 CA--C 1.509 -0.286 0 N-CA-C 110.874 -0.891 . . . . 0.54000000000000004 110.874 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.595 ' HD1' ' HB3' ' A' ' 8' ' ' ALA . 95.4 m-85 -138.57 -173.49 3.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.947 -1.131 . . . . 0.97999999999999998 107.947 178.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -162.22 178.77 8.44 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.05 -0.722 . . . . 2.54 109.05 170.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.41 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 9.3 ptp85 -88.0 134.16 33.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.431 0.634 . . . . 3.8300000000000001 110.5 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.9 p -80.82 -166.15 1.05 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.446 -0.797 . . . . 1.3500000000000001 109.614 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.16 -35.95 80.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.794 0.331 . . . . 1.1899999999999999 111.08 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -101.85 0.06 34.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.2 0.524 . . . . 2.4500000000000002 111.147 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 93.88 26.86 13.61 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.575 -0.821 . . . . 0.46999999999999997 113.675 174.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -88.62 171.69 9.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.24 -0.652 . . . . 4.2300000000000004 109.24 174.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.1 m -97.1 107.03 19.47 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.014 0.376 . . . . 0.37 112.014 -174.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -105.2 130.33 23.27 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 109.491 -0.559 . . . . 3.1400000000000001 109.491 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -61.05 138.37 77.92 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.559 2.173 . . . . 0.56999999999999995 112.144 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 p -86.92 128.91 35.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.241 -0.436 . . . . 1.3899999999999999 110.947 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.604 -0.712 . . . . 2.9199999999999999 110.166 -179.207 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.722 0.296 . . . . 12.67 111.493 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -105.01 10.64 34.03 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.068 0.766 . . . . 10.84 113.068 -166.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -77.77 123.45 26.72 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.427 -0.509 . . . . 8.0600000000000005 109.952 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.72 134.96 37.04 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.979 -0.555 . . . . 6.8300000000000001 111.393 -175.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.93 172.36 7.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.838 -0.619 . . . . 4.4000000000000004 110.477 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 12' ' ' GLN . . . -86.36 -161.87 36.19 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.155 -0.545 . . . . 3.3100000000000001 112.243 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 m -120.05 -87.01 0.64 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.948 0.404 . . . . 1.3300000000000001 110.344 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.686 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -92.51 -176.61 4.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.248 -0.433 . . . . 1.05 110.222 175.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.8 t -64.34 -19.1 65.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.513 0.197 . . . . 2.2799999999999998 111.355 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.74 11.43 7.89 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.721 -0.752 . . . . 0.54000000000000004 112.052 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.686 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 23.7 m-85 -126.27 160.45 30.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.027 -0.36 . . . . 0.97999999999999998 110.027 -176.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.476 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 53.6 tt0 -147.24 159.64 43.41 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.545 -0.539 . . . . 2.54 109.545 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.535 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 11.8 mtp180 -87.62 116.17 25.56 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.478 -0.934 . . . . 3.8300000000000001 108.478 174.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.0 p -79.87 -162.52 0.44 Allowed 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.756 -1.111 . . . . 1.3500000000000001 110.424 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.03 -10.88 33.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.851 0.357 . . . . 1.1899999999999999 110.712 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -107.88 2.25 23.31 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.454 -0.339 . . . . 2.4500000000000002 111.891 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 68.38 11.93 62.73 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.033 -1.079 . . . . 0.46999999999999997 111.031 -172.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -82.3 134.23 35.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.383 -0.599 . . . . 4.2300000000000004 109.383 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.7 m -79.28 93.08 5.22 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.272 0.558 . . . . 0.37 110.652 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -99.52 140.24 21.47 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.491 -0.777 . . . . 3.1400000000000001 109.844 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -66.26 126.12 15.16 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.011 1.807 . . . . 0.56999999999999995 110.757 171.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.2 p -83.98 126.57 33.16 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.021 0.438 . . . . 1.3899999999999999 111.177 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.24 -0.886 . . . . 2.9199999999999999 109.743 179.173 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.48 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.971 0.415 . . . . 0.44 112.02 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -63.96 -15.75 59.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.654 -0.703 . . . . 1.6699999999999999 112.267 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.98 1.91 30.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.644 -0.788 . . . . 0.34000000000000002 111.411 173.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.48 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 4.4 m-85 -117.69 -178.72 3.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.094 0.473 . . . . 0.40999999999999998 110.111 -175.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -160.78 158.55 28.73 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.613 -0.884 . . . . 1.8899999999999999 108.613 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.554 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 15.8 ptt180 -88.32 126.5 35.22 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 108.688 -0.856 . . . . 3.3599999999999999 108.688 174.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.4 p -79.48 -166.63 1.0 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.19 -0.914 . . . . 0.69999999999999996 110.348 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.95 -22.95 67.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.067 0.461 . . . . 0.72999999999999998 110.727 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -108.22 10.01 27.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.008 -0.542 . . . . 2.4500000000000002 111.398 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.554 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 77.69 19.35 75.94 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.499 -0.858 . . . . 0.40999999999999998 112.482 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HE ' ' HB2' ' A' ' 18' ' ' ARG . 13.9 ttm180 -82.56 139.35 33.88 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.837 -0.431 . . . . 3.6299999999999999 109.837 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.1 m -83.89 99.63 10.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.23 0.538 . . . . 0.37 110.505 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -113.73 136.74 22.05 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.816 -0.629 . . . . 2.6099999999999999 109.836 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.21 138.13 83.08 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.043 1.829 . . . . 0.41999999999999998 110.374 171.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--N 1.323 -0.556 0 N-CA-C 113.445 0.906 . . . . 1.3200000000000001 113.445 -168.756 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.573 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.759 0.314 . . . . 0.44 111.375 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.2 m -59.53 -33.56 71.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.908 -0.587 . . . . 1.6699999999999999 110.993 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.49 29.61 5.4 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.863 -0.684 . . . . 0.34000000000000002 111.886 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.573 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 51.2 m-85 -133.44 172.17 13.07 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.98 -0.378 . . . . 0.40999999999999998 109.98 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 4.7 pt20 -151.44 160.04 43.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.124 -0.489 . . . . 1.8899999999999999 110.778 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.624 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 52.6 mtm180 -91.27 115.98 28.46 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.736 -0.468 . . . . 3.3599999999999999 109.736 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.7 p -84.91 -154.13 0.18 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.737 -0.665 . . . . 0.69999999999999996 110.671 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.51 -54.41 22.51 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.234 0.334 . . . . 0.72999999999999998 111.805 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -93.93 20.87 7.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.936 0.398 . . . . 2.4500000000000002 110.829 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.624 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 66.59 26.03 72.85 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.433 -0.889 . . . . 0.40999999999999998 111.63 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 18' ' ' ARG . 12.0 ttm180 -78.78 134.31 37.02 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.105 -0.702 . . . . 3.6299999999999999 109.105 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 77.2 m -78.76 101.46 7.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.331 0.586 . . . . 0.37 111.519 -173.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -102.88 138.1 19.48 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.053 -0.976 . . . . 2.6099999999999999 110.104 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.76 141.92 92.1 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.264 1.976 . . . . 0.41999999999999998 111.131 175.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 C--N 1.32 -0.684 0 CA-C-O 120.936 0.398 . . . . 1.3200000000000001 111.862 -173.696 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 120.601 0.239 . . . . 0.44 111.246 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.0 m -61.49 -29.65 70.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 1.6699999999999999 110.879 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.81 17.72 8.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.125 -0.56 . . . . 0.34000000000000002 112.25 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 17.7 m-85 -127.03 156.96 40.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.042 -0.355 . . . . 0.40999999999999998 110.042 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -146.23 172.52 13.33 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 110.209 -0.293 . . . . 1.8899999999999999 110.209 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -88.97 133.28 34.37 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.248 -0.649 . . . . 3.3599999999999999 109.248 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 18' ' ' ARG . 82.1 p -79.59 -173.32 3.71 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.063 -0.971 . . . . 0.69999999999999996 110.066 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.33 -11.52 57.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.463 0.649 . . . . 0.72999999999999998 110.167 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.675 ' OD2' ' HD3' ' A' ' 18' ' ' ARG . 10.3 p-10 -117.98 18.32 13.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.664 -0.698 . . . . 2.4500000000000002 111.706 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.66 23.83 76.53 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.891 -0.671 . . . . 0.40999999999999998 113.776 170.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.675 ' HD3' ' OD2' ' A' ' 16' ' ' ASP . 31.3 mtp180 -104.72 147.1 28.05 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 117.079 0.439 . . . . 3.6299999999999999 110.016 176.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.6 m -81.81 111.24 17.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.363 0.601 . . . . 0.37 111.35 -173.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.454 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 56.0 tttp -113.05 137.2 21.83 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.391 -0.822 . . . . 2.6099999999999999 109.091 176.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 8.5 Cg_exo -70.02 141.73 44.94 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.433 2.088 . . . . 0.41999999999999998 111.145 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 p . . . . . 0 C--N 1.323 -0.582 0 CA-C-O 120.901 0.381 . . . . 1.3200000000000001 111.753 -175.821 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.512 ' HB3' ' HD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.457 -0.113 0 N-CA-C 110.443 -0.206 . . . . 0.44 110.443 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.3 m -56.09 -41.25 74.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.177 0.513 . . . . 1.6699999999999999 110.858 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.594 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -113.63 31.17 6.75 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.805 -0.712 . . . . 0.34000000000000002 112.167 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.512 ' HD1' ' HB3' ' A' ' 8' ' ' ALA . 60.8 m-85 -138.13 158.14 44.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.25 0.547 . . . . 0.40999999999999998 110.57 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 27.3 tt0 -146.17 155.77 42.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.631 -0.713 . . . . 1.8899999999999999 109.886 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.615 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 83.2 mtm180 -87.05 120.2 28.06 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.438 -0.578 . . . . 3.3599999999999999 109.438 176.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.1 p -79.59 -162.32 0.41 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.988 -1.005 . . . . 0.69999999999999996 110.59 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.89 -18.43 62.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.78 0.324 . . . . 0.72999999999999998 111.282 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.515 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 4.0 m-20 -105.11 2.89 29.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.312 -0.404 . . . . 2.4500000000000002 110.854 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.615 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 74.89 12.25 83.24 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 119.98 -1.105 . . . . 0.40999999999999998 111.333 -173.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HG3' ' HB2' ' A' ' 16' ' ' ASP . 54.0 mtm180 -79.57 137.22 37.08 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.367 -0.605 . . . . 3.6299999999999999 109.367 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 72.4 m -79.61 103.1 9.29 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.921 -0.581 . . . . 0.37 111.244 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -104.5 139.53 20.19 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.587 -0.733 . . . . 2.6099999999999999 109.728 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 36.9 Cg_exo -57.08 136.31 75.85 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.626 2.218 . . . . 0.41999999999999998 112.065 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 1.3200000000000001 111.084 179.477 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.432 ' N ' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 110.378 -0.23 . . . . 0.44 110.378 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 m -63.91 -23.19 67.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.224 0.535 . . . . 1.6699999999999999 110.582 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.08 24.44 5.38 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.836 -0.62 . . . . 0.34000000000000002 111.637 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.432 ' HB2' ' N ' ' A' ' 8' ' ' ALA . 40.4 m-85 -135.11 155.86 50.0 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.159 0.504 . . . . 0.40999999999999998 110.181 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -138.76 156.75 47.11 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.89 -0.595 . . . . 1.8899999999999999 110.077 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.554 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 65.1 mtp180 -88.76 122.77 32.52 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.277 -0.638 . . . . 3.3599999999999999 109.277 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.2 p -79.87 -168.74 1.71 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.674 -0.693 . . . . 0.69999999999999996 110.046 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.3 -19.73 48.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.105 0.479 . . . . 0.72999999999999998 111.272 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -111.99 10.94 20.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.43 0.633 . . . . 2.4500000000000002 110.621 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 71.01 15.51 74.27 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.62 -0.718 . . . . 0.40999999999999998 112.868 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -79.68 139.59 37.33 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.009 -0.737 . . . . 3.6299999999999999 109.009 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.9 98.47 7.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.524 0.678 . . . . 0.37 111.351 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 81.6 tttt -101.99 133.55 20.62 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.154 -0.93 . . . . 2.6099999999999999 109.615 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 22.9 Cg_exo -62.97 138.04 65.78 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.325 2.017 . . . . 0.41999999999999998 112.314 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 116.402 -0.363 . . . . 1.3200000000000001 110.877 178.593 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 121.03 0.443 . . . . 0.44 111.633 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 p -69.93 -14.96 62.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.617 -0.719 . . . . 1.6699999999999999 111.071 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.37 21.29 5.16 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.934 -0.866 . . . . 0.34000000000000002 110.934 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.482 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 51.0 m-85 -136.66 153.1 51.0 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.336 0.589 . . . . 0.40999999999999998 110.49 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -136.15 160.13 39.6 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.444 -0.798 . . . . 1.8899999999999999 109.852 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.435 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 25.7 ptt180 -87.11 129.7 34.82 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.739 -0.837 . . . . 3.3599999999999999 108.739 175.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.2 p -81.07 -170.3 2.65 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.872 -0.604 . . . . 0.69999999999999996 109.541 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.29 -17.75 62.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.307 0.575 . . . . 0.72999999999999998 110.723 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -113.69 14.72 18.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.444 -0.798 . . . . 2.4500000000000002 111.531 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 69.34 24.87 75.9 Favored Glycine 0 C--O 1.235 0.187 0 C-N-CA 121.277 -0.487 . . . . 0.40999999999999998 113.161 174.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -91.03 143.33 26.82 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.163 -0.68 . . . . 3.6299999999999999 109.163 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.69 100.12 7.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.265 0.555 . . . . 0.37 110.913 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -97.72 134.31 22.53 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.269 -0.878 . . . . 2.6099999999999999 110.305 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -66.3 141.6 63.07 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.03 1.82 . . . . 0.41999999999999998 110.205 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.3 p . . . . . 0 C--N 1.319 -0.723 0 CA-C-O 121.065 0.459 . . . . 1.3200000000000001 112.118 -172.498 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 121.055 0.455 . . . . 0.44 112.147 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -69.08 -38.85 79.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.138 0.494 . . . . 1.6699999999999999 110.297 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.56 -3.18 86.39 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.563 -0.615 . . . . 0.34000000000000002 111.563 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 10.0 m-85 -117.43 178.77 4.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.898 -0.408 . . . . 0.40999999999999998 109.898 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.445 ' HB3' HG22 ' A' ' 22' ' ' THR . 13.6 pt20 -159.24 179.09 9.31 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.594 -0.521 . . . . 1.8899999999999999 109.594 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.552 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 39.1 ptt180 -88.37 133.68 34.03 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.378 0.609 . . . . 3.3599999999999999 110.61 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.6 p -81.72 -167.02 1.35 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.366 -0.834 . . . . 0.69999999999999996 109.57 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.61 69.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.955 0.354 . . . . 0.72999999999999998 111.955 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -105.17 6.09 32.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.374 -0.376 . . . . 2.4500000000000002 111.494 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.552 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 83.48 41.34 8.44 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.354 -0.927 . . . . 0.40999999999999998 112.779 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -99.17 178.36 4.94 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.832 -1.173 . . . . 3.6299999999999999 107.832 172.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.1 m -103.92 123.88 47.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.986 0.422 . . . . 0.37 111.671 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -139.8 143.72 35.92 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.771 -0.65 . . . . 2.6099999999999999 109.401 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.44 147.3 22.75 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.877 2.384 . . . . 0.41999999999999998 112.329 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 12' ' ' GLN . 43.6 p . . . . . 0 C--N 1.32 -0.701 0 N-CA-C 112.568 0.581 . . . . 1.3200000000000001 112.568 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 120.601 0.238 . . . . 0.44 111.109 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -66.14 -25.24 66.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.855 0.36 . . . . 1.6699999999999999 110.505 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -121.53 21.76 7.98 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.151 -0.547 . . . . 0.34000000000000002 112.136 175.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.519 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 54.6 m-85 -134.71 149.88 50.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.995 0.426 . . . . 0.40999999999999998 110.385 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -131.85 154.23 49.38 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.92 -0.582 . . . . 1.8899999999999999 109.437 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.627 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 11.2 ptm180 -87.89 147.04 25.27 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.487 0.661 . . . . 3.3599999999999999 109.733 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 p -99.76 -164.53 1.13 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.705 -1.134 . . . . 0.69999999999999996 109.473 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.98 -34.7 63.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.007 0.432 . . . . 0.72999999999999998 111.187 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.37 -3.76 57.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.971 -0.559 . . . . 2.4500000000000002 111.609 -175.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.627 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 82.21 6.42 88.8 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.105 -1.045 . . . . 0.40999999999999998 110.635 -174.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -79.21 133.03 36.7 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.617 -0.512 . . . . 3.6299999999999999 109.617 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.27 127.35 32.26 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.097 -0.502 . . . . 0.37 112.24 -171.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 63.3 mttp -123.3 142.09 37.71 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.658 -0.701 . . . . 2.6099999999999999 109.165 170.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 13.0 Cg_exo -68.3 144.19 61.3 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.081 2.521 . . . . 0.41999999999999998 112.011 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.2 p . . . . . 0 C--N 1.318 -0.779 0 CA-C-N 115.984 -0.553 . . . . 1.3200000000000001 111.163 179.726 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.518 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 109.56 -0.533 . . . . 0.44 109.56 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 m -61.01 -37.24 81.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.038 0.447 . . . . 1.6699999999999999 110.965 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.78 29.03 7.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.719 -0.753 . . . . 0.34000000000000002 112.078 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.518 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 27.5 m-85 -133.64 163.65 28.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.034 0.445 . . . . 0.40999999999999998 110.698 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -153.32 175.88 12.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.969 -0.56 . . . . 1.8899999999999999 109.881 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -88.66 139.17 30.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.256 0.551 . . . . 3.3599999999999999 110.645 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.2 p -83.0 -173.37 4.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.203 -0.908 . . . . 0.69999999999999996 108.792 172.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.76 -4.83 21.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.008 0.432 . . . . 0.72999999999999998 110.724 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.448 ' OD2' ' HD3' ' A' ' 18' ' ' ARG . 22.2 t70 -108.4 6.81 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.872 -0.604 . . . . 2.4500000000000002 110.476 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.47 4.37 84.39 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.832 -0.622 . . . . 0.40999999999999998 113.051 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.448 ' HD3' ' OD2' ' A' ' 16' ' ' ASP . 36.0 mtp180 -96.49 159.54 14.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.682 0.277 . . . . 3.6299999999999999 110.668 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.2 m -88.54 122.32 31.87 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.579 0.704 . . . . 0.37 112.7 -168.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -121.68 139.72 30.5 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 114.991 -1.004 . . . . 2.6099999999999999 110.257 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -58.27 148.22 80.18 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.397 2.065 . . . . 0.41999999999999998 111.19 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 C--N 1.32 -0.71 0 CA-C-O 121.208 0.528 . . . . 1.3200000000000001 111.849 -174.66 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.574 ' HB3' ' HD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.392 0.139 . . . . 0.44 110.686 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -22.95 62.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.28 0.562 . . . . 1.6699999999999999 110.801 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.73 16.74 25.87 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.235 -0.746 . . . . 0.34000000000000002 111.235 175.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.574 ' HD1' ' HB3' ' A' ' 8' ' ' ALA . 64.7 m-85 -136.16 173.29 11.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.43 0.633 . . . . 0.40999999999999998 110.982 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 9.8 pt20 -148.46 171.96 15.24 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.874 -0.787 . . . . 1.8899999999999999 108.874 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.565 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 11.0 ptp180 -104.46 139.04 39.96 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.608 0.718 . . . . 3.3599999999999999 110.408 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.0 p -79.39 -172.45 3.22 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.702 -1.135 . . . . 0.69999999999999996 109.167 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.03 -31.59 67.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.131 0.491 . . . . 0.72999999999999998 110.789 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.36 -14.28 20.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.126 -0.488 . . . . 2.4500000000000002 111.937 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.565 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 105.52 18.3 12.08 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 119.729 -1.224 . . . . 0.40999999999999998 113.364 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -80.02 141.34 36.01 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.159 -0.682 . . . . 3.6299999999999999 109.159 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 64.1 m -82.02 109.68 16.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.244 0.545 . . . . 0.37 111.727 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 17.5 tptp -110.28 136.76 20.51 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.54 -0.755 . . . . 2.6099999999999999 109.339 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.68 141.93 74.12 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.72 2.28 . . . . 0.41999999999999998 112.34 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.985 0.421 . . . . 1.3200000000000001 110.87 178.693 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 120.696 0.284 . . . . 0.44 110.747 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -62.69 -29.06 70.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.998 -0.546 . . . . 1.6699999999999999 110.714 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.41 30.27 4.77 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.671 -0.695 . . . . 0.34000000000000002 111.875 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.568 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 37.6 m-85 -136.34 161.14 36.63 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.307 0.575 . . . . 0.40999999999999998 111.0 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -143.54 163.98 31.66 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.765 -0.652 . . . . 1.8899999999999999 109.945 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.2 mtm180 -89.73 127.82 36.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.139 0.495 . . . . 3.3599999999999999 109.999 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.3 p -80.51 -176.52 5.76 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.386 -0.825 . . . . 0.69999999999999996 109.12 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.77 47.77 0.26 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.229 0.538 . . . . 0.72999999999999998 111.25 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -161.04 -35.8 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.521 -0.763 . . . . 2.4500000000000002 110.828 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.36 -0.39 23.67 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.416 -0.897 . . . . 0.40999999999999998 110.945 -171.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -78.12 133.85 37.78 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.395 -0.594 . . . . 3.6299999999999999 109.395 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.1 m -86.2 126.46 34.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.265 -0.425 . . . . 0.37 111.223 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.535 ' HG3' ' HD2' ' A' ' 21' ' ' PRO . 36.0 ttmt -124.19 140.49 35.04 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.858 -0.61 . . . . 2.6099999999999999 109.474 176.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.535 ' HD2' ' HG3' ' A' ' 20' ' ' LYS . 44.6 Cg_exo -55.12 145.11 66.43 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.047 2.498 . . . . 0.41999999999999998 112.013 177.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.9 p . . . . . 0 C--N 1.318 -0.803 0 CA-C-N 116.075 -0.511 . . . . 1.3200000000000001 111.714 -177.181 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.523 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 C--O 1.228 -0.06 0 N-CA-C 112.367 0.506 . . . . 0.44 112.367 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -31.82 71.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.727 -0.669 . . . . 1.6699999999999999 110.802 175.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.45 10.76 73.98 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.965 -0.636 . . . . 0.34000000000000002 111.725 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.523 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 47.5 m-85 -130.83 -179.87 5.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.002 0.429 . . . . 0.40999999999999998 110.057 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -157.93 171.19 20.71 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.939 -0.763 . . . . 1.8899999999999999 108.939 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.2 ptp180 -89.07 138.24 31.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.1 0.476 . . . . 3.3599999999999999 110.664 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.6 p -87.65 -167.77 2.0 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.615 -0.72 . . . . 0.69999999999999996 109.394 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.15 -31.58 70.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.89 0.376 . . . . 0.72999999999999998 110.874 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -107.4 19.98 19.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.889 0.852 . . . . 2.4500000000000002 110.384 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 69.44 25.89 75.06 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.321 -0.854 . . . . 0.40999999999999998 113.297 175.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 16.0 mmt180 -87.77 169.01 12.46 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.644 -0.873 . . . . 3.6299999999999999 108.644 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.1 m -98.16 113.46 25.37 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.162 0.506 . . . . 0.37 111.886 -174.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -111.15 136.53 20.86 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.345 -0.843 . . . . 2.6099999999999999 109.73 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.24 134.44 48.87 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.646 2.231 . . . . 0.41999999999999998 112.209 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.552 -0.295 . . . . 1.3200000000000001 110.871 179.733 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.507 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 109.874 -0.417 . . . . 0.44 109.874 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 m -61.5 -36.39 80.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.044 0.45 . . . . 1.6699999999999999 110.848 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.16 25.1 14.59 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.943 -0.646 . . . . 0.34000000000000002 111.798 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.507 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 43.9 m-85 -134.62 166.27 23.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.251 0.548 . . . . 0.40999999999999998 110.674 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -158.74 146.83 18.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.19 -0.671 . . . . 1.8899999999999999 109.19 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 17.3 ptp180 -87.85 125.59 34.55 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.595 0.712 . . . . 3.3599999999999999 109.517 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.1 p -80.63 -164.51 0.72 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.447 -1.251 . . . . 0.69999999999999996 110.186 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.77 -11.88 41.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.032 0.444 . . . . 0.72999999999999998 111.032 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.427 ' HB3' ' HG2' ' A' ' 18' ' ' ARG . 8.0 t70 -102.47 1.35 35.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.318 0.58 . . . . 2.4500000000000002 111.078 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 74.54 13.41 81.89 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.934 -0.651 . . . . 0.40999999999999998 112.045 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 13.9 mmt180 -93.11 137.61 32.3 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.015 -0.365 . . . . 3.6299999999999999 110.015 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.3 m -79.45 98.07 6.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.922 -0.581 . . . . 0.37 110.494 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -98.19 139.04 20.97 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.447 -0.797 . . . . 2.6099999999999999 109.122 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.32 121.5 9.72 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.42 2.08 . . . . 0.41999999999999998 111.33 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 121.124 0.488 . . . . 1.3200000000000001 111.072 -179.39 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 110.342 -0.244 . . . . 0.44 110.342 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -71.93 -7.36 48.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.14 0.495 . . . . 1.6699999999999999 111.029 177.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.94 22.31 3.29 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.753 -0.939 . . . . 0.34000000000000002 110.753 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.453 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 18.2 m-85 -134.27 155.92 49.35 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.984 -0.376 . . . . 0.40999999999999998 109.984 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -144.77 155.46 43.54 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.55 -0.537 . . . . 1.8899999999999999 109.55 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.633 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 99.5 mtt180 -88.67 120.34 29.97 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.466 0.651 . . . . 3.3599999999999999 109.655 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.462 HG21 ' HD2' ' A' ' 20' ' ' LYS . 58.9 p -80.43 -163.3 0.55 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.493 -1.231 . . . . 0.69999999999999996 110.606 -177.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.81 -27.48 59.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.896 0.332 . . . . 0.72999999999999998 111.896 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.17 1.59 45.07 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.601 -0.272 . . . . 2.4500000000000002 111.469 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.633 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 79.89 12.64 83.23 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.186 -1.007 . . . . 0.40999999999999998 111.526 -175.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -84.87 142.77 29.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.546 -0.327 . . . . 3.6299999999999999 110.5 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.1 m -82.89 104.01 12.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.186 -0.461 . . . . 0.37 111.573 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.462 ' HD2' HG21 ' A' ' 14' ' ' THR . 87.4 mttt -108.24 146.1 32.87 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.021 -0.536 . . . . 2.6099999999999999 109.837 172.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 4.9 Cg_exo -72.93 129.14 13.93 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.38 2.054 . . . . 0.41999999999999998 112.206 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 116.095 -0.502 . . . . 1.3200000000000001 110.502 176.885 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 110.147 -0.316 . . . . 0.44 110.147 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -65.31 -25.7 67.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.113 0.482 . . . . 1.6699999999999999 110.386 174.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.08 24.92 8.58 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.078 -0.582 . . . . 0.34000000000000002 111.756 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.438 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 39.7 m-85 -141.21 160.26 40.49 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.045 0.45 . . . . 0.40999999999999998 110.913 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -144.67 171.64 14.11 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.86 -0.609 . . . . 1.8899999999999999 109.815 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.405 ' HE ' ' HA2' ' A' ' 17' ' ' GLY . 48.2 mtp180 -89.08 142.17 27.87 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.252 0.549 . . . . 3.3599999999999999 110.687 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 p -90.08 -175.78 4.67 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.616 -0.883 . . . . 0.69999999999999996 108.616 171.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.35 -14.99 31.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.004 0.43 . . . . 0.72999999999999998 110.911 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -107.97 10.54 28.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.028 -0.533 . . . . 2.4500000000000002 111.246 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.405 ' HA2' ' HE ' ' A' ' 13' ' ' ARG . . . 74.49 5.76 74.07 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.038 -0.601 . . . . 0.40999999999999998 113.206 176.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -80.05 150.92 30.17 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.524 -0.547 . . . . 3.6299999999999999 109.524 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.2 m -86.17 110.22 19.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.478 0.656 . . . . 0.37 111.09 -174.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 46.9 tttp -101.5 136.89 19.52 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.075 -0.966 . . . . 2.6099999999999999 109.37 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 24.4 Cg_exo -62.76 140.08 78.43 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.292 1.995 . . . . 0.41999999999999998 111.995 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.6 p . . . . . 0 C--N 1.326 -0.443 0 CA-C-O 120.7 0.286 . . . . 1.3200000000000001 110.875 179.142 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.142 0 N-CA-C 112.192 0.442 . . . . 0.44 112.192 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.7 m -66.27 -36.96 84.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.954 -0.566 . . . . 1.6699999999999999 110.861 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.03 6.04 84.06 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.128 -0.558 . . . . 0.34000000000000002 111.872 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -123.83 -179.44 4.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.008 -0.738 . . . . 0.40999999999999998 109.008 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -161.26 170.35 20.4 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.916 -0.402 . . . . 1.8899999999999999 109.916 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 76.1 mtm180 -88.43 123.7 33.23 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.224 0.535 . . . . 3.3599999999999999 109.702 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.437 ' C ' ' H ' ' A' ' 16' ' ' ASP . 70.7 p -80.88 -167.7 1.5 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.116 -0.947 . . . . 0.69999999999999996 110.614 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.69 41.37 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.009 0.433 . . . . 0.72999999999999998 111.651 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.476 ' OD2' ' HG3' ' A' ' 18' ' ' ARG . 19.4 t70 -160.55 -31.75 0.06 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.708 -0.678 . . . . 2.4500000000000002 109.662 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.33 -0.64 20.66 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.576 -0.821 . . . . 0.40999999999999998 112.004 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.476 ' HG3' ' OD2' ' A' ' 16' ' ' ASP . 74.4 mtp180 -79.16 164.36 24.29 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.058 -0.349 . . . . 3.6299999999999999 110.058 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.3 m -104.7 110.83 23.32 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.861 -0.609 . . . . 0.37 111.465 -172.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 30.4 mtpp -121.66 146.69 46.2 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.861 -0.609 . . . . 2.6099999999999999 109.958 174.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 23.5 Cg_exo -63.49 148.26 92.66 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.909 2.406 . . . . 0.41999999999999998 111.97 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.3 p . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.956 -0.565 . . . . 1.3200000000000001 110.756 179.228 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.689 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 112.886 0.698 . . . . 0.44 112.886 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -65.1 -33.97 77.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.545 -0.752 . . . . 1.6699999999999999 111.05 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.34 6.65 80.86 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.936 -0.649 . . . . 0.34000000000000002 111.552 176.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.689 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 30.9 m-85 -123.09 178.18 5.2 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.653 -0.499 . . . . 0.40999999999999998 109.653 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -161.1 170.92 19.5 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.094 -0.706 . . . . 1.8899999999999999 109.094 171.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.578 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.3 ptp180 -88.5 137.63 32.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.303 0.573 . . . . 3.3599999999999999 110.922 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 18' ' ' ARG . 48.3 p -86.54 -165.32 1.24 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.031 -0.986 . . . . 0.69999999999999996 109.845 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.01 -18.62 65.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.644 0.259 . . . . 0.72999999999999998 111.406 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -109.54 -6.6 15.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.614 0.721 . . . . 2.4500000000000002 110.594 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 91.24 20.1 39.82 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.168 -1.015 . . . . 0.40999999999999998 111.92 -177.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 18' ' ' ARG . 1.8 mmp_? -79.23 155.69 28.47 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.88 -0.785 . . . . 3.6299999999999999 108.88 175.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -91.04 99.95 12.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.494 0.664 . . . . 0.37 111.708 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -96.92 127.95 37.25 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.01 -0.995 . . . . 2.6099999999999999 109.71 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.92 147.19 96.25 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.653 2.235 . . . . 0.41999999999999998 111.75 176.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.205 -0.452 . . . . 1.3200000000000001 110.865 179.328 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.575 ' HB3' ' HD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 120.77 0.319 . . . . 0.44 111.511 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 m -75.67 76.1 2.66 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.342 -0.984 . . . . 1.6699999999999999 108.342 168.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.87 -16.95 1.78 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.798 -1.092 . . . . 0.34000000000000002 110.885 -171.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.575 ' HD1' ' HB3' ' A' ' 8' ' ' ALA . 82.2 m-85 -120.12 170.45 9.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.409 0.623 . . . . 0.40999999999999998 110.019 174.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 29.6 pt20 -144.38 174.89 10.52 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.523 -0.762 . . . . 1.8899999999999999 109.297 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 13' ' ' ARG . 11.4 ptp180 -89.54 143.12 27.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.99 0.424 . . . . 3.3599999999999999 110.997 -175.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 18' ' ' ARG . 58.2 p -90.8 -171.65 3.1 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.731 -0.84 . . . . 0.69999999999999996 108.731 171.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.48 -16.36 60.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.921 0.391 . . . . 0.72999999999999998 111.147 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -109.83 -23.29 11.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.019 -0.537 . . . . 2.4500000000000002 111.282 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.2 15.79 8.17 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.138 -1.029 . . . . 0.40999999999999998 112.892 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.446 ' O ' HG23 ' A' ' 14' ' ' THR . 33.6 ttm180 -78.57 155.87 29.45 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.982 -0.747 . . . . 3.6299999999999999 108.982 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.4 m -86.52 107.96 18.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.472 0.653 . . . . 0.37 111.184 -175.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 38.3 ttpt -107.1 130.65 22.55 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.565 -0.743 . . . . 2.6099999999999999 109.559 174.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.25 148.8 68.24 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.112 1.875 . . . . 0.41999999999999998 111.5 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.1 p . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 116.001 -0.545 . . . . 1.3200000000000001 112.224 -174.541 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.608 ' HB3' ' HD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 C--O 1.22 -0.455 0 N-CA-C 111.634 0.235 . . . . 0.44 111.634 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -73.87 -27.23 60.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.268 0.556 . . . . 1.6699999999999999 110.957 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.35 6.8 59.42 Favored Glycine 0 CA--C 1.509 -0.286 0 N-CA-C 110.874 -0.891 . . . . 0.34000000000000002 110.874 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.608 ' HD1' ' HB3' ' A' ' 8' ' ' ALA . 95.4 m-85 -138.57 -173.49 3.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.947 -1.131 . . . . 0.40999999999999998 107.947 178.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -162.22 178.77 8.44 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.05 -0.722 . . . . 1.8899999999999999 109.05 170.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.439 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 9.3 ptp85 -88.0 134.16 33.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.431 0.634 . . . . 3.3599999999999999 110.5 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.9 p -80.82 -166.15 1.05 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.446 -0.797 . . . . 0.69999999999999996 109.614 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.16 -35.95 80.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.794 0.331 . . . . 0.72999999999999998 111.08 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -101.85 0.06 34.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.2 0.524 . . . . 2.4500000000000002 111.147 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.439 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 93.88 26.86 13.61 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.575 -0.821 . . . . 0.40999999999999998 113.675 174.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -88.62 171.69 9.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.24 -0.652 . . . . 3.6299999999999999 109.24 174.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.1 m -97.1 107.03 19.47 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.014 0.376 . . . . 0.37 112.014 -174.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -105.2 130.33 23.27 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 109.491 -0.559 . . . . 2.6099999999999999 109.491 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -61.05 138.37 77.92 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.559 2.173 . . . . 0.41999999999999998 112.144 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 116.241 -0.436 . . . . 1.3200000000000001 110.947 -179.568 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 110.222 -0.288 . . . . 0.44 110.222 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.8 t -64.34 -19.1 65.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.513 0.197 . . . . 1.6699999999999999 111.355 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.74 11.43 7.89 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.721 -0.752 . . . . 0.34000000000000002 112.052 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.505 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 23.7 m-85 -126.27 160.45 30.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.027 -0.36 . . . . 0.40999999999999998 110.027 -176.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -147.24 159.64 43.41 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.545 -0.539 . . . . 1.8899999999999999 109.545 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.537 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 11.8 mtp180 -87.62 116.17 25.56 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.478 -0.934 . . . . 3.3599999999999999 108.478 174.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.0 p -79.87 -162.52 0.44 Allowed 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.756 -1.111 . . . . 0.69999999999999996 110.424 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.03 -10.88 33.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.851 0.357 . . . . 0.72999999999999998 110.712 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -107.88 2.25 23.31 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.454 -0.339 . . . . 2.4500000000000002 111.891 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.537 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 68.38 11.93 62.73 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.033 -1.079 . . . . 0.40999999999999998 111.031 -172.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -82.3 134.23 35.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.383 -0.599 . . . . 3.6299999999999999 109.383 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.7 m -79.28 93.08 5.22 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.272 0.558 . . . . 0.37 110.652 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -99.52 140.24 21.47 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.491 -0.777 . . . . 2.6099999999999999 109.844 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -66.26 126.12 15.16 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.011 1.807 . . . . 0.41999999999999998 110.757 171.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 C--N 1.318 -0.772 0 CA-C-O 121.021 0.438 . . . . 1.3200000000000001 111.177 -179.069 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 120.489 0.185 . . . . 12.67 110.973 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -97.36 -69.41 0.76 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.063 0.459 . . . . 10.640000000000001 110.081 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -98.85 111.69 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.567 0.698 . . . . 7.8700000000000001 110.175 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.09 84.45 7.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.817 -0.629 . . . . 6.4800000000000004 110.007 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -146.63 -121.8 0.07 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.538 -0.756 . . . . 4.25 110.373 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.625 ' HA2' ' HG2' ' A' ' 13' ' ' ARG . . . -169.53 -155.86 10.34 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.511 -0.852 . . . . 2.7400000000000002 112.513 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 84.1 m -115.88 -146.37 0.4 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.28 -0.267 . . . . 1.1499999999999999 110.28 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.48 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . -54.82 162.95 1.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.971 0.415 . . . . 0.44 112.02 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -63.96 -15.75 59.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.654 -0.703 . . . . 1.6699999999999999 112.267 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.98 1.91 30.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.644 -0.788 . . . . 0.34000000000000002 111.411 173.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.48 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 4.4 m-85 -117.69 -178.72 3.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.094 0.473 . . . . 0.40999999999999998 110.111 -175.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -160.78 158.55 28.73 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.613 -0.884 . . . . 1.8899999999999999 108.613 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.625 ' HG2' ' HA2' ' A' ' 6' ' ' GLY . 15.8 ptt180 -88.32 126.5 35.22 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 108.688 -0.856 . . . . 3.3599999999999999 108.688 174.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.4 p -79.48 -166.63 1.0 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.19 -0.914 . . . . 0.69999999999999996 110.348 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.95 -22.95 67.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.067 0.461 . . . . 0.72999999999999998 110.727 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -108.22 10.01 27.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.008 -0.542 . . . . 2.4500000000000002 111.398 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.554 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 77.69 19.35 75.94 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.499 -0.858 . . . . 0.40999999999999998 112.482 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HE ' ' HB2' ' A' ' 18' ' ' ARG . 13.9 ttm180 -82.56 139.35 33.88 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.837 -0.431 . . . . 3.6299999999999999 109.837 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.1 m -83.89 99.63 10.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.23 0.538 . . . . 0.37 110.505 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -113.73 136.74 22.05 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.816 -0.629 . . . . 2.6099999999999999 109.836 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.645 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 34.5 Cg_exo -59.21 138.13 83.08 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.043 1.829 . . . . 0.41999999999999998 110.374 171.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -81.18 -53.84 6.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.445 0.906 . . . . 1.3200000000000001 113.445 -168.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.645 ' CE2' ' HB2' ' A' ' 21' ' ' PRO . 91.8 m-85 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.105 -0.95 . . . . 2.9199999999999999 110.59 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 109.132 -0.692 . . . . 12.67 109.132 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -61.34 -40.87 95.84 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.003 -0.74 . . . . 10.640000000000001 109.003 171.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -144.78 137.64 26.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.208 -1.034 . . . . 7.8700000000000001 108.208 170.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.77 121.41 44.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.787 0.327 . . . . 6.4800000000000004 111.023 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.57 -84.34 0.61 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.806 -0.633 . . . . 4.25 110.878 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.61 -75.16 2.27 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.187 -1.006 . . . . 2.7400000000000002 111.741 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.2 m -106.35 -107.13 0.31 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.777 0.322 . . . . 1.1499999999999999 110.825 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.731 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.4 -176.46 4.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.347 -0.388 . . . . 0.44 111.375 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.2 m -59.53 -33.56 71.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.908 -0.587 . . . . 1.6699999999999999 110.993 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.49 29.61 5.4 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.863 -0.684 . . . . 0.34000000000000002 111.886 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.731 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 51.2 m-85 -133.44 172.17 13.07 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.98 -0.378 . . . . 0.40999999999999998 109.98 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 4.7 pt20 -151.44 160.04 43.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.124 -0.489 . . . . 1.8899999999999999 110.778 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.624 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 52.6 mtm180 -91.27 115.98 28.46 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.736 -0.468 . . . . 3.3599999999999999 109.736 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.7 p -84.91 -154.13 0.18 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.737 -0.665 . . . . 0.69999999999999996 110.671 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.51 -54.41 22.51 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.234 0.334 . . . . 0.72999999999999998 111.805 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -93.93 20.87 7.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.936 0.398 . . . . 2.4500000000000002 110.829 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.624 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 66.59 26.03 72.85 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.433 -0.889 . . . . 0.40999999999999998 111.63 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 18' ' ' ARG . 12.0 ttm180 -78.78 134.31 37.02 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.105 -0.702 . . . . 3.6299999999999999 109.105 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 77.2 m -78.76 101.46 7.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.331 0.586 . . . . 0.37 111.519 -173.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -102.88 138.1 19.48 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.053 -0.976 . . . . 2.6099999999999999 110.104 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.644 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 26.5 Cg_exo -61.76 141.92 92.1 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.264 1.976 . . . . 0.41999999999999998 111.131 175.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.8 p -81.09 122.89 27.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.936 0.398 . . . . 1.3200000000000001 111.862 -173.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.644 ' CE2' ' HB2' ' A' ' 21' ' ' PRO . 66.3 m-85 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 118.332 -0.842 . . . . 2.9199999999999999 109.554 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.275 -0.269 . . . . 12.67 110.275 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -149.68 -76.45 0.15 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.59 0.233 . . . . 10.640000000000001 110.576 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -116.23 -73.35 0.65 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.008 0.432 . . . . 7.8700000000000001 110.228 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.41 -74.45 0.07 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.033 -0.53 . . . . 6.4800000000000004 109.914 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.48 157.09 39.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.709 -0.678 . . . . 4.25 109.794 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 12' ' ' GLN . . . -77.13 -79.26 0.7 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.777 -0.725 . . . . 2.7400000000000002 112.928 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.442 ' N ' ' HA ' ' A' ' 12' ' ' GLN . 22.6 m -128.73 -95.45 0.41 Allowed 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.501 -0.411 . . . . 1.1499999999999999 110.906 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.737 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.72 -175.61 4.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.457 -0.338 . . . . 0.44 111.246 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.0 m -61.49 -29.65 70.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 1.6699999999999999 110.879 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.81 17.72 8.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.125 -0.56 . . . . 0.34000000000000002 112.25 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.737 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 17.7 m-85 -127.03 156.96 40.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.042 -0.355 . . . . 0.40999999999999998 110.042 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.511 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 13.1 pt20 -146.23 172.52 13.33 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 110.209 -0.293 . . . . 1.8899999999999999 110.209 175.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -88.97 133.28 34.37 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.248 -0.649 . . . . 3.3599999999999999 109.248 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 18' ' ' ARG . 82.1 p -79.59 -173.32 3.71 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.063 -0.971 . . . . 0.69999999999999996 110.066 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.33 -11.52 57.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.463 0.649 . . . . 0.72999999999999998 110.167 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.675 ' OD2' ' HD3' ' A' ' 18' ' ' ARG . 10.3 p-10 -117.98 18.32 13.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.664 -0.698 . . . . 2.4500000000000002 111.706 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.66 23.83 76.53 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.891 -0.671 . . . . 0.40999999999999998 113.776 170.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.675 ' HD3' ' OD2' ' A' ' 16' ' ' ASP . 31.3 mtp180 -104.72 147.1 28.05 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 117.079 0.439 . . . . 3.6299999999999999 110.016 176.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.6 m -81.81 111.24 17.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.363 0.601 . . . . 0.37 111.35 -173.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.454 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 56.0 tttp -113.05 137.2 21.83 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.391 -0.822 . . . . 2.6099999999999999 109.091 176.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.486 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 8.5 Cg_exo -70.02 141.73 44.94 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.433 2.088 . . . . 0.41999999999999998 111.145 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 p -87.57 105.29 17.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.901 0.381 . . . . 1.3200000000000001 111.753 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' A' ' 21' ' ' PRO . 76.8 m-85 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.339 -0.839 . . . . 2.9199999999999999 109.617 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.474 0.178 . . . . 12.67 111.096 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -60.52 -43.18 97.39 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.096 0.474 . . . . 10.640000000000001 110.324 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -120.46 136.71 54.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.892 -0.595 . . . . 7.8700000000000001 110.433 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.06 -40.48 0.92 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.317 -0.856 . . . . 6.4800000000000004 109.43 174.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.46 128.79 33.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.553 -0.749 . . . . 4.25 110.058 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 12' ' ' GLN . . . -69.59 -39.99 78.09 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.8 -0.714 . . . . 2.7400000000000002 112.251 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.517 ' SG ' ' HG3' ' A' ' 13' ' ' ARG . 2.9 m -132.97 -90.15 0.4 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.858 -0.423 . . . . 1.1499999999999999 109.858 177.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.782 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -92.94 -175.09 3.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.158 -0.473 . . . . 0.44 110.443 175.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.3 m -56.09 -41.25 74.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.177 0.513 . . . . 1.6699999999999999 110.858 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.594 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -113.63 31.17 6.75 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.805 -0.712 . . . . 0.34000000000000002 112.167 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.782 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 60.8 m-85 -138.13 158.14 44.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.25 0.547 . . . . 0.40999999999999998 110.57 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.58 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 27.3 tt0 -146.17 155.77 42.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.631 -0.713 . . . . 1.8899999999999999 109.886 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.615 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 83.2 mtm180 -87.05 120.2 28.06 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.438 -0.578 . . . . 3.3599999999999999 109.438 176.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.1 p -79.59 -162.32 0.41 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.988 -1.005 . . . . 0.69999999999999996 110.59 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.89 -18.43 62.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.78 0.324 . . . . 0.72999999999999998 111.282 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.515 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 4.0 m-20 -105.11 2.89 29.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.312 -0.404 . . . . 2.4500000000000002 110.854 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.615 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 74.89 12.25 83.24 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 119.98 -1.105 . . . . 0.40999999999999998 111.333 -173.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HG3' ' HB2' ' A' ' 16' ' ' ASP . 54.0 mtm180 -79.57 137.22 37.08 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.367 -0.605 . . . . 3.6299999999999999 109.367 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 72.4 m -79.61 103.1 9.29 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.921 -0.581 . . . . 0.37 111.244 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -104.5 139.53 20.19 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.587 -0.733 . . . . 2.6099999999999999 109.728 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 36.9 Cg_exo -57.08 136.31 75.85 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.626 2.218 . . . . 0.41999999999999998 112.065 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 p -89.37 -14.46 35.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 1.3200000000000001 111.084 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 . . . . . 0 C--O 1.247 0.957 0 CA-C-O 117.747 -1.121 . . . . 2.9199999999999999 111.1 179.617 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.723 0.297 . . . . 12.67 110.526 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -96.16 157.4 15.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.299 -0.41 . . . . 10.640000000000001 110.273 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -129.68 134.05 47.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.366 -0.379 . . . . 7.8700000000000001 111.092 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.75 -45.59 7.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.067 0.461 . . . . 6.4800000000000004 110.08 174.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.82 12.61 23.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.703 -0.68 . . . . 4.25 110.573 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.517 ' HA2' ' H ' ' A' ' 13' ' ' ARG . . . -140.11 -170.54 12.04 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.927 -0.869 . . . . 2.7400000000000002 110.927 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.6 m -119.09 -92.2 0.54 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.842 0.321 . . . . 1.1499999999999999 110.402 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.817 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -92.02 -175.3 4.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.47 -0.332 . . . . 0.44 110.378 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 m -63.91 -23.19 67.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.224 0.535 . . . . 1.6699999999999999 110.582 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.08 24.44 5.38 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.836 -0.62 . . . . 0.34000000000000002 111.637 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.817 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 40.4 m-85 -135.11 155.86 50.0 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.159 0.504 . . . . 0.40999999999999998 110.181 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -138.76 156.75 47.11 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.89 -0.595 . . . . 1.8899999999999999 110.077 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.554 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 65.1 mtp180 -88.76 122.77 32.52 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.277 -0.638 . . . . 3.3599999999999999 109.277 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.2 p -79.87 -168.74 1.71 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.674 -0.693 . . . . 0.69999999999999996 110.046 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.3 -19.73 48.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.105 0.479 . . . . 0.72999999999999998 111.272 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -111.99 10.94 20.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.43 0.633 . . . . 2.4500000000000002 110.621 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 71.01 15.51 74.27 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.62 -0.718 . . . . 0.40999999999999998 112.868 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -79.68 139.59 37.33 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.009 -0.737 . . . . 3.6299999999999999 109.009 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.9 98.47 7.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.524 0.678 . . . . 0.37 111.351 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 81.6 tttt -101.99 133.55 20.62 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.154 -0.93 . . . . 2.6099999999999999 109.615 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 22.9 Cg_exo -62.97 138.04 65.78 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.325 2.017 . . . . 0.41999999999999998 112.314 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 p -91.58 -12.84 33.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.402 -0.363 . . . . 1.3200000000000001 110.877 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 . . . . . 0 C--O 1.245 0.866 0 CA-C-N 115.497 -0.774 . . . . 2.9199999999999999 111.434 177.696 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.73 0.3 . . . . 12.67 110.487 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -150.0 -30.76 0.21 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.071 0.462 . . . . 10.640000000000001 110.186 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -118.76 116.56 26.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.892 -0.595 . . . . 7.8700000000000001 110.582 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.18 132.44 49.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.363 -0.38 . . . . 6.4800000000000004 110.185 177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.03 -65.77 0.98 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.064 0.459 . . . . 4.25 111.169 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.54 -91.89 0.14 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.508 -0.853 . . . . 2.7400000000000002 112.355 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.8 m -118.61 -109.98 0.35 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.818 -0.353 . . . . 1.1499999999999999 111.73 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.739 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.75 -175.27 4.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.03 0.443 . . . . 0.44 111.633 -175.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 p -69.93 -14.96 62.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.617 -0.719 . . . . 1.6699999999999999 111.071 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.37 21.29 5.16 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.934 -0.866 . . . . 0.34000000000000002 110.934 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.739 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 51.0 m-85 -136.66 153.1 51.0 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.336 0.589 . . . . 0.40999999999999998 110.49 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -136.15 160.13 39.6 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.444 -0.798 . . . . 1.8899999999999999 109.852 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.435 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 25.7 ptt180 -87.11 129.7 34.82 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.739 -0.837 . . . . 3.3599999999999999 108.739 175.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.2 p -81.07 -170.3 2.65 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.872 -0.604 . . . . 0.69999999999999996 109.541 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.29 -17.75 62.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.307 0.575 . . . . 0.72999999999999998 110.723 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -113.69 14.72 18.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.444 -0.798 . . . . 2.4500000000000002 111.531 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 69.34 24.87 75.9 Favored Glycine 0 C--O 1.235 0.187 0 C-N-CA 121.277 -0.487 . . . . 0.40999999999999998 113.161 174.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -91.03 143.33 26.82 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.163 -0.68 . . . . 3.6299999999999999 109.163 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.69 100.12 7.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.265 0.555 . . . . 0.37 110.913 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -97.72 134.31 22.53 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.269 -0.878 . . . . 2.6099999999999999 110.305 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.537 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 14.2 Cg_exo -66.3 141.6 63.07 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.03 1.82 . . . . 0.41999999999999998 110.205 172.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.3 p -80.08 113.49 18.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.065 0.459 . . . . 1.3200000000000001 112.118 -172.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.537 ' CE2' ' HB2' ' A' ' 21' ' ' PRO . 56.5 m-85 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 108.782 -0.821 . . . . 2.9199999999999999 108.782 176.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.21 0.052 . . . . 12.67 111.097 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -67.92 -55.5 12.55 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.709 0.29 . . . . 10.640000000000001 111.27 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -139.13 -78.34 0.34 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.122 -0.49 . . . . 7.8700000000000001 109.704 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.87 -71.07 0.25 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.795 -0.817 . . . . 6.4800000000000004 108.795 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.94 -4.79 53.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.677 -0.692 . . . . 4.25 109.613 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.9 93.4 1.28 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.445 -0.798 . . . . 2.7400000000000002 111.405 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.2 m -107.72 -179.11 3.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.674 0.273 . . . . 1.1499999999999999 110.853 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . . . -60.69 169.15 1.93 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.606 -0.725 . . . . 0.44 112.147 -177.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -69.08 -38.85 79.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.138 0.494 . . . . 1.6699999999999999 110.297 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.56 -3.18 86.39 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.563 -0.615 . . . . 0.34000000000000002 111.563 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 10.0 m-85 -117.43 178.77 4.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.898 -0.408 . . . . 0.40999999999999998 109.898 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.445 ' HB3' HG22 ' A' ' 22' ' ' THR . 13.6 pt20 -159.24 179.09 9.31 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.594 -0.521 . . . . 1.8899999999999999 109.594 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.552 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 39.1 ptt180 -88.37 133.68 34.03 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.378 0.609 . . . . 3.3599999999999999 110.61 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.6 p -81.72 -167.02 1.35 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.366 -0.834 . . . . 0.69999999999999996 109.57 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.61 69.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.955 0.354 . . . . 0.72999999999999998 111.955 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -105.17 6.09 32.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.374 -0.376 . . . . 2.4500000000000002 111.494 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.552 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 83.48 41.34 8.44 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.354 -0.927 . . . . 0.40999999999999998 112.779 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -99.17 178.36 4.94 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.832 -1.173 . . . . 3.6299999999999999 107.832 172.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.1 m -103.92 123.88 47.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.986 0.422 . . . . 0.37 111.671 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -139.8 143.72 35.92 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.771 -0.65 . . . . 2.6099999999999999 109.401 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.44 147.3 22.75 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.877 2.384 . . . . 0.41999999999999998 112.329 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 12' ' ' GLN . 43.6 p -86.77 -21.13 26.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.568 0.581 . . . . 1.3200000000000001 112.568 -174.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 . . . . . 0 C--O 1.245 0.852 0 O-C-N 123.851 0.719 . . . . 2.9199999999999999 110.414 -176.627 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 121.021 0.439 . . . . 12.67 110.105 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -87.8 121.67 30.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.834 -0.621 . . . . 10.640000000000001 111.544 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -139.81 104.7 4.95 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.868 -0.606 . . . . 7.8700000000000001 109.529 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.73 116.08 30.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.117 0.484 . . . . 6.4800000000000004 110.695 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.94 -51.72 3.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.876 -0.602 . . . . 4.25 110.436 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.489 ' HA2' ' H ' ' A' ' 13' ' ' ARG . . . 124.77 -119.0 3.5 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.676 -0.773 . . . . 2.7400000000000002 112.334 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 m -125.69 -95.72 0.45 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.739 0.304 . . . . 1.1499999999999999 111.033 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.759 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -92.15 -174.71 3.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.234 -0.439 . . . . 0.44 111.109 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -66.14 -25.24 66.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.855 0.36 . . . . 1.6699999999999999 110.505 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -121.53 21.76 7.98 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.151 -0.547 . . . . 0.34000000000000002 112.136 175.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.759 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 54.6 m-85 -134.71 149.88 50.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.995 0.426 . . . . 0.40999999999999998 110.385 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.415 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 34.3 tt0 -131.85 154.23 49.38 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.92 -0.582 . . . . 1.8899999999999999 109.437 176.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.627 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 11.2 ptm180 -87.89 147.04 25.27 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.487 0.661 . . . . 3.3599999999999999 109.733 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 p -99.76 -164.53 1.13 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.705 -1.134 . . . . 0.69999999999999996 109.473 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.98 -34.7 63.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.007 0.432 . . . . 0.72999999999999998 111.187 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.37 -3.76 57.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.971 -0.559 . . . . 2.4500000000000002 111.609 -175.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.627 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 82.21 6.42 88.8 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.105 -1.045 . . . . 0.40999999999999998 110.635 -174.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -79.21 133.03 36.7 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.617 -0.512 . . . . 3.6299999999999999 109.617 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.27 127.35 32.26 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.097 -0.502 . . . . 0.37 112.24 -171.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 63.3 mttp -123.3 142.09 37.71 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.658 -0.701 . . . . 2.6099999999999999 109.165 170.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 13.0 Cg_exo -68.3 144.19 61.3 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.081 2.521 . . . . 0.41999999999999998 112.011 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.2 p -95.66 110.84 22.89 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.984 -0.553 . . . . 1.3200000000000001 111.163 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 . . . . . 0 C--O 1.243 0.714 0 CA-C-O 118.234 -0.889 . . . . 2.9199999999999999 110.123 -179.006 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.587 ' HG3' ' H ' ' A' ' 2' ' ' ASN . 5.2 pt-20 . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 111.714 0.264 . . . . 12.67 111.714 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.587 ' H ' ' HG3' ' A' ' 1' ' ' GLU . 17.6 m120 71.56 121.73 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.2 0.6 . . . . 10.640000000000001 110.995 -175.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.481 ' CE2' ' HB2' ' A' ' 5' ' ' ALA . 59.7 t80 -88.4 130.13 35.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.838 -0.619 . . . . 7.8700000000000001 110.74 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.55 95.31 3.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.998 0.428 . . . . 6.4800000000000004 110.743 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.481 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . . . -93.15 116.61 29.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.069 -0.514 . . . . 4.25 111.411 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.47 -144.45 18.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.107 -0.568 . . . . 2.7400000000000002 112.338 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' N ' ' HA ' ' A' ' 12' ' ' GLN . 1.2 m -125.1 -89.37 0.58 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.218 -0.66 . . . . 1.1499999999999999 109.218 173.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.801 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -90.67 -175.34 4.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.886 -0.597 . . . . 0.44 109.56 172.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 m -61.01 -37.24 81.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.038 0.447 . . . . 1.6699999999999999 110.965 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.78 29.03 7.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.719 -0.753 . . . . 0.34000000000000002 112.078 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.801 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 27.5 m-85 -133.64 163.65 28.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.034 0.445 . . . . 0.40999999999999998 110.698 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.412 ' HA ' ' N ' ' A' ' 7' ' ' CYS . 28.4 pt20 -153.32 175.88 12.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.969 -0.56 . . . . 1.8899999999999999 109.881 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -88.66 139.17 30.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.256 0.551 . . . . 3.3599999999999999 110.645 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.2 p -83.0 -173.37 4.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.203 -0.908 . . . . 0.69999999999999996 108.792 172.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.76 -4.83 21.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.008 0.432 . . . . 0.72999999999999998 110.724 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.448 ' OD2' ' HD3' ' A' ' 18' ' ' ARG . 22.2 t70 -108.4 6.81 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.872 -0.604 . . . . 2.4500000000000002 110.476 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.47 4.37 84.39 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.832 -0.622 . . . . 0.40999999999999998 113.051 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.448 ' HD3' ' OD2' ' A' ' 16' ' ' ASP . 36.0 mtp180 -96.49 159.54 14.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.682 0.277 . . . . 3.6299999999999999 110.668 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.2 m -88.54 122.32 31.87 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.579 0.704 . . . . 0.37 112.7 -168.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -121.68 139.72 30.5 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 114.991 -1.004 . . . . 2.6099999999999999 110.257 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.492 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 34.4 Cg_exo -58.27 148.22 80.18 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.397 2.065 . . . . 0.41999999999999998 111.19 174.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.3 p -86.19 120.22 27.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.208 0.528 . . . . 1.3200000000000001 111.849 -174.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 21' ' ' PRO . 73.6 m-85 . . . . . 0 C--O 1.245 0.865 0 CA-C-N 115.302 -0.863 . . . . 2.9199999999999999 109.064 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.573 0.225 . . . . 12.67 110.734 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -59.39 -47.65 84.65 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.048 0.451 . . . . 10.640000000000001 110.961 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -139.95 141.22 36.46 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.151 -0.477 . . . . 7.8700000000000001 110.045 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.07 150.27 38.93 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.166 -0.47 . . . . 6.4800000000000004 109.895 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.3 113.09 15.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.83 0.348 . . . . 4.25 110.887 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.827 ' HA2' ' HG2' ' A' ' 13' ' ' ARG . . . -86.01 -100.74 0.74 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.001 -0.619 . . . . 2.7400000000000002 112.021 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.96 -95.44 0.44 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.7 0.286 . . . . 1.1499999999999999 110.378 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.74 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.71 -178.07 4.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.624 -0.262 . . . . 0.44 110.686 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -22.95 62.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.28 0.562 . . . . 1.6699999999999999 110.801 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.73 16.74 25.87 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.235 -0.746 . . . . 0.34000000000000002 111.235 175.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.74 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 64.7 m-85 -136.16 173.29 11.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.43 0.633 . . . . 0.40999999999999998 110.982 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.507 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 9.8 pt20 -148.46 171.96 15.24 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.874 -0.787 . . . . 1.8899999999999999 108.874 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.827 ' HG2' ' HA2' ' A' ' 6' ' ' GLY . 11.0 ptp180 -104.46 139.04 39.96 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.608 0.718 . . . . 3.3599999999999999 110.408 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.0 p -79.39 -172.45 3.22 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.702 -1.135 . . . . 0.69999999999999996 109.167 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.03 -31.59 67.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.131 0.491 . . . . 0.72999999999999998 110.789 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.36 -14.28 20.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.126 -0.488 . . . . 2.4500000000000002 111.937 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.565 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 105.52 18.3 12.08 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 119.729 -1.224 . . . . 0.40999999999999998 113.364 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -80.02 141.34 36.01 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.159 -0.682 . . . . 3.6299999999999999 109.159 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 64.1 m -82.02 109.68 16.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.244 0.545 . . . . 0.37 111.727 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 17.5 tptp -110.28 136.76 20.51 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.54 -0.755 . . . . 2.6099999999999999 109.339 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.68 141.93 74.12 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.72 2.28 . . . . 0.41999999999999998 112.34 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 p -90.98 128.4 36.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.985 0.421 . . . . 1.3200000000000001 110.87 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.562 -0.733 . . . . 2.9199999999999999 109.959 -178.286 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 110.193 -0.299 . . . . 12.67 110.193 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.6 t30 65.41 110.33 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.526 0.73 . . . . 10.640000000000001 111.576 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -118.61 157.74 26.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.034 -0.53 . . . . 7.8700000000000001 110.609 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.73 -57.62 1.44 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.04 -0.527 . . . . 6.4800000000000004 110.942 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.71 -23.97 14.15 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.11 0.411 . . . . 4.25 112.11 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.29 -158.28 22.99 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.57 -0.824 . . . . 2.7400000000000002 112.036 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.4 m -113.79 -96.5 0.45 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.799 0.333 . . . . 1.1499999999999999 110.255 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.778 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.73 -175.91 4.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.433 -0.348 . . . . 0.44 110.747 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -62.69 -29.06 70.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.998 -0.546 . . . . 1.6699999999999999 110.714 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.41 30.27 4.77 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.671 -0.695 . . . . 0.34000000000000002 111.875 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.778 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 37.6 m-85 -136.34 161.14 36.63 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.307 0.575 . . . . 0.40999999999999998 111.0 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -143.54 163.98 31.66 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.765 -0.652 . . . . 1.8899999999999999 109.945 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.2 mtm180 -89.73 127.82 36.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.139 0.495 . . . . 3.3599999999999999 109.999 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.3 p -80.51 -176.52 5.76 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.386 -0.825 . . . . 0.69999999999999996 109.12 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.77 47.77 0.26 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.229 0.538 . . . . 0.72999999999999998 111.25 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -161.04 -35.8 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.521 -0.763 . . . . 2.4500000000000002 110.828 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.36 -0.39 23.67 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.416 -0.897 . . . . 0.40999999999999998 110.945 -171.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -78.12 133.85 37.78 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.395 -0.594 . . . . 3.6299999999999999 109.395 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.1 m -86.2 126.46 34.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.265 -0.425 . . . . 0.37 111.223 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.535 ' HG3' ' HD2' ' A' ' 21' ' ' PRO . 36.0 ttmt -124.19 140.49 35.04 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.858 -0.61 . . . . 2.6099999999999999 109.474 176.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.535 ' HD2' ' HG3' ' A' ' 20' ' ' LYS . 44.6 Cg_exo -55.12 145.11 66.43 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.047 2.498 . . . . 0.41999999999999998 112.013 177.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.9 p -88.35 120.36 29.64 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.075 -0.511 . . . . 1.3200000000000001 111.714 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.121 -0.942 . . . . 2.9199999999999999 109.367 177.849 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.781 0.324 . . . . 12.67 110.256 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -97.93 172.96 7.31 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.267 -0.642 . . . . 10.640000000000001 109.267 171.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -144.21 150.32 37.78 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.615 -0.434 . . . . 7.8700000000000001 110.909 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.97 -76.33 0.59 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.033 -0.53 . . . . 6.4800000000000004 110.415 177.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.2 96.81 7.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.258 -0.428 . . . . 4.25 110.777 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.09 86.08 0.65 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.646 -0.788 . . . . 2.7400000000000002 111.809 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.9 m -79.66 176.71 9.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 1.1499999999999999 111.091 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.523 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . -60.29 169.37 1.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.893 -0.594 . . . . 0.44 112.367 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -31.82 71.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.727 -0.669 . . . . 1.6699999999999999 110.802 175.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.45 10.76 73.98 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.965 -0.636 . . . . 0.34000000000000002 111.725 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.523 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 47.5 m-85 -130.83 -179.87 5.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.002 0.429 . . . . 0.40999999999999998 110.057 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -157.93 171.19 20.71 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.939 -0.763 . . . . 1.8899999999999999 108.939 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.2 ptp180 -89.07 138.24 31.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.1 0.476 . . . . 3.3599999999999999 110.664 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.6 p -87.65 -167.77 2.0 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.615 -0.72 . . . . 0.69999999999999996 109.394 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.15 -31.58 70.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.89 0.376 . . . . 0.72999999999999998 110.874 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -107.4 19.98 19.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.889 0.852 . . . . 2.4500000000000002 110.384 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 69.44 25.89 75.06 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.321 -0.854 . . . . 0.40999999999999998 113.297 175.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 16.0 mmt180 -87.77 169.01 12.46 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.644 -0.873 . . . . 3.6299999999999999 108.644 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.1 m -98.16 113.46 25.37 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.162 0.506 . . . . 0.37 111.886 -174.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -111.15 136.53 20.86 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.345 -0.843 . . . . 2.6099999999999999 109.73 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.24 134.44 48.87 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.646 2.231 . . . . 0.41999999999999998 112.209 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.4 p -82.15 131.54 35.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.552 -0.295 . . . . 1.3200000000000001 110.871 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.585 -0.721 . . . . 2.9199999999999999 110.068 -179.442 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.761 0.315 . . . . 12.67 110.806 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -58.85 -57.23 13.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.742 -0.663 . . . . 10.640000000000001 111.982 -174.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -129.49 84.76 2.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.972 0.415 . . . . 7.8700000000000001 111.16 -176.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.86 102.43 15.03 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.011 -0.541 . . . . 6.4800000000000004 109.945 174.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.7 142.23 34.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.213 -0.448 . . . . 4.25 111.224 -175.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.659 ' HA2' ' HG3' ' A' ' 12' ' ' GLN . . . 112.61 -124.19 6.58 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.57 -0.824 . . . . 2.7400000000000002 112.37 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.0 m -138.61 -90.54 0.21 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.197 -0.297 . . . . 1.1499999999999999 110.197 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.741 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.28 -177.73 4.94 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.874 -0.417 . . . . 0.44 109.874 172.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 m -61.5 -36.39 80.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.044 0.45 . . . . 1.6699999999999999 110.848 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.16 25.1 14.59 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.943 -0.646 . . . . 0.34000000000000002 111.798 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.741 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 43.9 m-85 -134.62 166.27 23.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.251 0.548 . . . . 0.40999999999999998 110.674 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.659 ' HG3' ' HA2' ' A' ' 6' ' ' GLY . 50.6 tt0 -158.74 146.83 18.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.19 -0.671 . . . . 1.8899999999999999 109.19 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 17.3 ptp180 -87.85 125.59 34.55 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.595 0.712 . . . . 3.3599999999999999 109.517 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.1 p -80.63 -164.51 0.72 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.447 -1.251 . . . . 0.69999999999999996 110.186 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.77 -11.88 41.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.032 0.444 . . . . 0.72999999999999998 111.032 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.427 ' HB3' ' HG2' ' A' ' 18' ' ' ARG . 8.0 t70 -102.47 1.35 35.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.318 0.58 . . . . 2.4500000000000002 111.078 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 74.54 13.41 81.89 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.934 -0.651 . . . . 0.40999999999999998 112.045 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 13.9 mmt180 -93.11 137.61 32.3 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.015 -0.365 . . . . 3.6299999999999999 110.015 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.3 m -79.45 98.07 6.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.922 -0.581 . . . . 0.37 110.494 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -98.19 139.04 20.97 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.447 -0.797 . . . . 2.6099999999999999 109.122 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.32 121.5 9.72 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.42 2.08 . . . . 0.41999999999999998 111.33 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p -95.29 125.0 39.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.124 0.488 . . . . 1.3200000000000001 111.072 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 C--O 1.249 1.058 0 CA-C-N 115.589 -0.732 . . . . 2.9199999999999999 110.118 -177.057 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 109.695 -0.483 . . . . 12.67 109.695 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -82.06 144.06 31.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.321 -0.4 . . . . 10.640000000000001 110.01 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -104.49 -180.0 4.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.343 -0.389 . . . . 7.8700000000000001 110.904 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.19 157.31 36.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.153 -0.476 . . . . 6.4800000000000004 110.57 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.48 160.09 14.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 4.25 111.198 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -114.67 -22.72 4.96 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.64 -0.791 . . . . 2.7400000000000002 112.806 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 32.0 m -122.94 -95.73 0.47 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.621 -0.34 . . . . 1.1499999999999999 110.897 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.764 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.89 -176.68 4.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.5 -0.318 . . . . 0.44 110.342 177.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -71.93 -7.36 48.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.14 0.495 . . . . 1.6699999999999999 111.029 177.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.94 22.31 3.29 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.753 -0.939 . . . . 0.34000000000000002 110.753 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.764 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 18.2 m-85 -134.27 155.92 49.35 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.984 -0.376 . . . . 0.40999999999999998 109.984 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -144.77 155.46 43.54 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.55 -0.537 . . . . 1.8899999999999999 109.55 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.633 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 99.5 mtt180 -88.67 120.34 29.97 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.466 0.651 . . . . 3.3599999999999999 109.655 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.462 HG21 ' HD2' ' A' ' 20' ' ' LYS . 58.9 p -80.43 -163.3 0.55 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.493 -1.231 . . . . 0.69999999999999996 110.606 -177.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.81 -27.48 59.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.896 0.332 . . . . 0.72999999999999998 111.896 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.17 1.59 45.07 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.601 -0.272 . . . . 2.4500000000000002 111.469 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.633 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 79.89 12.64 83.23 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.186 -1.007 . . . . 0.40999999999999998 111.526 -175.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -84.87 142.77 29.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.546 -0.327 . . . . 3.6299999999999999 110.5 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.1 m -82.89 104.01 12.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.186 -0.461 . . . . 0.37 111.573 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.462 ' HD2' HG21 ' A' ' 14' ' ' THR . 87.4 mttt -108.24 146.1 32.87 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.021 -0.536 . . . . 2.6099999999999999 109.837 172.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 4.9 Cg_exo -72.93 129.14 13.93 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.38 2.054 . . . . 0.41999999999999998 112.206 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 p -91.34 -20.81 21.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.095 -0.502 . . . . 1.3200000000000001 110.502 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 . . . . . 0 C--O 1.251 1.134 0 CA-C-N 114.953 -1.021 . . . . 2.9199999999999999 110.282 179.226 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.67 0.272 . . . . 12.67 111.313 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -77.33 151.14 35.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.777 -0.192 . . . . 10.640000000000001 110.488 -177.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -104.58 136.63 43.76 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.296 -0.261 . . . . 7.8700000000000001 110.296 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -101.94 -35.3 9.04 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.696 -0.483 . . . . 6.4800000000000004 109.696 175.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -160.26 173.5 15.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.447 -0.797 . . . . 4.25 109.647 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 12' ' ' GLN . . . -88.23 -92.85 1.04 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.821 -0.704 . . . . 2.7400000000000002 111.784 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -128.21 -88.09 0.55 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.724 -0.473 . . . . 1.1499999999999999 109.724 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.758 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -92.02 -177.07 4.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.122 -0.49 . . . . 0.44 110.147 173.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -65.31 -25.7 67.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.113 0.482 . . . . 1.6699999999999999 110.386 174.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.08 24.92 8.58 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.078 -0.582 . . . . 0.34000000000000002 111.756 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.758 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 39.7 m-85 -141.21 160.26 40.49 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.045 0.45 . . . . 0.40999999999999998 110.913 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.572 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 13.0 pt20 -144.67 171.64 14.11 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.86 -0.609 . . . . 1.8899999999999999 109.815 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.405 ' HE ' ' HA2' ' A' ' 17' ' ' GLY . 48.2 mtp180 -89.08 142.17 27.87 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.252 0.549 . . . . 3.3599999999999999 110.687 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 p -90.08 -175.78 4.67 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.616 -0.883 . . . . 0.69999999999999996 108.616 171.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.35 -14.99 31.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.004 0.43 . . . . 0.72999999999999998 110.911 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -107.97 10.54 28.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.028 -0.533 . . . . 2.4500000000000002 111.246 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.405 ' HA2' ' HE ' ' A' ' 13' ' ' ARG . . . 74.49 5.76 74.07 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.038 -0.601 . . . . 0.40999999999999998 113.206 176.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -80.05 150.92 30.17 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.524 -0.547 . . . . 3.6299999999999999 109.524 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.2 m -86.17 110.22 19.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.478 0.656 . . . . 0.37 111.09 -174.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 46.9 tttp -101.5 136.89 19.52 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.075 -0.966 . . . . 2.6099999999999999 109.37 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 24.4 Cg_exo -62.76 140.08 78.43 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.292 1.995 . . . . 0.41999999999999998 111.995 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.6 p -88.48 -5.53 58.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.7 0.286 . . . . 1.3200000000000001 110.875 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.061 -0.971 . . . . 2.9199999999999999 111.418 176.251 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 109.591 -0.522 . . . . 12.67 109.591 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 72.41 -55.98 0.66 Allowed 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.727 0.642 . . . . 10.640000000000001 109.869 -173.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 5' ' ' ALA . 24.8 t80 -80.54 119.09 22.74 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.239 -0.652 . . . . 7.8700000000000001 109.239 173.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.73 93.98 8.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.096 0.474 . . . . 6.4800000000000004 111.203 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.472 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . . . -116.62 12.36 14.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.874 -0.603 . . . . 4.25 110.878 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.41 -92.27 1.01 Allowed Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.658 -0.782 . . . . 2.7400000000000002 112.643 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.4 m -119.58 176.42 5.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.698 0.285 . . . . 1.1499999999999999 111.289 -175.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.5 166.86 3.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.936 -0.574 . . . . 0.44 112.192 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.7 m -66.27 -36.96 84.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.954 -0.566 . . . . 1.6699999999999999 110.861 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.03 6.04 84.06 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.128 -0.558 . . . . 0.34000000000000002 111.872 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -123.83 -179.44 4.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.008 -0.738 . . . . 0.40999999999999998 109.008 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -161.26 170.35 20.4 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.916 -0.402 . . . . 1.8899999999999999 109.916 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 76.1 mtm180 -88.43 123.7 33.23 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.224 0.535 . . . . 3.3599999999999999 109.702 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.437 ' C ' ' H ' ' A' ' 16' ' ' ASP . 70.7 p -80.88 -167.7 1.5 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.116 -0.947 . . . . 0.69999999999999996 110.614 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.69 41.37 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.009 0.433 . . . . 0.72999999999999998 111.651 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.476 ' OD2' ' HG3' ' A' ' 18' ' ' ARG . 19.4 t70 -160.55 -31.75 0.06 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.708 -0.678 . . . . 2.4500000000000002 109.662 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.33 -0.64 20.66 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.576 -0.821 . . . . 0.40999999999999998 112.004 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.476 ' HG3' ' OD2' ' A' ' 16' ' ' ASP . 74.4 mtp180 -79.16 164.36 24.29 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.058 -0.349 . . . . 3.6299999999999999 110.058 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.3 m -104.7 110.83 23.32 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.861 -0.609 . . . . 0.37 111.465 -172.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 30.4 mtpp -121.66 146.69 46.2 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.861 -0.609 . . . . 2.6099999999999999 109.958 174.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 23.5 Cg_exo -63.49 148.26 92.66 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.909 2.406 . . . . 0.41999999999999998 111.97 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.3 p -90.92 -6.27 54.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.956 -0.565 . . . . 1.3200000000000001 110.756 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 . . . . . 0 C--O 1.251 1.152 0 CA-C-N 114.993 -1.003 . . . . 2.9199999999999999 111.132 178.241 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.705 0.288 . . . . 12.67 111.198 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -72.11 150.23 44.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.277 0.56 . . . . 10.640000000000001 112.014 -173.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -97.37 115.07 27.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.692 -0.685 . . . . 7.8700000000000001 109.721 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.79 120.33 37.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.824 0.345 . . . . 6.4800000000000004 111.399 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.32 156.34 19.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.713 -0.676 . . . . 4.25 109.765 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.43 -71.61 0.32 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.506 -0.854 . . . . 2.7400000000000002 111.886 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 86.6 m -125.78 165.26 18.97 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.765 -0.457 . . . . 1.1499999999999999 109.765 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.689 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . -63.74 172.42 2.2 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.886 0.698 . . . . 0.44 112.886 -173.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -65.1 -33.97 77.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.545 -0.752 . . . . 1.6699999999999999 111.05 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.34 6.65 80.86 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.936 -0.649 . . . . 0.34000000000000002 111.552 176.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.689 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 30.9 m-85 -123.09 178.18 5.2 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.653 -0.499 . . . . 0.40999999999999998 109.653 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -161.1 170.92 19.5 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.094 -0.706 . . . . 1.8899999999999999 109.094 171.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.578 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.3 ptp180 -88.5 137.63 32.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.303 0.573 . . . . 3.3599999999999999 110.922 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 18' ' ' ARG . 48.3 p -86.54 -165.32 1.24 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.031 -0.986 . . . . 0.69999999999999996 109.845 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.01 -18.62 65.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.644 0.259 . . . . 0.72999999999999998 111.406 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -109.54 -6.6 15.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.614 0.721 . . . . 2.4500000000000002 110.594 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 91.24 20.1 39.82 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.168 -1.015 . . . . 0.40999999999999998 111.92 -177.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 18' ' ' ARG . 1.8 mmp_? -79.23 155.69 28.47 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.88 -0.785 . . . . 3.6299999999999999 108.88 175.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -91.04 99.95 12.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.494 0.664 . . . . 0.37 111.708 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -96.92 127.95 37.25 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.01 -0.995 . . . . 2.6099999999999999 109.71 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.92 147.19 96.25 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.653 2.235 . . . . 0.41999999999999998 111.75 176.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.2 p -96.76 -5.12 39.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.205 -0.452 . . . . 1.3200000000000001 110.865 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 . . . . . 0 C--O 1.249 1.059 0 CA-C-N 115.352 -0.84 . . . . 2.9199999999999999 110.949 178.339 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 111.495 0.183 . . . . 12.67 111.495 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.33 -18.52 26.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.947 0.403 . . . . 10.640000000000001 111.336 -175.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -97.53 106.67 19.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.163 -0.471 . . . . 7.8700000000000001 109.864 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.6 110.12 19.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.133 -0.485 . . . . 6.4800000000000004 110.016 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.64 81.0 7.85 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.153 -0.476 . . . . 4.25 110.518 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' HA3' ' N ' ' A' ' 13' ' ' ARG . . . -141.92 -81.88 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.444 -0.884 . . . . 2.7400000000000002 113.033 -176.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.4 t -114.35 -101.24 0.42 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.746 -0.381 . . . . 1.1499999999999999 111.149 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.647 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -92.41 173.69 7.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.164 -0.471 . . . . 0.44 111.511 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 m -75.67 76.1 2.66 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.342 -0.984 . . . . 1.6699999999999999 108.342 168.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.87 -16.95 1.78 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.798 -1.092 . . . . 0.34000000000000002 110.885 -171.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.647 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 82.2 m-85 -120.12 170.45 9.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.409 0.623 . . . . 0.40999999999999998 110.019 174.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 29.6 pt20 -144.38 174.89 10.52 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.523 -0.762 . . . . 1.8899999999999999 109.297 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 13' ' ' ARG . 11.4 ptp180 -89.54 143.12 27.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.99 0.424 . . . . 3.3599999999999999 110.997 -175.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 18' ' ' ARG . 58.2 p -90.8 -171.65 3.1 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.731 -0.84 . . . . 0.69999999999999996 108.731 171.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.48 -16.36 60.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.921 0.391 . . . . 0.72999999999999998 111.147 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -109.83 -23.29 11.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.019 -0.537 . . . . 2.4500000000000002 111.282 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.2 15.79 8.17 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.138 -1.029 . . . . 0.40999999999999998 112.892 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.446 ' O ' HG23 ' A' ' 14' ' ' THR . 33.6 ttm180 -78.57 155.87 29.45 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.982 -0.747 . . . . 3.6299999999999999 108.982 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.4 m -86.52 107.96 18.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.472 0.653 . . . . 0.37 111.184 -175.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 38.3 ttpt -107.1 130.65 22.55 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.565 -0.743 . . . . 2.6099999999999999 109.559 174.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 32.5 Cg_exo -57.25 148.8 68.24 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.112 1.875 . . . . 0.41999999999999998 111.5 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.1 p -84.83 98.55 10.36 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.001 -0.545 . . . . 1.3200000000000001 112.224 -174.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 21' ' ' PRO . 51.6 m-85 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.268 -0.872 . . . . 2.9199999999999999 109.934 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.611 0.243 . . . . 12.67 111.217 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -65.4 -60.87 2.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.763 0.316 . . . . 10.640000000000001 110.975 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -107.39 95.88 6.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.907 0.384 . . . . 7.8700000000000001 110.264 -178.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.9 15.25 14.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.023 0.44 . . . . 6.4800000000000004 111.21 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -97.23 105.39 17.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.054 -0.521 . . . . 4.25 110.966 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.14 -126.57 8.02 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.668 -0.777 . . . . 2.7400000000000002 112.301 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 84.4 m -128.1 172.22 11.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.692 0.246 . . . . 1.1499999999999999 110.385 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.608 ' HB3' ' HD1' ' A' ' 11' ' ' TYR . . . -61.91 168.41 3.16 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.992 -0.549 . . . . 0.44 111.634 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -73.87 -27.23 60.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.268 0.556 . . . . 1.6699999999999999 110.957 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.35 6.8 59.42 Favored Glycine 0 CA--C 1.509 -0.286 0 N-CA-C 110.874 -0.891 . . . . 0.34000000000000002 110.874 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.608 ' HD1' ' HB3' ' A' ' 8' ' ' ALA . 95.4 m-85 -138.57 -173.49 3.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.947 -1.131 . . . . 0.40999999999999998 107.947 178.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -162.22 178.77 8.44 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.05 -0.722 . . . . 1.8899999999999999 109.05 170.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.439 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 9.3 ptp85 -88.0 134.16 33.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.431 0.634 . . . . 3.3599999999999999 110.5 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.9 p -80.82 -166.15 1.05 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.446 -0.797 . . . . 0.69999999999999996 109.614 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.16 -35.95 80.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.794 0.331 . . . . 0.72999999999999998 111.08 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -101.85 0.06 34.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.2 0.524 . . . . 2.4500000000000002 111.147 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.439 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 93.88 26.86 13.61 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.575 -0.821 . . . . 0.40999999999999998 113.675 174.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -88.62 171.69 9.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.24 -0.652 . . . . 3.6299999999999999 109.24 174.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.1 m -97.1 107.03 19.47 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.014 0.376 . . . . 0.37 112.014 -174.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -105.2 130.33 23.27 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 109.491 -0.559 . . . . 2.6099999999999999 109.491 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -61.05 138.37 77.92 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.559 2.173 . . . . 0.41999999999999998 112.144 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 p -86.92 128.91 35.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.241 -0.436 . . . . 1.3200000000000001 110.947 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.604 -0.712 . . . . 2.9199999999999999 110.166 -179.207 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.722 0.296 . . . . 12.67 111.493 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -105.01 10.64 34.03 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.068 0.766 . . . . 10.640000000000001 113.068 -166.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -77.77 123.45 26.72 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.427 -0.509 . . . . 7.8700000000000001 109.952 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.72 134.96 37.04 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.979 -0.555 . . . . 6.4800000000000004 111.393 -175.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.93 172.36 7.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.838 -0.619 . . . . 4.25 110.477 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 12' ' ' GLN . . . -86.36 -161.87 36.19 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.155 -0.545 . . . . 2.7400000000000002 112.243 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 m -120.05 -87.01 0.64 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.948 0.404 . . . . 1.1499999999999999 110.344 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.791 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -92.51 -176.61 4.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.248 -0.433 . . . . 0.44 110.222 175.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.8 t -64.34 -19.1 65.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.513 0.197 . . . . 1.6699999999999999 111.355 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.74 11.43 7.89 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.721 -0.752 . . . . 0.34000000000000002 112.052 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.791 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 23.7 m-85 -126.27 160.45 30.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.027 -0.36 . . . . 0.40999999999999998 110.027 -176.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.509 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 53.6 tt0 -147.24 159.64 43.41 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.545 -0.539 . . . . 1.8899999999999999 109.545 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.537 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 11.8 mtp180 -87.62 116.17 25.56 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.478 -0.934 . . . . 3.3599999999999999 108.478 174.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.0 p -79.87 -162.52 0.44 Allowed 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.756 -1.111 . . . . 0.69999999999999996 110.424 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.03 -10.88 33.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.851 0.357 . . . . 0.72999999999999998 110.712 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -107.88 2.25 23.31 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.454 -0.339 . . . . 2.4500000000000002 111.891 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.537 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 68.38 11.93 62.73 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.033 -1.079 . . . . 0.40999999999999998 111.031 -172.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -82.3 134.23 35.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.383 -0.599 . . . . 3.6299999999999999 109.383 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.7 m -79.28 93.08 5.22 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.272 0.558 . . . . 0.37 110.652 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -99.52 140.24 21.47 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.491 -0.777 . . . . 2.6099999999999999 109.844 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -66.26 126.12 15.16 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.011 1.807 . . . . 0.41999999999999998 110.757 171.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.2 p -83.98 126.57 33.16 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.021 0.438 . . . . 1.3200000000000001 111.177 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.24 -0.886 . . . . 2.9199999999999999 109.743 179.173 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.48 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.463 0.185 0 CA-C-O 120.971 0.415 . . . . 0.44 112.02 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -63.96 -15.75 59.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.654 -0.703 . . . . 1.67 112.267 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.98 1.91 30.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.644 -0.788 . . . . 0.34 111.411 173.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.48 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 4.4 m-85 -117.69 -178.72 3.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.094 0.473 . . . . 0.41 110.111 -175.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -160.78 158.55 28.73 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.613 -0.884 . . . . 1.89 108.613 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.554 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 15.8 ptt180 -88.32 126.5 35.22 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 108.688 -0.856 . . . . 3.36 108.688 174.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.4 p -79.48 -166.63 1.0 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.19 -0.914 . . . . 0.7 110.348 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.95 -22.95 67.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.067 0.461 . . . . 0.73 110.727 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -108.22 10.01 27.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.008 -0.542 . . . . 2.45 111.398 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.554 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 77.69 19.35 75.94 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.499 -0.858 . . . . 0.41 112.482 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HE ' ' HB2' ' A' ' 18' ' ' ARG . 13.9 ttm180 -82.56 139.35 33.88 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.837 -0.431 . . . . 3.63 109.837 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.1 m -83.89 99.63 10.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.23 0.538 . . . . 0.37 110.505 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -113.73 136.74 22.05 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.816 -0.629 . . . . 2.61 109.836 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.21 138.13 83.08 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.043 1.829 . . . . 0.42 110.374 171.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--N 1.323 -0.556 0 N-CA-C 113.445 0.906 . . . . 1.32 113.445 -168.756 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.573 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.759 0.314 . . . . 0.44 111.375 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.2 m -59.53 -33.56 71.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.908 -0.587 . . . . 1.67 110.993 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.49 29.61 5.4 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.863 -0.684 . . . . 0.34 111.886 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.573 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 51.2 m-85 -133.44 172.17 13.07 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.98 -0.378 . . . . 0.41 109.98 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 4.7 pt20 -151.44 160.04 43.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.124 -0.489 . . . . 1.89 110.778 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.624 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 52.6 mtm180 -91.27 115.98 28.46 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.736 -0.468 . . . . 3.36 109.736 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.7 p -84.91 -154.13 0.18 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.737 -0.665 . . . . 0.7 110.671 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.51 -54.41 22.51 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.234 0.334 . . . . 0.73 111.805 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -93.93 20.87 7.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.936 0.398 . . . . 2.45 110.829 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.624 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 66.59 26.03 72.85 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.433 -0.889 . . . . 0.41 111.63 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 18' ' ' ARG . 12.0 ttm180 -78.78 134.31 37.02 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.105 -0.702 . . . . 3.63 109.105 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 77.2 m -78.76 101.46 7.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.331 0.586 . . . . 0.37 111.519 -173.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -102.88 138.1 19.48 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.053 -0.976 . . . . 2.61 110.104 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -61.76 141.92 92.1 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.264 1.976 . . . . 0.42 111.131 175.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 C--N 1.32 -0.684 0 CA-C-O 120.936 0.398 . . . . 1.32 111.862 -173.696 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 120.601 0.239 . . . . 0.44 111.246 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.0 m -61.49 -29.65 70.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 1.67 110.879 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.81 17.72 8.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.125 -0.56 . . . . 0.34 112.25 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 17.7 m-85 -127.03 156.96 40.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.042 -0.355 . . . . 0.41 110.042 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -146.23 172.52 13.33 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 110.209 -0.293 . . . . 1.89 110.209 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -88.97 133.28 34.37 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.248 -0.649 . . . . 3.36 109.248 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 18' ' ' ARG . 82.1 p -79.59 -173.32 3.71 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.063 -0.971 . . . . 0.7 110.066 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.33 -11.52 57.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.463 0.649 . . . . 0.73 110.167 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.675 ' OD2' ' HD3' ' A' ' 18' ' ' ARG . 10.3 p-10 -117.98 18.32 13.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.664 -0.698 . . . . 2.45 111.706 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.66 23.83 76.53 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.891 -0.671 . . . . 0.41 113.776 170.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.675 ' HD3' ' OD2' ' A' ' 16' ' ' ASP . 31.3 mtp180 -104.72 147.1 28.05 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 117.079 0.439 . . . . 3.63 110.016 176.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.6 m -81.81 111.24 17.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.363 0.601 . . . . 0.37 111.35 -173.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.454 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 56.0 tttp -113.05 137.2 21.83 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.391 -0.822 . . . . 2.61 109.091 176.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 8.5 Cg_exo -70.02 141.73 44.94 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.433 2.088 . . . . 0.42 111.145 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 p . . . . . 0 C--N 1.323 -0.582 0 CA-C-O 120.901 0.381 . . . . 1.32 111.753 -175.821 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.512 ' HB3' ' HD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.457 -0.113 0 N-CA-C 110.443 -0.206 . . . . 0.44 110.443 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.3 m -56.09 -41.25 74.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.177 0.513 . . . . 1.67 110.858 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.594 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -113.63 31.17 6.75 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.805 -0.712 . . . . 0.34 112.167 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.512 ' HD1' ' HB3' ' A' ' 8' ' ' ALA . 60.8 m-85 -138.13 158.14 44.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.25 0.547 . . . . 0.41 110.57 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 27.3 tt0 -146.17 155.77 42.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.631 -0.713 . . . . 1.89 109.886 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.615 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 83.2 mtm180 -87.05 120.2 28.06 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.438 -0.578 . . . . 3.36 109.438 176.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.1 p -79.59 -162.32 0.41 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.988 -1.005 . . . . 0.7 110.59 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.89 -18.43 62.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.78 0.324 . . . . 0.73 111.282 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.515 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 4.0 m-20 -105.11 2.89 29.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.312 -0.404 . . . . 2.45 110.854 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.615 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 74.89 12.25 83.24 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 119.98 -1.105 . . . . 0.41 111.333 -173.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HG3' ' HB2' ' A' ' 16' ' ' ASP . 54.0 mtm180 -79.57 137.22 37.08 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.367 -0.605 . . . . 3.63 109.367 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 72.4 m -79.61 103.1 9.29 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.921 -0.581 . . . . 0.37 111.244 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -104.5 139.53 20.19 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.587 -0.733 . . . . 2.61 109.728 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 36.9 Cg_exo -57.08 136.31 75.85 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.626 2.218 . . . . 0.42 112.065 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 1.32 111.084 179.477 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.432 ' N ' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 110.378 -0.23 . . . . 0.44 110.378 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 m -63.91 -23.19 67.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.224 0.535 . . . . 1.67 110.582 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.08 24.44 5.38 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.836 -0.62 . . . . 0.34 111.637 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.432 ' HB2' ' N ' ' A' ' 8' ' ' ALA . 40.4 m-85 -135.11 155.86 50.0 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.159 0.504 . . . . 0.41 110.181 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -138.76 156.75 47.11 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.89 -0.595 . . . . 1.89 110.077 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.554 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 65.1 mtp180 -88.76 122.77 32.52 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.277 -0.638 . . . . 3.36 109.277 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.2 p -79.87 -168.74 1.71 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.674 -0.693 . . . . 0.7 110.046 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.3 -19.73 48.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.105 0.479 . . . . 0.73 111.272 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -111.99 10.94 20.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.43 0.633 . . . . 2.45 110.621 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 71.01 15.51 74.27 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.62 -0.718 . . . . 0.41 112.868 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -79.68 139.59 37.33 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.009 -0.737 . . . . 3.63 109.009 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.9 98.47 7.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.524 0.678 . . . . 0.37 111.351 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 81.6 tttt -101.99 133.55 20.62 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.154 -0.93 . . . . 2.61 109.615 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 22.9 Cg_exo -62.97 138.04 65.78 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.325 2.017 . . . . 0.42 112.314 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 116.402 -0.363 . . . . 1.32 110.877 178.593 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 121.03 0.443 . . . . 0.44 111.633 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 p -69.93 -14.96 62.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.617 -0.719 . . . . 1.67 111.071 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.37 21.29 5.16 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.934 -0.866 . . . . 0.34 110.934 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.482 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 51.0 m-85 -136.66 153.1 51.0 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.336 0.589 . . . . 0.41 110.49 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -136.15 160.13 39.6 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.444 -0.798 . . . . 1.89 109.852 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.435 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 25.7 ptt180 -87.11 129.7 34.82 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.739 -0.837 . . . . 3.36 108.739 175.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.2 p -81.07 -170.3 2.65 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.872 -0.604 . . . . 0.7 109.541 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.29 -17.75 62.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.307 0.575 . . . . 0.73 110.723 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -113.69 14.72 18.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.444 -0.798 . . . . 2.45 111.531 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 69.34 24.87 75.9 Favored Glycine 0 C--O 1.235 0.187 0 C-N-CA 121.277 -0.487 . . . . 0.41 113.161 174.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -91.03 143.33 26.82 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.163 -0.68 . . . . 3.63 109.163 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.69 100.12 7.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.265 0.555 . . . . 0.37 110.913 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -97.72 134.31 22.53 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.269 -0.878 . . . . 2.61 110.305 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -66.3 141.6 63.07 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.03 1.82 . . . . 0.42 110.205 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.3 p . . . . . 0 C--N 1.319 -0.723 0 CA-C-O 121.065 0.459 . . . . 1.32 112.118 -172.498 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 121.055 0.455 . . . . 0.44 112.147 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -69.08 -38.85 79.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.138 0.494 . . . . 1.67 110.297 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.56 -3.18 86.39 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.563 -0.615 . . . . 0.34 111.563 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 10.0 m-85 -117.43 178.77 4.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.898 -0.408 . . . . 0.41 109.898 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.544 HE21 HG22 ' A' ' 22' ' ' THR . 4.0 pt20 -159.24 179.09 9.31 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.594 -0.521 . . . . 1.89 109.594 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.552 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 39.1 ptt180 -88.37 133.68 34.03 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.378 0.609 . . . . 3.36 110.61 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.6 p -81.72 -167.02 1.35 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.366 -0.834 . . . . 0.7 109.57 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.61 69.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.955 0.354 . . . . 0.73 111.955 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -105.17 6.09 32.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.374 -0.376 . . . . 2.45 111.494 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.552 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 83.48 41.34 8.44 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.354 -0.927 . . . . 0.41 112.779 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -99.17 178.36 4.94 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.832 -1.173 . . . . 3.63 107.832 172.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.1 m -103.92 123.88 47.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.986 0.422 . . . . 0.37 111.671 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -139.8 143.72 35.92 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.771 -0.65 . . . . 2.61 109.401 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.44 147.3 22.75 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.877 2.384 . . . . 0.42 112.329 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.544 HG22 HE21 ' A' ' 12' ' ' GLN . 43.6 p . . . . . 0 C--N 1.32 -0.701 0 N-CA-C 112.568 0.581 . . . . 1.32 112.568 -174.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 120.601 0.238 . . . . 0.44 111.109 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -66.14 -25.24 66.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.855 0.36 . . . . 1.67 110.505 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -121.53 21.76 7.98 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.151 -0.547 . . . . 0.34 112.136 175.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.519 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 54.6 m-85 -134.71 149.88 50.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.995 0.426 . . . . 0.41 110.385 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -131.85 154.23 49.38 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.92 -0.582 . . . . 1.89 109.437 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.627 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 11.2 ptm180 -87.89 147.04 25.27 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.487 0.661 . . . . 3.36 109.733 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 p -99.76 -164.53 1.13 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.705 -1.134 . . . . 0.7 109.473 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.98 -34.7 63.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.007 0.432 . . . . 0.73 111.187 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.37 -3.76 57.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.971 -0.559 . . . . 2.45 111.609 -175.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.627 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 82.21 6.42 88.8 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.105 -1.045 . . . . 0.41 110.635 -174.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -79.21 133.03 36.7 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.617 -0.512 . . . . 3.63 109.617 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.27 127.35 32.26 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.097 -0.502 . . . . 0.37 112.24 -171.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 63.3 mttp -123.3 142.09 37.71 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.658 -0.701 . . . . 2.61 109.165 170.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 13.0 Cg_exo -68.3 144.19 61.3 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.081 2.521 . . . . 0.42 112.011 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.2 p . . . . . 0 C--N 1.318 -0.779 0 CA-C-N 115.984 -0.553 . . . . 1.32 111.163 179.726 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.518 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 109.56 -0.533 . . . . 0.44 109.56 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 m -61.01 -37.24 81.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.038 0.447 . . . . 1.67 110.965 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.78 29.03 7.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.719 -0.753 . . . . 0.34 112.078 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.518 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 27.5 m-85 -133.64 163.65 28.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.034 0.445 . . . . 0.41 110.698 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -153.32 175.88 12.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.969 -0.56 . . . . 1.89 109.881 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -88.66 139.17 30.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.256 0.551 . . . . 3.36 110.645 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.2 p -83.0 -173.37 4.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.203 -0.908 . . . . 0.7 108.792 172.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.76 -4.83 21.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.008 0.432 . . . . 0.73 110.724 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.448 ' OD2' ' HD3' ' A' ' 18' ' ' ARG . 22.2 t70 -108.4 6.81 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.872 -0.604 . . . . 2.45 110.476 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.47 4.37 84.39 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.832 -0.622 . . . . 0.41 113.051 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.448 ' HD3' ' OD2' ' A' ' 16' ' ' ASP . 36.0 mtp180 -96.49 159.54 14.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.682 0.277 . . . . 3.63 110.668 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.2 m -88.54 122.32 31.87 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.579 0.704 . . . . 0.37 112.7 -168.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -121.68 139.72 30.5 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 114.991 -1.004 . . . . 2.61 110.257 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -58.27 148.22 80.18 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.397 2.065 . . . . 0.42 111.19 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 C--N 1.32 -0.71 0 CA-C-O 121.208 0.528 . . . . 1.32 111.849 -174.66 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.574 ' HB3' ' HD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.392 0.139 . . . . 0.44 110.686 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -22.95 62.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.28 0.562 . . . . 1.67 110.801 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.73 16.74 25.87 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.235 -0.746 . . . . 0.34 111.235 175.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.574 ' HD1' ' HB3' ' A' ' 8' ' ' ALA . 64.7 m-85 -136.16 173.29 11.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.43 0.633 . . . . 0.41 110.982 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 9.8 pt20 -148.46 171.96 15.24 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.874 -0.787 . . . . 1.89 108.874 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.565 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 11.0 ptp180 -104.46 139.04 39.96 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.608 0.718 . . . . 3.36 110.408 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.0 p -79.39 -172.45 3.22 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.702 -1.135 . . . . 0.7 109.167 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.03 -31.59 67.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.131 0.491 . . . . 0.73 110.789 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.36 -14.28 20.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.126 -0.488 . . . . 2.45 111.937 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.565 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 105.52 18.3 12.08 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 119.729 -1.224 . . . . 0.41 113.364 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -80.02 141.34 36.01 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.159 -0.682 . . . . 3.63 109.159 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 64.1 m -82.02 109.68 16.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.244 0.545 . . . . 0.37 111.727 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 17.5 tptp -110.28 136.76 20.51 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.54 -0.755 . . . . 2.61 109.339 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.68 141.93 74.12 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.72 2.28 . . . . 0.42 112.34 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.985 0.421 . . . . 1.32 110.87 178.693 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.568 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 120.696 0.284 . . . . 0.44 110.747 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -62.69 -29.06 70.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.998 -0.546 . . . . 1.67 110.714 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.41 30.27 4.77 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.671 -0.695 . . . . 0.34 111.875 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.568 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 37.6 m-85 -136.34 161.14 36.63 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.307 0.575 . . . . 0.41 111.0 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -143.54 163.98 31.66 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.765 -0.652 . . . . 1.89 109.945 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.2 mtm180 -89.73 127.82 36.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.139 0.495 . . . . 3.36 109.999 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.3 p -80.51 -176.52 5.76 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.386 -0.825 . . . . 0.7 109.12 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.77 47.77 0.26 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.229 0.538 . . . . 0.73 111.25 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -161.04 -35.8 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.521 -0.763 . . . . 2.45 110.828 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.36 -0.39 23.67 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.416 -0.897 . . . . 0.41 110.945 -171.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -78.12 133.85 37.78 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.395 -0.594 . . . . 3.63 109.395 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.1 m -86.2 126.46 34.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.265 -0.425 . . . . 0.37 111.223 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.535 ' HG3' ' HD2' ' A' ' 21' ' ' PRO . 36.0 ttmt -124.19 140.49 35.04 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.858 -0.61 . . . . 2.61 109.474 176.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.535 ' HD2' ' HG3' ' A' ' 20' ' ' LYS . 44.6 Cg_exo -55.12 145.11 66.43 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.047 2.498 . . . . 0.42 112.013 177.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.9 p . . . . . 0 C--N 1.318 -0.803 0 CA-C-N 116.075 -0.511 . . . . 1.32 111.714 -177.181 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.523 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 C--O 1.228 -0.06 0 N-CA-C 112.367 0.506 . . . . 0.44 112.367 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -31.82 71.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.727 -0.669 . . . . 1.67 110.802 175.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.45 10.76 73.98 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.965 -0.636 . . . . 0.34 111.725 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.523 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 47.5 m-85 -130.83 -179.87 5.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.002 0.429 . . . . 0.41 110.057 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -157.93 171.19 20.71 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.939 -0.763 . . . . 1.89 108.939 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.2 ptp180 -89.07 138.24 31.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.1 0.476 . . . . 3.36 110.664 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.6 p -87.65 -167.77 2.0 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.615 -0.72 . . . . 0.7 109.394 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.15 -31.58 70.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.89 0.376 . . . . 0.73 110.874 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -107.4 19.98 19.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.889 0.852 . . . . 2.45 110.384 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 69.44 25.89 75.06 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.321 -0.854 . . . . 0.41 113.297 175.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 16.0 mmt180 -87.77 169.01 12.46 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.644 -0.873 . . . . 3.63 108.644 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.1 m -98.16 113.46 25.37 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.162 0.506 . . . . 0.37 111.886 -174.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -111.15 136.53 20.86 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.345 -0.843 . . . . 2.61 109.73 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.24 134.44 48.87 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.646 2.231 . . . . 0.42 112.209 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.552 -0.295 . . . . 1.32 110.871 179.733 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.507 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 109.874 -0.417 . . . . 0.44 109.874 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 m -61.5 -36.39 80.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.044 0.45 . . . . 1.67 110.848 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.16 25.1 14.59 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.943 -0.646 . . . . 0.34 111.798 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.507 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 43.9 m-85 -134.62 166.27 23.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.251 0.548 . . . . 0.41 110.674 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.415 HE21 ' HB2' ' A' ' 12' ' ' GLN . 7.5 tt0 -158.74 146.83 18.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.19 -0.671 . . . . 1.89 109.19 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 17.3 ptp180 -87.85 125.59 34.55 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.595 0.712 . . . . 3.36 109.517 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.1 p -80.63 -164.51 0.72 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.447 -1.251 . . . . 0.7 110.186 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.77 -11.88 41.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.032 0.444 . . . . 0.73 111.032 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.427 ' HB3' ' HG2' ' A' ' 18' ' ' ARG . 8.0 t70 -102.47 1.35 35.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.318 0.58 . . . . 2.45 111.078 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 74.54 13.41 81.89 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.934 -0.651 . . . . 0.41 112.045 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 13.9 mmt180 -93.11 137.61 32.3 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.015 -0.365 . . . . 3.63 110.015 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.3 m -79.45 98.07 6.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.922 -0.581 . . . . 0.37 110.494 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -98.19 139.04 20.97 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.447 -0.797 . . . . 2.61 109.122 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.32 121.5 9.72 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.42 2.08 . . . . 0.42 111.33 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 121.124 0.488 . . . . 1.32 111.072 -179.39 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 110.342 -0.244 . . . . 0.44 110.342 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -71.93 -7.36 48.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.14 0.495 . . . . 1.67 111.029 177.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.94 22.31 3.29 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.753 -0.939 . . . . 0.34 110.753 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.453 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 18.2 m-85 -134.27 155.92 49.35 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.984 -0.376 . . . . 0.41 109.984 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -144.77 155.46 43.54 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.55 -0.537 . . . . 1.89 109.55 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.633 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 99.5 mtt180 -88.67 120.34 29.97 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.466 0.651 . . . . 3.36 109.655 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.462 HG21 ' HD2' ' A' ' 20' ' ' LYS . 58.9 p -80.43 -163.3 0.55 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.493 -1.231 . . . . 0.7 110.606 -177.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.81 -27.48 59.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.896 0.332 . . . . 0.73 111.896 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.17 1.59 45.07 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.601 -0.272 . . . . 2.45 111.469 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.633 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 79.89 12.64 83.23 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.186 -1.007 . . . . 0.41 111.526 -175.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -84.87 142.77 29.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.546 -0.327 . . . . 3.63 110.5 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.1 m -82.89 104.01 12.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.186 -0.461 . . . . 0.37 111.573 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.462 ' HD2' HG21 ' A' ' 14' ' ' THR . 87.4 mttt -108.24 146.1 32.87 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.021 -0.536 . . . . 2.61 109.837 172.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 4.9 Cg_exo -72.93 129.14 13.93 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.38 2.054 . . . . 0.42 112.206 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 116.095 -0.502 . . . . 1.32 110.502 176.885 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 110.147 -0.316 . . . . 0.44 110.147 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -65.31 -25.7 67.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.113 0.482 . . . . 1.67 110.386 174.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.08 24.92 8.58 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.078 -0.582 . . . . 0.34 111.756 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.438 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 39.7 m-85 -141.21 160.26 40.49 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.045 0.45 . . . . 0.41 110.913 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -144.67 171.64 14.11 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.86 -0.609 . . . . 1.89 109.815 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.405 ' HE ' ' HA2' ' A' ' 17' ' ' GLY . 48.2 mtp180 -89.08 142.17 27.87 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.252 0.549 . . . . 3.36 110.687 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 p -90.08 -175.78 4.67 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.616 -0.883 . . . . 0.7 108.616 171.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.35 -14.99 31.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.004 0.43 . . . . 0.73 110.911 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -107.97 10.54 28.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.028 -0.533 . . . . 2.45 111.246 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.405 ' HA2' ' HE ' ' A' ' 13' ' ' ARG . . . 74.49 5.76 74.07 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.038 -0.601 . . . . 0.41 113.206 176.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -80.05 150.92 30.17 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.524 -0.547 . . . . 3.63 109.524 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.2 m -86.17 110.22 19.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.478 0.656 . . . . 0.37 111.09 -174.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 46.9 tttp -101.5 136.89 19.52 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.075 -0.966 . . . . 2.61 109.37 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 24.4 Cg_exo -62.76 140.08 78.43 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.292 1.995 . . . . 0.42 111.995 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.6 p . . . . . 0 C--N 1.326 -0.443 0 CA-C-O 120.7 0.286 . . . . 1.32 110.875 179.142 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.142 0 N-CA-C 112.192 0.442 . . . . 0.44 112.192 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.7 m -66.27 -36.96 84.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.954 -0.566 . . . . 1.67 110.861 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.03 6.04 84.06 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.128 -0.558 . . . . 0.34 111.872 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -123.83 -179.44 4.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.008 -0.738 . . . . 0.41 109.008 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -161.26 170.35 20.4 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.916 -0.402 . . . . 1.89 109.916 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 76.1 mtm180 -88.43 123.7 33.23 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.224 0.535 . . . . 3.36 109.702 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.437 ' C ' ' H ' ' A' ' 16' ' ' ASP . 70.7 p -80.88 -167.7 1.5 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.116 -0.947 . . . . 0.7 110.614 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.69 41.37 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.009 0.433 . . . . 0.73 111.651 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.476 ' OD2' ' HG3' ' A' ' 18' ' ' ARG . 19.4 t70 -160.55 -31.75 0.06 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.708 -0.678 . . . . 2.45 109.662 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.33 -0.64 20.66 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.576 -0.821 . . . . 0.41 112.004 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.476 ' HG3' ' OD2' ' A' ' 16' ' ' ASP . 74.4 mtp180 -79.16 164.36 24.29 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.058 -0.349 . . . . 3.63 110.058 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.3 m -104.7 110.83 23.32 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.861 -0.609 . . . . 0.37 111.465 -172.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 30.4 mtpp -121.66 146.69 46.2 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.861 -0.609 . . . . 2.61 109.958 174.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 23.5 Cg_exo -63.49 148.26 92.66 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.909 2.406 . . . . 0.42 111.97 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.3 p . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.956 -0.565 . . . . 1.32 110.756 179.228 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.689 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 112.886 0.698 . . . . 0.44 112.886 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -65.1 -33.97 77.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.545 -0.752 . . . . 1.67 111.05 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.34 6.65 80.86 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.936 -0.649 . . . . 0.34 111.552 176.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.689 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 30.9 m-85 -123.09 178.18 5.2 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.653 -0.499 . . . . 0.41 109.653 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -161.1 170.92 19.5 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.094 -0.706 . . . . 1.89 109.094 171.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.578 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.3 ptp180 -88.5 137.63 32.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.303 0.573 . . . . 3.36 110.922 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 18' ' ' ARG . 48.3 p -86.54 -165.32 1.24 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.031 -0.986 . . . . 0.7 109.845 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.01 -18.62 65.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.644 0.259 . . . . 0.73 111.406 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -109.54 -6.6 15.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.614 0.721 . . . . 2.45 110.594 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 91.24 20.1 39.82 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.168 -1.015 . . . . 0.41 111.92 -177.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 18' ' ' ARG . 1.8 mmp_? -79.23 155.69 28.47 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.88 -0.785 . . . . 3.63 108.88 175.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -91.04 99.95 12.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.494 0.664 . . . . 0.37 111.708 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -96.92 127.95 37.25 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.01 -0.995 . . . . 2.61 109.71 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.92 147.19 96.25 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.653 2.235 . . . . 0.42 111.75 176.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.205 -0.452 . . . . 1.32 110.865 179.328 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.575 ' HB3' ' HD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 120.77 0.319 . . . . 0.44 111.511 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 m -75.67 76.1 2.66 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.342 -0.984 . . . . 1.67 108.342 168.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.87 -16.95 1.78 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.798 -1.092 . . . . 0.34 110.885 -171.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.575 ' HD1' ' HB3' ' A' ' 8' ' ' ALA . 82.2 m-85 -120.12 170.45 9.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.409 0.623 . . . . 0.41 110.019 174.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 29.6 pt20 -144.38 174.89 10.52 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.523 -0.762 . . . . 1.89 109.297 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 13' ' ' ARG . 11.4 ptp180 -89.54 143.12 27.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.99 0.424 . . . . 3.36 110.997 -175.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 18' ' ' ARG . 58.2 p -90.8 -171.65 3.1 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.731 -0.84 . . . . 0.7 108.731 171.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.48 -16.36 60.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.921 0.391 . . . . 0.73 111.147 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -109.83 -23.29 11.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.019 -0.537 . . . . 2.45 111.282 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.2 15.79 8.17 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.138 -1.029 . . . . 0.41 112.892 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.446 ' O ' HG23 ' A' ' 14' ' ' THR . 33.6 ttm180 -78.57 155.87 29.45 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.982 -0.747 . . . . 3.63 108.982 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.4 m -86.52 107.96 18.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.472 0.653 . . . . 0.37 111.184 -175.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 38.3 ttpt -107.1 130.65 22.55 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.565 -0.743 . . . . 2.61 109.559 174.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.25 148.8 68.24 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.112 1.875 . . . . 0.42 111.5 177.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.1 p . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 116.001 -0.545 . . . . 1.32 112.224 -174.541 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.608 ' HB3' ' HD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 C--O 1.22 -0.455 0 N-CA-C 111.634 0.235 . . . . 0.44 111.634 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -73.87 -27.23 60.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.268 0.556 . . . . 1.67 110.957 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.35 6.8 59.42 Favored Glycine 0 CA--C 1.509 -0.286 0 N-CA-C 110.874 -0.891 . . . . 0.34 110.874 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.608 ' HD1' ' HB3' ' A' ' 8' ' ' ALA . 95.4 m-85 -138.57 -173.49 3.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.947 -1.131 . . . . 0.41 107.947 178.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -162.22 178.77 8.44 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.05 -0.722 . . . . 1.89 109.05 170.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.439 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 9.3 ptp85 -88.0 134.16 33.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.431 0.634 . . . . 3.36 110.5 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.9 p -80.82 -166.15 1.05 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.446 -0.797 . . . . 0.7 109.614 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.16 -35.95 80.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.794 0.331 . . . . 0.73 111.08 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -101.85 0.06 34.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.2 0.524 . . . . 2.45 111.147 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.439 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 93.88 26.86 13.61 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.575 -0.821 . . . . 0.41 113.675 174.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -88.62 171.69 9.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.24 -0.652 . . . . 3.63 109.24 174.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.1 m -97.1 107.03 19.47 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.014 0.376 . . . . 0.37 112.014 -174.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -105.2 130.33 23.27 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 109.491 -0.559 . . . . 2.61 109.491 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -61.05 138.37 77.92 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.559 2.173 . . . . 0.42 112.144 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 C--N 1.323 -0.586 0 CA-C-N 116.241 -0.436 . . . . 1.32 110.947 -179.568 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 110.222 -0.288 . . . . 0.44 110.222 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.8 t -64.34 -19.1 65.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.513 0.197 . . . . 1.67 111.355 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.74 11.43 7.89 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.721 -0.752 . . . . 0.34 112.052 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.505 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 23.7 m-85 -126.27 160.45 30.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.027 -0.36 . . . . 0.41 110.027 -176.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -147.24 159.64 43.41 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.545 -0.539 . . . . 1.89 109.545 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.537 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 11.8 mtp180 -87.62 116.17 25.56 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.478 -0.934 . . . . 3.36 108.478 174.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.0 p -79.87 -162.52 0.44 Allowed 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.756 -1.111 . . . . 0.7 110.424 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.03 -10.88 33.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.851 0.357 . . . . 0.73 110.712 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -107.88 2.25 23.31 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.454 -0.339 . . . . 2.45 111.891 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.537 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 68.38 11.93 62.73 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.033 -1.079 . . . . 0.41 111.031 -172.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -82.3 134.23 35.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.383 -0.599 . . . . 3.63 109.383 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.7 m -79.28 93.08 5.22 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.272 0.558 . . . . 0.37 110.652 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -99.52 140.24 21.47 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.491 -0.777 . . . . 2.61 109.844 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -66.26 126.12 15.16 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.011 1.807 . . . . 0.42 110.757 171.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 C--N 1.318 -0.772 0 CA-C-O 121.021 0.438 . . . . 1.32 111.177 -179.069 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 120.489 0.185 . . . . 12.67 110.973 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -97.36 -69.41 0.76 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.063 0.459 . . . . 10.64 110.081 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -98.85 111.69 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.567 0.698 . . . . 7.87 110.175 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.09 84.45 7.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.817 -0.629 . . . . 6.48 110.007 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -146.63 -121.8 0.07 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.538 -0.756 . . . . 4.25 110.373 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.625 ' HA2' ' HG2' ' A' ' 13' ' ' ARG . . . -169.53 -155.86 10.34 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.511 -0.852 . . . . 2.74 112.513 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 84.1 m -115.88 -146.37 0.4 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.28 -0.267 . . . . 1.15 110.28 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.48 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . -54.82 162.95 1.08 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.971 0.415 . . . . 0.44 112.02 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -63.96 -15.75 59.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.654 -0.703 . . . . 1.67 112.267 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.98 1.91 30.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.644 -0.788 . . . . 0.34 111.411 173.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.48 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 4.4 m-85 -117.69 -178.72 3.54 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.094 0.473 . . . . 0.41 110.111 -175.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -160.78 158.55 28.73 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.613 -0.884 . . . . 1.89 108.613 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.625 ' HG2' ' HA2' ' A' ' 6' ' ' GLY . 15.8 ptt180 -88.32 126.5 35.22 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 108.688 -0.856 . . . . 3.36 108.688 174.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.4 p -79.48 -166.63 1.0 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.19 -0.914 . . . . 0.7 110.348 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.95 -22.95 67.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.067 0.461 . . . . 0.73 110.727 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -108.22 10.01 27.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.008 -0.542 . . . . 2.45 111.398 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.554 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 77.69 19.35 75.94 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.499 -0.858 . . . . 0.41 112.482 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HE ' ' HB2' ' A' ' 18' ' ' ARG . 13.9 ttm180 -82.56 139.35 33.88 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.837 -0.431 . . . . 3.63 109.837 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.1 m -83.89 99.63 10.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.23 0.538 . . . . 0.37 110.505 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -113.73 136.74 22.05 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.816 -0.629 . . . . 2.61 109.836 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.645 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 34.5 Cg_exo -59.21 138.13 83.08 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.043 1.829 . . . . 0.42 110.374 171.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -81.18 -53.84 6.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 113.445 0.906 . . . . 1.32 113.445 -168.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.645 ' CE2' ' HB2' ' A' ' 21' ' ' PRO . 91.8 m-85 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.105 -0.95 . . . . 2.92 110.59 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 109.132 -0.692 . . . . 12.67 109.132 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -61.34 -40.87 95.84 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.003 -0.74 . . . . 10.64 109.003 171.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -144.78 137.64 26.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.208 -1.034 . . . . 7.87 108.208 170.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.77 121.41 44.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.787 0.327 . . . . 6.48 111.023 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.57 -84.34 0.61 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.806 -0.633 . . . . 4.25 110.878 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.61 -75.16 2.27 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.187 -1.006 . . . . 2.74 111.741 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.2 m -106.35 -107.13 0.31 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.777 0.322 . . . . 1.15 110.825 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.731 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.4 -176.46 4.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.347 -0.388 . . . . 0.44 111.375 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.2 m -59.53 -33.56 71.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.908 -0.587 . . . . 1.67 110.993 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.49 29.61 5.4 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.863 -0.684 . . . . 0.34 111.886 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.731 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 51.2 m-85 -133.44 172.17 13.07 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.98 -0.378 . . . . 0.41 109.98 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 19' ' ' CYS . 4.7 pt20 -151.44 160.04 43.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.124 -0.489 . . . . 1.89 110.778 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.624 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 52.6 mtm180 -91.27 115.98 28.46 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.736 -0.468 . . . . 3.36 109.736 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.7 p -84.91 -154.13 0.18 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.737 -0.665 . . . . 0.7 110.671 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.51 -54.41 22.51 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.234 0.334 . . . . 0.73 111.805 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -93.93 20.87 7.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.936 0.398 . . . . 2.45 110.829 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.624 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 66.59 26.03 72.85 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.433 -0.889 . . . . 0.41 111.63 -176.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 18' ' ' ARG . 12.0 ttm180 -78.78 134.31 37.02 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.105 -0.702 . . . . 3.63 109.105 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 77.2 m -78.76 101.46 7.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.331 0.586 . . . . 0.37 111.519 -173.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -102.88 138.1 19.48 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.053 -0.976 . . . . 2.61 110.104 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.644 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 26.5 Cg_exo -61.76 141.92 92.1 Favored 'Trans proline' 0 CA--C 1.53 0.313 0 C-N-CA 122.264 1.976 . . . . 0.42 111.131 175.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.8 p -81.09 122.89 27.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.936 0.398 . . . . 1.32 111.862 -173.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.644 ' CE2' ' HB2' ' A' ' 21' ' ' PRO . 66.3 m-85 . . . . . 0 C--O 1.253 1.272 0 CA-C-O 118.332 -0.842 . . . . 2.92 109.554 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.275 -0.269 . . . . 12.67 110.275 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -149.68 -76.45 0.15 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.59 0.233 . . . . 10.64 110.576 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -116.23 -73.35 0.65 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.008 0.432 . . . . 7.87 110.228 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.41 -74.45 0.07 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.033 -0.53 . . . . 6.48 109.914 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.48 157.09 39.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.709 -0.678 . . . . 4.25 109.794 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 12' ' ' GLN . . . -77.13 -79.26 0.7 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.777 -0.725 . . . . 2.74 112.928 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.442 ' N ' ' HA ' ' A' ' 12' ' ' GLN . 22.6 m -128.73 -95.45 0.41 Allowed 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.501 -0.411 . . . . 1.15 110.906 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.737 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.72 -175.61 4.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.457 -0.338 . . . . 0.44 111.246 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.0 m -61.49 -29.65 70.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 1.67 110.879 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.81 17.72 8.7 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.125 -0.56 . . . . 0.34 112.25 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.737 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 17.7 m-85 -127.03 156.96 40.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.042 -0.355 . . . . 0.41 110.042 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.511 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 4.1 pt20 -146.23 172.52 13.33 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 110.209 -0.293 . . . . 1.89 110.209 175.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -88.97 133.28 34.37 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.248 -0.649 . . . . 3.36 109.248 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 18' ' ' ARG . 82.1 p -79.59 -173.32 3.71 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.063 -0.971 . . . . 0.7 110.066 177.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.33 -11.52 57.84 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.463 0.649 . . . . 0.73 110.167 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.675 ' OD2' ' HD3' ' A' ' 18' ' ' ARG . 10.3 p-10 -117.98 18.32 13.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.664 -0.698 . . . . 2.45 111.706 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.66 23.83 76.53 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.891 -0.671 . . . . 0.41 113.776 170.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.675 ' HD3' ' OD2' ' A' ' 16' ' ' ASP . 31.3 mtp180 -104.72 147.1 28.05 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 117.079 0.439 . . . . 3.63 110.016 176.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.6 m -81.81 111.24 17.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.363 0.601 . . . . 0.37 111.35 -173.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.454 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 56.0 tttp -113.05 137.2 21.83 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.391 -0.822 . . . . 2.61 109.091 176.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.486 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 8.5 Cg_exo -70.02 141.73 44.94 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.433 2.088 . . . . 0.42 111.145 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.9 p -87.57 105.29 17.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.901 0.381 . . . . 1.32 111.753 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' A' ' 21' ' ' PRO . 76.8 m-85 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.339 -0.839 . . . . 2.92 109.617 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.474 0.178 . . . . 12.67 111.096 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -60.52 -43.18 97.39 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.096 0.474 . . . . 10.64 110.324 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -120.46 136.71 54.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.892 -0.595 . . . . 7.87 110.433 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.06 -40.48 0.92 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.317 -0.856 . . . . 6.48 109.43 174.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.46 128.79 33.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.553 -0.749 . . . . 4.25 110.058 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 12' ' ' GLN . . . -69.59 -39.99 78.09 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.8 -0.714 . . . . 2.74 112.251 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.517 ' SG ' ' HG3' ' A' ' 13' ' ' ARG . 2.9 m -132.97 -90.15 0.4 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.858 -0.423 . . . . 1.15 109.858 177.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.782 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -92.94 -175.09 3.78 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.158 -0.473 . . . . 0.44 110.443 175.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.3 m -56.09 -41.25 74.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.177 0.513 . . . . 1.67 110.858 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.594 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -113.63 31.17 6.75 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.805 -0.712 . . . . 0.34 112.167 178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.782 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 60.8 m-85 -138.13 158.14 44.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.25 0.547 . . . . 0.41 110.57 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.58 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 27.3 tt0 -146.17 155.77 42.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.631 -0.713 . . . . 1.89 109.886 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.615 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 83.2 mtm180 -87.05 120.2 28.06 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 109.438 -0.578 . . . . 3.36 109.438 176.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.1 p -79.59 -162.32 0.41 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.988 -1.005 . . . . 0.7 110.59 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.89 -18.43 62.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.78 0.324 . . . . 0.73 111.282 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.515 ' HB2' ' HG3' ' A' ' 18' ' ' ARG . 4.0 m-20 -105.11 2.89 29.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 116.312 -0.404 . . . . 2.45 110.854 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.615 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 74.89 12.25 83.24 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 119.98 -1.105 . . . . 0.41 111.333 -173.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HG3' ' HB2' ' A' ' 16' ' ' ASP . 54.0 mtm180 -79.57 137.22 37.08 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.367 -0.605 . . . . 3.63 109.367 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 72.4 m -79.61 103.1 9.29 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.921 -0.581 . . . . 0.37 111.244 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 tttm -104.5 139.53 20.19 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.587 -0.733 . . . . 2.61 109.728 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.594 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 36.9 Cg_exo -57.08 136.31 75.85 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.626 2.218 . . . . 0.42 112.065 176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.5 p -89.37 -14.46 35.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.155 -0.475 . . . . 1.32 111.084 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 . . . . . 0 C--O 1.247 0.957 0 CA-C-O 117.747 -1.121 . . . . 2.92 111.1 179.617 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.723 0.297 . . . . 12.67 110.526 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -96.16 157.4 15.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.299 -0.41 . . . . 10.64 110.273 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -129.68 134.05 47.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.366 -0.379 . . . . 7.87 111.092 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.75 -45.59 7.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.067 0.461 . . . . 6.48 110.08 174.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.82 12.61 23.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.703 -0.68 . . . . 4.25 110.573 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.517 ' HA2' ' H ' ' A' ' 13' ' ' ARG . . . -140.11 -170.54 12.04 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.927 -0.869 . . . . 2.74 110.927 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.6 m -119.09 -92.2 0.54 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.842 0.321 . . . . 1.15 110.402 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.817 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -92.02 -175.3 4.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.47 -0.332 . . . . 0.44 110.378 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 m -63.91 -23.19 67.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.224 0.535 . . . . 1.67 110.582 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.08 24.44 5.38 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.836 -0.62 . . . . 0.34 111.637 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.817 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 40.4 m-85 -135.11 155.86 50.0 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.159 0.504 . . . . 0.41 110.181 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -138.76 156.75 47.11 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.89 -0.595 . . . . 1.89 110.077 -175.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.554 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 65.1 mtp180 -88.76 122.77 32.52 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 109.277 -0.638 . . . . 3.36 109.277 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.2 p -79.87 -168.74 1.71 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.674 -0.693 . . . . 0.7 110.046 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.3 -19.73 48.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.105 0.479 . . . . 0.73 111.272 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -111.99 10.94 20.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.43 0.633 . . . . 2.45 110.621 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 71.01 15.51 74.27 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.62 -0.718 . . . . 0.41 112.868 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -79.68 139.59 37.33 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.009 -0.737 . . . . 3.63 109.009 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.9 98.47 7.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.524 0.678 . . . . 0.37 111.351 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 81.6 tttt -101.99 133.55 20.62 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.154 -0.93 . . . . 2.61 109.615 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 22.9 Cg_exo -62.97 138.04 65.78 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.325 2.017 . . . . 0.42 112.314 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 p -91.58 -12.84 33.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.402 -0.363 . . . . 1.32 110.877 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 . . . . . 0 C--O 1.245 0.866 0 CA-C-N 115.497 -0.774 . . . . 2.92 111.434 177.696 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.73 0.3 . . . . 12.67 110.487 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -150.0 -30.76 0.21 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.071 0.462 . . . . 10.64 110.186 175.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -118.76 116.56 26.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.892 -0.595 . . . . 7.87 110.582 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.18 132.44 49.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.363 -0.38 . . . . 6.48 110.185 177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.03 -65.77 0.98 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.064 0.459 . . . . 4.25 111.169 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.54 -91.89 0.14 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.508 -0.853 . . . . 2.74 112.355 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 33.8 m -118.61 -109.98 0.35 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.818 -0.353 . . . . 1.15 111.73 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.739 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.75 -175.27 4.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.03 0.443 . . . . 0.44 111.633 -175.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.6 p -69.93 -14.96 62.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.617 -0.719 . . . . 1.67 111.071 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.37 21.29 5.16 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.934 -0.866 . . . . 0.34 110.934 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.739 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 51.0 m-85 -136.66 153.1 51.0 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.336 0.589 . . . . 0.41 110.49 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -136.15 160.13 39.6 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.444 -0.798 . . . . 1.89 109.852 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.435 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 25.7 ptt180 -87.11 129.7 34.82 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.739 -0.837 . . . . 3.36 108.739 175.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.2 p -81.07 -170.3 2.65 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.872 -0.604 . . . . 0.7 109.541 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.29 -17.75 62.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.307 0.575 . . . . 0.73 110.723 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -113.69 14.72 18.85 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.444 -0.798 . . . . 2.45 111.531 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 69.34 24.87 75.9 Favored Glycine 0 C--O 1.235 0.187 0 C-N-CA 121.277 -0.487 . . . . 0.41 113.161 174.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -91.03 143.33 26.82 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.163 -0.68 . . . . 3.63 109.163 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.0 m -79.69 100.12 7.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.265 0.555 . . . . 0.37 110.913 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -97.72 134.31 22.53 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.269 -0.878 . . . . 2.61 110.305 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.537 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 14.2 Cg_exo -66.3 141.6 63.07 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.03 1.82 . . . . 0.42 110.205 172.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.3 p -80.08 113.49 18.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.065 0.459 . . . . 1.32 112.118 -172.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.537 ' CE2' ' HB2' ' A' ' 21' ' ' PRO . 56.5 m-85 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 108.782 -0.821 . . . . 2.92 108.782 176.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.21 0.052 . . . . 12.67 111.097 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -67.92 -55.5 12.55 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.709 0.29 . . . . 10.64 111.27 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -139.13 -78.34 0.34 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.122 -0.49 . . . . 7.87 109.704 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.87 -71.07 0.25 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.795 -0.817 . . . . 6.48 108.795 174.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.94 -4.79 53.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.677 -0.692 . . . . 4.25 109.613 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.9 93.4 1.28 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.445 -0.798 . . . . 2.74 111.405 176.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.2 m -107.72 -179.11 3.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.674 0.273 . . . . 1.15 110.853 -177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.445 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . . . -60.69 169.15 1.93 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.606 -0.725 . . . . 0.44 112.147 -177.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -69.08 -38.85 79.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.138 0.494 . . . . 1.67 110.297 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.56 -3.18 86.39 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.563 -0.615 . . . . 0.34 111.563 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 8' ' ' ALA . 10.0 m-85 -117.43 178.77 4.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.898 -0.408 . . . . 0.41 109.898 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.544 HE21 HG22 ' A' ' 22' ' ' THR . 4.0 pt20 -159.24 179.09 9.31 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.594 -0.521 . . . . 1.89 109.594 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.552 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 39.1 ptt180 -88.37 133.68 34.03 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.378 0.609 . . . . 3.36 110.61 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.6 p -81.72 -167.02 1.35 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.366 -0.834 . . . . 0.7 109.57 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.61 69.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.955 0.354 . . . . 0.73 111.955 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -105.17 6.09 32.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.374 -0.376 . . . . 2.45 111.494 -178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.552 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 83.48 41.34 8.44 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.354 -0.927 . . . . 0.41 112.779 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -99.17 178.36 4.94 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.832 -1.173 . . . . 3.63 107.832 172.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 68.1 m -103.92 123.88 47.97 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.986 0.422 . . . . 0.37 111.671 -173.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -139.8 143.72 35.92 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.771 -0.65 . . . . 2.61 109.401 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.44 147.3 22.75 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.877 2.384 . . . . 0.42 112.329 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.544 HG22 HE21 ' A' ' 12' ' ' GLN . 43.6 p -86.77 -21.13 26.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.568 0.581 . . . . 1.32 112.568 -174.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 . . . . . 0 C--O 1.245 0.852 0 O-C-N 123.851 0.719 . . . . 2.92 110.414 -176.627 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 121.021 0.439 . . . . 12.67 110.105 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -87.8 121.67 30.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.834 -0.621 . . . . 10.64 111.544 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -139.81 104.7 4.95 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.868 -0.606 . . . . 7.87 109.529 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.73 116.08 30.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.117 0.484 . . . . 6.48 110.695 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.94 -51.72 3.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.876 -0.602 . . . . 4.25 110.436 177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.489 ' HA2' ' H ' ' A' ' 13' ' ' ARG . . . 124.77 -119.0 3.5 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.676 -0.773 . . . . 2.74 112.334 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 m -125.69 -95.72 0.45 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.739 0.304 . . . . 1.15 111.033 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.759 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -92.15 -174.71 3.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.234 -0.439 . . . . 0.44 111.109 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -66.14 -25.24 66.88 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.855 0.36 . . . . 1.67 110.505 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -121.53 21.76 7.98 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.151 -0.547 . . . . 0.34 112.136 175.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.759 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 54.6 m-85 -134.71 149.88 50.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.995 0.426 . . . . 0.41 110.385 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.415 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 34.3 tt0 -131.85 154.23 49.38 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.92 -0.582 . . . . 1.89 109.437 176.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.627 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 11.2 ptm180 -87.89 147.04 25.27 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-O 121.487 0.661 . . . . 3.36 109.733 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 p -99.76 -164.53 1.13 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.705 -1.134 . . . . 0.7 109.473 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.98 -34.7 63.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.007 0.432 . . . . 0.73 111.187 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.37 -3.76 57.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.971 -0.559 . . . . 2.45 111.609 -175.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.627 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 82.21 6.42 88.8 Favored Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.105 -1.045 . . . . 0.41 110.635 -174.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -79.21 133.03 36.7 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.617 -0.512 . . . . 3.63 109.617 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -80.27 127.35 32.26 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.097 -0.502 . . . . 0.37 112.24 -171.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 63.3 mttp -123.3 142.09 37.71 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.658 -0.701 . . . . 2.61 109.165 170.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 13.0 Cg_exo -68.3 144.19 61.3 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.081 2.521 . . . . 0.42 112.011 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.2 p -95.66 110.84 22.89 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.984 -0.553 . . . . 1.32 111.163 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 . . . . . 0 C--O 1.243 0.714 0 CA-C-O 118.234 -0.889 . . . . 2.92 110.123 -179.006 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.587 ' HG3' ' H ' ' A' ' 2' ' ' ASN . 5.2 pt-20 . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 111.714 0.264 . . . . 12.67 111.714 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.587 ' H ' ' HG3' ' A' ' 1' ' ' GLU . 17.6 m120 71.56 121.73 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.2 0.6 . . . . 10.64 110.995 -175.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.481 ' CE2' ' HB2' ' A' ' 5' ' ' ALA . 59.7 t80 -88.4 130.13 35.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.838 -0.619 . . . . 7.87 110.74 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.55 95.31 3.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.998 0.428 . . . . 6.48 110.743 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.481 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . . . -93.15 116.61 29.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.069 -0.514 . . . . 4.25 111.411 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.47 -144.45 18.44 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.107 -0.568 . . . . 2.74 112.338 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' N ' ' HA ' ' A' ' 12' ' ' GLN . 1.2 m -125.1 -89.37 0.58 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.218 -0.66 . . . . 1.15 109.218 173.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.801 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -90.67 -175.34 4.38 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.886 -0.597 . . . . 0.44 109.56 172.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 m -61.01 -37.24 81.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.038 0.447 . . . . 1.67 110.965 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.78 29.03 7.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.719 -0.753 . . . . 0.34 112.078 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.801 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 27.5 m-85 -133.64 163.65 28.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.034 0.445 . . . . 0.41 110.698 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.412 ' HA ' ' N ' ' A' ' 7' ' ' CYS . 28.4 pt20 -153.32 175.88 12.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.969 -0.56 . . . . 1.89 109.881 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -88.66 139.17 30.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.256 0.551 . . . . 3.36 110.645 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.2 p -83.0 -173.37 4.67 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.203 -0.908 . . . . 0.7 108.792 172.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.76 -4.83 21.64 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.008 0.432 . . . . 0.73 110.724 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.448 ' OD2' ' HD3' ' A' ' 18' ' ' ARG . 22.2 t70 -108.4 6.81 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.872 -0.604 . . . . 2.45 110.476 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.47 4.37 84.39 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.832 -0.622 . . . . 0.41 113.051 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.448 ' HD3' ' OD2' ' A' ' 16' ' ' ASP . 36.0 mtp180 -96.49 159.54 14.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.682 0.277 . . . . 3.63 110.668 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.2 m -88.54 122.32 31.87 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.579 0.704 . . . . 0.37 112.7 -168.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -121.68 139.72 30.5 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 114.991 -1.004 . . . . 2.61 110.257 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.492 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 34.4 Cg_exo -58.27 148.22 80.18 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 122.397 2.065 . . . . 0.42 111.19 174.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.3 p -86.19 120.22 27.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.208 0.528 . . . . 1.32 111.849 -174.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.492 ' CE2' ' HB2' ' A' ' 21' ' ' PRO . 73.6 m-85 . . . . . 0 C--O 1.245 0.865 0 CA-C-N 115.302 -0.863 . . . . 2.92 109.064 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.573 0.225 . . . . 12.67 110.734 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -59.39 -47.65 84.65 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.048 0.451 . . . . 10.64 110.961 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -139.95 141.22 36.46 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.151 -0.477 . . . . 7.87 110.045 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.07 150.27 38.93 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.166 -0.47 . . . . 6.48 109.895 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.3 113.09 15.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.83 0.348 . . . . 4.25 110.887 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.827 ' HA2' ' HG2' ' A' ' 13' ' ' ARG . . . -86.01 -100.74 0.74 Allowed Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.001 -0.619 . . . . 2.74 112.021 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.96 -95.44 0.44 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.7 0.286 . . . . 1.15 110.378 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.74 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.71 -178.07 4.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.624 -0.262 . . . . 0.44 110.686 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -22.95 62.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.28 0.562 . . . . 1.67 110.801 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.73 16.74 25.87 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.235 -0.746 . . . . 0.34 111.235 175.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.74 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 64.7 m-85 -136.16 173.29 11.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.43 0.633 . . . . 0.41 110.982 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.507 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 9.8 pt20 -148.46 171.96 15.24 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.874 -0.787 . . . . 1.89 108.874 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.827 ' HG2' ' HA2' ' A' ' 6' ' ' GLY . 11.0 ptp180 -104.46 139.04 39.96 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.608 0.718 . . . . 3.36 110.408 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.0 p -79.39 -172.45 3.22 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.702 -1.135 . . . . 0.7 109.167 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.03 -31.59 67.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.131 0.491 . . . . 0.73 110.789 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.36 -14.28 20.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.126 -0.488 . . . . 2.45 111.937 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.565 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 105.52 18.3 12.08 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 119.729 -1.224 . . . . 0.41 113.364 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -80.02 141.34 36.01 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.159 -0.682 . . . . 3.63 109.159 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 64.1 m -82.02 109.68 16.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.244 0.545 . . . . 0.37 111.727 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 17.5 tptp -110.28 136.76 20.51 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.54 -0.755 . . . . 2.61 109.339 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.68 141.93 74.12 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.72 2.28 . . . . 0.42 112.34 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 p -90.98 128.4 36.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.985 0.421 . . . . 1.32 110.87 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.562 -0.733 . . . . 2.92 109.959 -178.286 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 110.193 -0.299 . . . . 12.67 110.193 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.6 t30 65.41 110.33 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.526 0.73 . . . . 10.64 111.576 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -118.61 157.74 26.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.034 -0.53 . . . . 7.87 110.609 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.73 -57.62 1.44 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.04 -0.527 . . . . 6.48 110.942 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.71 -23.97 14.15 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.11 0.411 . . . . 4.25 112.11 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.29 -158.28 22.99 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.57 -0.824 . . . . 2.74 112.036 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.4 m -113.79 -96.5 0.45 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.799 0.333 . . . . 1.15 110.255 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.778 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.73 -175.91 4.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.433 -0.348 . . . . 0.44 110.747 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -62.69 -29.06 70.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.998 -0.546 . . . . 1.67 110.714 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.41 30.27 4.77 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.671 -0.695 . . . . 0.34 111.875 175.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.778 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 37.6 m-85 -136.34 161.14 36.63 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.307 0.575 . . . . 0.41 111.0 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -143.54 163.98 31.66 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.765 -0.652 . . . . 1.89 109.945 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.2 mtm180 -89.73 127.82 36.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.139 0.495 . . . . 3.36 109.999 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.3 p -80.51 -176.52 5.76 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.386 -0.825 . . . . 0.7 109.12 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.77 47.77 0.26 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.229 0.538 . . . . 0.73 111.25 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -161.04 -35.8 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.521 -0.763 . . . . 2.45 110.828 -177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.36 -0.39 23.67 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.416 -0.897 . . . . 0.41 110.945 -171.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -78.12 133.85 37.78 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.395 -0.594 . . . . 3.63 109.395 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.1 m -86.2 126.46 34.27 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.265 -0.425 . . . . 0.37 111.223 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.535 ' HG3' ' HD2' ' A' ' 21' ' ' PRO . 36.0 ttmt -124.19 140.49 35.04 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.858 -0.61 . . . . 2.61 109.474 176.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.535 ' HD2' ' HG3' ' A' ' 20' ' ' LYS . 44.6 Cg_exo -55.12 145.11 66.43 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.047 2.498 . . . . 0.42 112.013 177.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.9 p -88.35 120.36 29.64 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.075 -0.511 . . . . 1.32 111.714 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.121 -0.942 . . . . 2.92 109.367 177.849 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.781 0.324 . . . . 12.67 110.256 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -97.93 172.96 7.31 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.267 -0.642 . . . . 10.64 109.267 171.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -144.21 150.32 37.78 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.615 -0.434 . . . . 7.87 110.909 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.97 -76.33 0.59 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.033 -0.53 . . . . 6.48 110.415 177.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.2 96.81 7.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.258 -0.428 . . . . 4.25 110.777 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.09 86.08 0.65 Allowed Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.646 -0.788 . . . . 2.74 111.809 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.9 m -79.66 176.71 9.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.928 0.394 . . . . 1.15 111.091 -178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.523 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . -60.29 169.37 1.66 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.893 -0.594 . . . . 0.44 112.367 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.12 -31.82 71.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.727 -0.669 . . . . 1.67 110.802 175.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.45 10.76 73.98 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.965 -0.636 . . . . 0.34 111.725 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.523 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 47.5 m-85 -130.83 -179.87 5.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.002 0.429 . . . . 0.41 110.057 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -157.93 171.19 20.71 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.939 -0.763 . . . . 1.89 108.939 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 7.2 ptp180 -89.07 138.24 31.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.1 0.476 . . . . 3.36 110.664 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.6 p -87.65 -167.77 2.0 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.615 -0.72 . . . . 0.7 109.394 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.15 -31.58 70.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.89 0.376 . . . . 0.73 110.874 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -107.4 19.98 19.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.889 0.852 . . . . 2.45 110.384 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 69.44 25.89 75.06 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.321 -0.854 . . . . 0.41 113.297 175.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 16.0 mmt180 -87.77 169.01 12.46 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.644 -0.873 . . . . 3.63 108.644 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 77.1 m -98.16 113.46 25.37 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.162 0.506 . . . . 0.37 111.886 -174.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -111.15 136.53 20.86 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.345 -0.843 . . . . 2.61 109.73 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.24 134.44 48.87 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.646 2.231 . . . . 0.42 112.209 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.4 p -82.15 131.54 35.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.552 -0.295 . . . . 1.32 110.871 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.585 -0.721 . . . . 2.92 110.068 -179.442 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.761 0.315 . . . . 12.67 110.806 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -58.85 -57.23 13.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.742 -0.663 . . . . 10.64 111.982 -174.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -129.49 84.76 2.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.972 0.415 . . . . 7.87 111.16 -176.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.86 102.43 15.03 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.011 -0.541 . . . . 6.48 109.945 174.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.7 142.23 34.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.213 -0.448 . . . . 4.25 111.224 -175.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.659 ' HA2' ' HG3' ' A' ' 12' ' ' GLN . . . 112.61 -124.19 6.58 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.57 -0.824 . . . . 2.74 112.37 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.0 m -138.61 -90.54 0.21 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.197 -0.297 . . . . 1.15 110.197 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.741 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.28 -177.73 4.94 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.874 -0.417 . . . . 0.44 109.874 172.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 m -61.5 -36.39 80.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.044 0.45 . . . . 1.67 110.848 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.16 25.1 14.59 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.943 -0.646 . . . . 0.34 111.798 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.741 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 43.9 m-85 -134.62 166.27 23.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.251 0.548 . . . . 0.41 110.674 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.659 ' HG3' ' HA2' ' A' ' 6' ' ' GLY . 7.5 tt0 -158.74 146.83 18.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.19 -0.671 . . . . 1.89 109.19 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 17.3 ptp180 -87.85 125.59 34.55 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.595 0.712 . . . . 3.36 109.517 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.1 p -80.63 -164.51 0.72 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 114.447 -1.251 . . . . 0.7 110.186 -177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.77 -11.88 41.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.032 0.444 . . . . 0.73 111.032 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.427 ' HB3' ' HG2' ' A' ' 18' ' ' ARG . 8.0 t70 -102.47 1.35 35.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.318 0.58 . . . . 2.45 111.078 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.46 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 74.54 13.41 81.89 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.934 -0.651 . . . . 0.41 112.045 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 13.9 mmt180 -93.11 137.61 32.3 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.015 -0.365 . . . . 3.63 110.015 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.3 m -79.45 98.07 6.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.922 -0.581 . . . . 0.37 110.494 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -98.19 139.04 20.97 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.447 -0.797 . . . . 2.61 109.122 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.32 121.5 9.72 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.42 2.08 . . . . 0.42 111.33 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 p -95.29 125.0 39.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.124 0.488 . . . . 1.32 111.072 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 C--O 1.249 1.058 0 CA-C-N 115.589 -0.732 . . . . 2.92 110.118 -177.057 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 109.695 -0.483 . . . . 12.67 109.695 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -82.06 144.06 31.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.321 -0.4 . . . . 10.64 110.01 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -104.49 -180.0 4.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.343 -0.389 . . . . 7.87 110.904 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -125.19 157.31 36.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.153 -0.476 . . . . 6.48 110.57 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.48 160.09 14.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 4.25 111.198 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -114.67 -22.72 4.96 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.64 -0.791 . . . . 2.74 112.806 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 32.0 m -122.94 -95.73 0.47 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.621 -0.34 . . . . 1.15 110.897 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.764 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -91.89 -176.68 4.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.5 -0.318 . . . . 0.44 110.342 177.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 p -71.93 -7.36 48.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.14 0.495 . . . . 1.67 111.029 177.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -136.94 22.31 3.29 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.753 -0.939 . . . . 0.34 110.753 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.764 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 18.2 m-85 -134.27 155.92 49.35 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.984 -0.376 . . . . 0.41 109.984 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -144.77 155.46 43.54 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.55 -0.537 . . . . 1.89 109.55 -176.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.633 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 99.5 mtt180 -88.67 120.34 29.97 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.466 0.651 . . . . 3.36 109.655 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.462 HG21 ' HD2' ' A' ' 20' ' ' LYS . 58.9 p -80.43 -163.3 0.55 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.493 -1.231 . . . . 0.7 110.606 -177.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.81 -27.48 59.97 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.896 0.332 . . . . 0.73 111.896 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.17 1.59 45.07 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.601 -0.272 . . . . 2.45 111.469 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.633 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 79.89 12.64 83.23 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.186 -1.007 . . . . 0.41 111.526 -175.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -84.87 142.77 29.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.546 -0.327 . . . . 3.63 110.5 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.1 m -82.89 104.01 12.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.186 -0.461 . . . . 0.37 111.573 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.462 ' HD2' HG21 ' A' ' 14' ' ' THR . 87.4 mttt -108.24 146.1 32.87 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.021 -0.536 . . . . 2.61 109.837 172.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 4.9 Cg_exo -72.93 129.14 13.93 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.38 2.054 . . . . 0.42 112.206 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 p -91.34 -20.81 21.46 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.095 -0.502 . . . . 1.32 110.502 176.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 . . . . . 0 C--O 1.251 1.134 0 CA-C-N 114.953 -1.021 . . . . 2.92 110.282 179.226 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.67 0.272 . . . . 12.67 111.313 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -77.33 151.14 35.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.777 -0.192 . . . . 10.64 110.488 -177.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -104.58 136.63 43.76 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.296 -0.261 . . . . 7.87 110.296 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -101.94 -35.3 9.04 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.696 -0.483 . . . . 6.48 109.696 175.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -160.26 173.5 15.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.447 -0.797 . . . . 4.25 109.647 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 12' ' ' GLN . . . -88.23 -92.85 1.04 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.821 -0.704 . . . . 2.74 111.784 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -128.21 -88.09 0.55 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.724 -0.473 . . . . 1.15 109.724 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.758 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -92.02 -177.07 4.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.122 -0.49 . . . . 0.44 110.147 173.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -65.31 -25.7 67.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.113 0.482 . . . . 1.67 110.386 174.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.08 24.92 8.58 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.078 -0.582 . . . . 0.34 111.756 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.758 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 39.7 m-85 -141.21 160.26 40.49 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.045 0.45 . . . . 0.41 110.913 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.572 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 3.9 pt20 -144.67 171.64 14.11 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.86 -0.609 . . . . 1.89 109.815 177.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.405 ' HE ' ' HA2' ' A' ' 17' ' ' GLY . 48.2 mtp180 -89.08 142.17 27.87 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 121.252 0.549 . . . . 3.36 110.687 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.1 p -90.08 -175.78 4.67 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.616 -0.883 . . . . 0.7 108.616 171.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.35 -14.99 31.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.004 0.43 . . . . 0.73 110.911 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -107.97 10.54 28.35 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.028 -0.533 . . . . 2.45 111.246 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.405 ' HA2' ' HE ' ' A' ' 13' ' ' ARG . . . 74.49 5.76 74.07 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.038 -0.601 . . . . 0.41 113.206 176.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -80.05 150.92 30.17 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.524 -0.547 . . . . 3.63 109.524 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.2 m -86.17 110.22 19.43 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.478 0.656 . . . . 0.37 111.09 -174.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 46.9 tttp -101.5 136.89 19.52 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.075 -0.966 . . . . 2.61 109.37 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 24.4 Cg_exo -62.76 140.08 78.43 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.292 1.995 . . . . 0.42 111.995 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.6 p -88.48 -5.53 58.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.7 0.286 . . . . 1.32 110.875 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.061 -0.971 . . . . 2.92 111.418 176.251 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 109.591 -0.522 . . . . 12.67 109.591 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 72.41 -55.98 0.66 Allowed 'General case' 0 N--CA 1.475 0.803 0 O-C-N 123.727 0.642 . . . . 10.64 109.869 -173.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 5' ' ' ALA . 24.8 t80 -80.54 119.09 22.74 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.239 -0.652 . . . . 7.87 109.239 173.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.73 93.98 8.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.096 0.474 . . . . 6.48 111.203 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.472 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . . . -116.62 12.36 14.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.874 -0.603 . . . . 4.25 110.878 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.41 -92.27 1.01 Allowed Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.658 -0.782 . . . . 2.74 112.643 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.4 m -119.58 176.42 5.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.698 0.285 . . . . 1.15 111.289 -175.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.5 166.86 3.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.936 -0.574 . . . . 0.44 112.192 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.7 m -66.27 -36.96 84.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.954 -0.566 . . . . 1.67 110.861 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.03 6.04 84.06 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.128 -0.558 . . . . 0.34 111.872 176.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -123.83 -179.44 4.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.008 -0.738 . . . . 0.41 109.008 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -161.26 170.35 20.4 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.916 -0.402 . . . . 1.89 109.916 173.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 76.1 mtm180 -88.43 123.7 33.23 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.224 0.535 . . . . 3.36 109.702 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.437 ' C ' ' H ' ' A' ' 16' ' ' ASP . 70.7 p -80.88 -167.7 1.5 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.116 -0.947 . . . . 0.7 110.614 -177.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.69 41.37 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.009 0.433 . . . . 0.73 111.651 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.476 ' OD2' ' HG3' ' A' ' 18' ' ' ARG . 19.4 t70 -160.55 -31.75 0.06 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.708 -0.678 . . . . 2.45 109.662 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.33 -0.64 20.66 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.576 -0.821 . . . . 0.41 112.004 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.476 ' HG3' ' OD2' ' A' ' 16' ' ' ASP . 74.4 mtp180 -79.16 164.36 24.29 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.058 -0.349 . . . . 3.63 110.058 178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.3 m -104.7 110.83 23.32 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.861 -0.609 . . . . 0.37 111.465 -172.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 30.4 mtpp -121.66 146.69 46.2 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.861 -0.609 . . . . 2.61 109.958 174.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 23.5 Cg_exo -63.49 148.26 92.66 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.909 2.406 . . . . 0.42 111.97 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.3 p -90.92 -6.27 54.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.956 -0.565 . . . . 1.32 110.756 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 . . . . . 0 C--O 1.251 1.152 0 CA-C-N 114.993 -1.003 . . . . 2.92 111.132 178.241 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.705 0.288 . . . . 12.67 111.198 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -72.11 150.23 44.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.277 0.56 . . . . 10.64 112.014 -173.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -97.37 115.07 27.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.692 -0.685 . . . . 7.87 109.721 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.79 120.33 37.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.824 0.345 . . . . 6.48 111.399 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.32 156.34 19.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.713 -0.676 . . . . 4.25 109.765 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.43 -71.61 0.32 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.506 -0.854 . . . . 2.74 111.886 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 86.6 m -125.78 165.26 18.97 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.765 -0.457 . . . . 1.15 109.765 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.689 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . . . -63.74 172.42 2.2 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.886 0.698 . . . . 0.44 112.886 -173.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -65.1 -33.97 77.29 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.545 -0.752 . . . . 1.67 111.05 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.34 6.65 80.86 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.936 -0.649 . . . . 0.34 111.552 176.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.689 ' CD1' ' HB3' ' A' ' 8' ' ' ALA . 30.9 m-85 -123.09 178.18 5.2 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.653 -0.499 . . . . 0.41 109.653 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -161.1 170.92 19.5 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.094 -0.706 . . . . 1.89 109.094 171.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.578 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 3.3 ptp180 -88.5 137.63 32.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.303 0.573 . . . . 3.36 110.922 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 18' ' ' ARG . 48.3 p -86.54 -165.32 1.24 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.031 -0.986 . . . . 0.7 109.845 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.01 -18.62 65.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.644 0.259 . . . . 0.73 111.406 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -109.54 -6.6 15.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.614 0.721 . . . . 2.45 110.594 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 91.24 20.1 39.82 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.168 -1.015 . . . . 0.41 111.92 -177.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 18' ' ' ARG . 1.8 mmp_? -79.23 155.69 28.47 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.88 -0.785 . . . . 3.63 108.88 175.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -91.04 99.95 12.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.494 0.664 . . . . 0.37 111.708 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -96.92 127.95 37.25 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.01 -0.995 . . . . 2.61 109.71 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -60.92 147.19 96.25 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.653 2.235 . . . . 0.42 111.75 176.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.2 p -96.76 -5.12 39.29 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.205 -0.452 . . . . 1.32 110.865 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 . . . . . 0 C--O 1.249 1.059 0 CA-C-N 115.352 -0.84 . . . . 2.92 110.949 178.339 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 111.495 0.183 . . . . 12.67 111.495 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -89.33 -18.52 26.77 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.947 0.403 . . . . 10.64 111.336 -175.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -97.53 106.67 19.03 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.163 -0.471 . . . . 7.87 109.864 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.6 110.12 19.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.133 -0.485 . . . . 6.48 110.016 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.64 81.0 7.85 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.153 -0.476 . . . . 4.25 110.518 -177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' HA3' ' N ' ' A' ' 13' ' ' ARG . . . -141.92 -81.88 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.444 -0.884 . . . . 2.74 113.033 -176.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.4 t -114.35 -101.24 0.42 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.746 -0.381 . . . . 1.15 111.149 -174.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.647 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -92.41 173.69 7.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.164 -0.471 . . . . 0.44 111.511 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 m -75.67 76.1 2.66 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.342 -0.984 . . . . 1.67 108.342 168.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.87 -16.95 1.78 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 114.798 -1.092 . . . . 0.34 110.885 -171.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.647 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 82.2 m-85 -120.12 170.45 9.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.409 0.623 . . . . 0.41 110.019 174.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 29.6 pt20 -144.38 174.89 10.52 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.523 -0.762 . . . . 1.89 109.297 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 13' ' ' ARG . 11.4 ptp180 -89.54 143.12 27.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.99 0.424 . . . . 3.36 110.997 -175.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 18' ' ' ARG . 58.2 p -90.8 -171.65 3.1 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.731 -0.84 . . . . 0.7 108.731 171.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.48 -16.36 60.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.921 0.391 . . . . 0.73 111.147 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -109.83 -23.29 11.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.019 -0.537 . . . . 2.45 111.282 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 114.2 15.79 8.17 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.138 -1.029 . . . . 0.41 112.892 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.446 ' O ' HG23 ' A' ' 14' ' ' THR . 33.6 ttm180 -78.57 155.87 29.45 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.982 -0.747 . . . . 3.63 108.982 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.4 m -86.52 107.96 18.34 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.472 0.653 . . . . 0.37 111.184 -175.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 12' ' ' GLN . 38.3 ttpt -107.1 130.65 22.55 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.565 -0.743 . . . . 2.61 109.559 174.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 23' ' ' PHE . 32.5 Cg_exo -57.25 148.8 68.24 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.112 1.875 . . . . 0.42 111.5 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.1 p -84.83 98.55 10.36 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.001 -0.545 . . . . 1.32 112.224 -174.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 21' ' ' PRO . 51.6 m-85 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.268 -0.872 . . . . 2.92 109.934 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.611 0.243 . . . . 12.67 111.217 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -65.4 -60.87 2.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.763 0.316 . . . . 10.64 110.975 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -107.39 95.88 6.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.907 0.384 . . . . 7.87 110.264 -178.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.9 15.25 14.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.023 0.44 . . . . 6.48 111.21 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -97.23 105.39 17.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.054 -0.521 . . . . 4.25 110.966 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.14 -126.57 8.02 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.668 -0.777 . . . . 2.74 112.301 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 84.4 m -128.1 172.22 11.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.692 0.246 . . . . 1.15 110.385 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.608 ' HB3' ' HD1' ' A' ' 11' ' ' TYR . . . -61.91 168.41 3.16 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.992 -0.549 . . . . 0.44 111.634 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -73.87 -27.23 60.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.268 0.556 . . . . 1.67 110.957 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -80.35 6.8 59.42 Favored Glycine 0 CA--C 1.509 -0.286 0 N-CA-C 110.874 -0.891 . . . . 0.34 110.874 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.608 ' HD1' ' HB3' ' A' ' 8' ' ' ALA . 95.4 m-85 -138.57 -173.49 3.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.947 -1.131 . . . . 0.41 107.947 178.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -162.22 178.77 8.44 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.05 -0.722 . . . . 1.89 109.05 170.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.439 ' HB2' ' HA2' ' A' ' 17' ' ' GLY . 9.3 ptp85 -88.0 134.16 33.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.431 0.634 . . . . 3.36 110.5 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.9 p -80.82 -166.15 1.05 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.446 -0.797 . . . . 0.7 109.614 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.16 -35.95 80.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.794 0.331 . . . . 0.73 111.08 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -101.85 0.06 34.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.2 0.524 . . . . 2.45 111.147 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.439 ' HA2' ' HB2' ' A' ' 13' ' ' ARG . . . 93.88 26.86 13.61 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.575 -0.821 . . . . 0.41 113.675 174.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -88.62 171.69 9.84 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.24 -0.652 . . . . 3.63 109.24 174.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.1 m -97.1 107.03 19.47 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.014 0.376 . . . . 0.37 112.014 -174.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -105.2 130.33 23.27 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 109.491 -0.559 . . . . 2.61 109.491 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -61.05 138.37 77.92 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.559 2.173 . . . . 0.42 112.144 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 p -86.92 128.91 35.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.241 -0.436 . . . . 1.32 110.947 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.604 -0.712 . . . . 2.92 110.166 -179.207 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.722 0.296 . . . . 12.67 111.493 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -105.01 10.64 34.03 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.068 0.766 . . . . 10.64 113.068 -166.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -77.77 123.45 26.72 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.427 -0.509 . . . . 7.87 109.952 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.72 134.96 37.04 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.979 -0.555 . . . . 6.48 111.393 -175.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.93 172.36 7.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.838 -0.619 . . . . 4.25 110.477 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 12' ' ' GLN . . . -86.36 -161.87 36.19 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.155 -0.545 . . . . 2.74 112.243 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 m -120.05 -87.01 0.64 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.948 0.404 . . . . 1.15 110.344 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.791 ' H ' ' HB2' ' A' ' 11' ' ' TYR . . . -92.51 -176.61 4.35 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.248 -0.433 . . . . 0.44 110.222 175.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.8 t -64.34 -19.1 65.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.513 0.197 . . . . 1.67 111.355 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.74 11.43 7.89 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.721 -0.752 . . . . 0.34 112.052 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.791 ' HB2' ' H ' ' A' ' 8' ' ' ALA . 23.7 m-85 -126.27 160.45 30.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.027 -0.36 . . . . 0.41 110.027 -176.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.509 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 53.6 tt0 -147.24 159.64 43.41 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.545 -0.539 . . . . 1.89 109.545 -178.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.537 ' HB3' ' HA2' ' A' ' 17' ' ' GLY . 11.8 mtp180 -87.62 116.17 25.56 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.478 -0.934 . . . . 3.36 108.478 174.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.0 p -79.87 -162.52 0.44 Allowed 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.756 -1.111 . . . . 0.7 110.424 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.03 -10.88 33.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.851 0.357 . . . . 0.73 110.712 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -107.88 2.25 23.31 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 116.454 -0.339 . . . . 2.45 111.891 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.537 ' HA2' ' HB3' ' A' ' 13' ' ' ARG . . . 68.38 11.93 62.73 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.033 -1.079 . . . . 0.41 111.031 -172.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -82.3 134.23 35.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.383 -0.599 . . . . 3.63 109.383 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.7 m -79.28 93.08 5.22 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.272 0.558 . . . . 0.37 110.652 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -99.52 140.24 21.47 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.491 -0.777 . . . . 2.61 109.844 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -66.26 126.12 15.16 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.011 1.807 . . . . 0.42 110.757 171.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.2 p -83.98 126.57 33.16 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.021 0.438 . . . . 1.32 111.177 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.24 -0.886 . . . . 2.92 109.743 179.173 . . . . . . . . 0 0 . 1 stop_ save_